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ABSTRACT 
Women with gestational diabetes mellitus (GDM) have increased weight and higher glucose levels 
during pregnancy and in the postpartum period compared to women without GDM. It is therefore 
recommended to prevent excess gestational weight gain (GWG) and also return to pre-pregnancy 
weight at 1-year postpartum. This is essential as higher postpartum weight retention (PPWR) at 1-
year postpartum is a significant risk factor for long-term weight gain and the most important 
predictor of future diabetes in women with GDM. To tackle weight and subsequent metabolic 
health problems such as weight and glucose control in these women, there is a need to comprehend 
their risk and to investigate different lifestyle approaches. This thesis provides a better 
understanding of the novel concept of intuitive eating during and after pregnancy and its 
associations with metabolic health. It also investigates the predictors and consequences of PPWR 
in a cohort of women with GDM.  
This thesis utilized data from the Lausanne University Hospital (CHUV) GDM longitudinal cohort. 
We assessed the cross-sectional and longitudinal associations between intuitive eating and 
metabolic health outcomes during pregnancy and in the postpartum period in women with GDM. 
We also investigated the predictors and consequences of weight retention in this cohort.   
The cross-sectional analysis showed that intuitive eating during and after pregnancy was 
significantly associated with metabolic health outcomes, both with weight and with glucose 
control. The longitudinal analyses revealed that intuitive eating during pregnancy was also related 
to later metabolic health outcomes, at the end of pregnancy, but also in the early (6-8 weeks) and 
late (1-year) postpartum period. Regarding the predictors and consequences of PPWR, GWG 
predicted higher PPWR, both in the early and late postpartum period. Women with PPWR had 
worsened glucose control at 1 year postpartum that was not observed in the early postpartum 
period.  
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These results suggest that intuitive eating could represent a novel approach to weight and glucose 
management in women with GDM. Our data regarding the consequences of PPWR also suggest 
that clinical care with a strong focus  on lifestyle interventions in order to improve weight and 
glucose control should be essential up to the late postpartum.   
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RÈSUME 
Les femmes avec un diabète gestationnel (DG) ont un poids plus élevé ainsi qu’un contrôle 
glycémique moins favorable que les femmes sans DG durant leur grossesse ainsi qu’en post-
partum. Les recommandations visent donc à prévenir une prise de poids excessive durant la 
grossesse ainsi que de revenir au poids d’avant la grossesse dans l’année qui suit l’accouchement. 
En effet, ne pas avoir perdu le poids pris durant la grossesse à un an post-partum est un facteur de 
risque significatif pour une évolution pondérale défavorable sur le long terme que pour le risque 
de DMII indépendamment du poids et de l’IMC avant grossesse. Aborder l’évolution du poids ainsi 
que les paramètres métaboliques chez ces femmes par de nouvelles approches impliquant le style 
de vie serait dès lors pertinent. Cette thèse a pour but d’apporter un nouvel éclairage sur 
l’association entre l’alimentation intuitive durant et après la grossesse et les paramètres 
métaboliques chez des femmes avec un diabète gestationnel. Elle recherche également les 
prédicteurs ainsi que les conséquences de la rétention de poids en post-partum chez les femmes 
avec un DG. 
Les données utilisées pour évaluer les associations transversales et longitudinales entre 
l’alimentation intuitive et les paramètres métaboliques durant la grossesse mais également en post-
partum sont issues d’une cohorte longitudinale de femmes suivies au Centre Hospitalier 
Universitaire Vaudois pour leur DG.  Des analyses sur les conséquences d’une rétention pondérale 
ainsi que ses prédicteurs ont aussi été réalisées. Les analyses transversales ont démontré une 
association significative entre l’alimentation intuitive et la santé métabolique durant la grossesse 
ainsi qu’en post-partum. Les analyses longitudinales ont révélé une association entre l’alimentation 
intuitive et l’amélioration des paramètres métaboliques aussi bien à la fin de la grossesse, à 6-8 
semaines post-partum ainsi qu’à 1 an post-partum. La prise de poids durant la grossesse était un 
prédicteur pour la rétention de poids après grossesse aussi bien à 6-8 semaines qu’à un an post-
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partum et ses conséquences étaient des issues métaboliques défavorables à 1 an, mais pas à 6-8 
semaines post-partum. 
Ces résultats suggèrent que pratiquer une alimentation intuitive pourrait être une nouvelle approche 
dans la gestion le poids ainsi que l’équilibre métabolique chez des femmes avec un diabète 
gestationnel. Ces données sur la rétention de poids et la santé métabolique laissent penser qu’un 
accompagnement, au-delà des recommandations, pourrait être nécessaire chez ces femmes avec un 
antécédent de DG afin d’améliorer plus spécifiquement leur contrôle glycémique ainsi que 
pondéral. 
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1.0 GENERAL INTRODUCTION 
1.1 Background 
The main interest of this thesis lies in the field of gestational diabetes mellitus (GDM) and 
metabolic health outcomes during and after pregnancy. Most importantly, the relationship between 
nutrition and eating behavior (intuitive eating) with weight and higher glucose levels during and 
after pregnancy in women diagnosed with GDM. This introductory chapter summarizes the 
different thesis themes. These themes are GDM and metabolic outcomes during and after 
pregnancy, the potential novel role of intuitive eating (IE) in the management of GDM and the 
predictors and consequences of postpartum weight retention (PPWR) in the early and late 
postpartum period in women with GDM.  
1.2 Gestational diabetes mellitus (GDM) 
GDM is defined as any degree of glucose intolerance or hyper-glycaemia with onset or first 
recognition during pregnancy that does not fulfil the criteria of overt diabetes prior to gestation (1).  
It is usually diagnosed in the second or third trimester of pregnancy. GDM develops when beta 
cells fail to keep pace with the increase in insulin resistance that is observed around 20-24 weeks 
of gestation. This then causes an imbalance between demand and supply of insulin production and 
action and raises glucose levels, especially during the second and third trimester (2). GDM is one 
of the most common pregnancy complications. Between 3-20% of pregnant women develop GDM 
globally (3) and about 11% of all pregnancies in Switzerland are complicated by GDM (4). 
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Fig 1: Median (interquartile range) prevalence (%) of GDM by WHO region 2005–2015 (5) 
 
 
Fig 2: Country-specific prevalence of GDM according to different diagnostic criteria.  
C&C: Carpenter and Coustan criteria, IADPSG: International Association of Diabetes and Pregnancy Study 
Groups, NDDG: National Diabetes Data Group, WHO: World Health Organization, other included 
International Classification of Diseases codes and local guidelines or criteria (5).  
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1.3 Detection and diagnosis  
Pregnant women with increased risk of GDM are recommended to undergo testing during the first 
prenatal visit (1). If results are negative during the initial screening, there is the need for another 
screening test between 24 and 28 weeks of pregnancy. Women with an average risk are however 
recommended to be screened at 24–28 weeks.  
During pregnancy, screening for abnormal glucose level is generally recommended as a routine 
component of prenatal care (1,6,7). This is because an abnormal glucose levels in pregnancy are 
associated with both short and long-term maternal and fetal risks. Several health 
organizations/countries have different and diverse recommendations for screening, diagnosis, 
management, and follow-up of GDM (8). Most of these proposals or recommendations for GDM 
are contentious because some of them were developed from unscientific studies, based on expert-
opinion, catered to preserve resources and subjectively modified for convenience. Because of the 
diverse recommendations, the approach to GDM can be extremely different from one country to 
another (8). This lack of consensus creates problems in addressing prevalence, complications, 
efficacy of treatment and follow-up of GDM.  
The American diabetes association (ADA) and the International Association of Diabetes and 
Pregnancy Study Groups (IADPSG) recommendations are widely used and accepted (1,9). These 
recommendations are based on the results from the Hyperglycemia and Adverse Pregnancy 
Outcome (HAPO) study. The HAPO study is a large-scale multinational cohort study of more than 
23,000 pregnant women, which showed that the risk of adverse maternal and neonatal outcomes 
continuously increased as a function of maternal glycaemia during the oral glucose tolerance test 
(oGTT) at 24–28 weeks of gestation (9). The ADA recommendation for GDM diagnosis consists 
of two strategies; the “one step” and the “two step” approaches.  
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The “one-step” approach is derived from the IADPSG criteria, which is based on a 75g oGTT with 
plasma glucose measurement at 1and 2h after an 8-hour overnight fasting. The “two-step” approach 
consist of, 1) performing a 50g glucose load test (non-fasting) with plasma glucose measurement 
at 1hour. If the plasma glucose level is ≥ 7.2, 7.5 or 7.8 mmol/L respectively then a 100g oGTT is 
followed. 2) A 100g oGTT is performed when the patient is fasting. 
Although differences exist in the management of GDM according to the ADA and the IADPSG 
guidelines, the screening guidelines somewhat remains the same except the two-step approach 
recommended by the ADA (10). Both guidelines recommend screening between 24 and 28 weeks. 
When a patient exceeds one or more threshold values, the diagnosis of GDM can be made. The 
threshold values for the ADA (“one step” approach) and IADPSG are; fasting glucose ≥5.1 mmol/l, 
1h ≥10.0 mmol/l and 2h ≥8.5 mmol/l. The threshold for the ADA “two-step” approach are fasting 
glucose ≥5.3 mmol/l, 1h ≥10.0 mmol/l, 2h ≥8.6 mmol/l and 3h ≥7.8 mmol/l. Recommendation with 
relatively low cut-off points leads to a relatively high incidence rate of GDM, including many 
women with mild hyperglycemia and vice versa (8).   
 
Table 1 Diagnosis of GDM with an HGPO of 75 g of glucose between 24-28 weeks of amenorrhea 
(plasma venous blood sugar) 
Glucose mmol/l 
Fasting ≥ 5.1 
1-h ≥ 10.0 
2-h ≥8.5 
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Table 2 Comparison of some diagnostic criteria of GDM 
Organization 
Glucose 
Load, 
Grams 
Glucose Thresholds 
(mmol/L) 
Number 
of OGTT 
Values for 
Diagnosis 
≥ 
Fasting 1-h 2-h 3-h 
NDDG (ACOG) 100 5.8 10.5 9.2 8.0 2 
C&C(ACOG) 100 5.3 10.0 8.6 7.8 2 
IADPSG/ADA/WHO/ADIPS/FIGO/BSD 75 5.1 10.0 8.5 - 1 
CDA 75 5.3 10.6 9.0 - 1 
NICE 75 5.6 - 7.8 - 1 
DIPSI 75 - - 7.8  - 
ACOG: American College of Obstetrics and Gynecology. ADA: American Diabetes Organization. ADIPS: 
Australian Diabetes in Pregnancy Society. BSD: Brazilian Society of Diabetes. CDA: Canadian Diabetes 
Association. C&C: Carpenter and Coustan. DIPSI: Diabetes in Pregnancy Study group in India. FIGO: The 
International Federation of Gynecology and Obstetrics. FPG: Fasting plasma glucose. IADPSG: The 
International Association of Diabetes and Pregnancy Study Groups. NDDG: National Diabetes Data Group. 
NICE: National Institute for Health and Care Excellence. WHO: World Health Organization. 
 
1.4 GDM risk factors and adverse outcomes  
The adverse maternal consequences of GDM are well documented (10). A meta-analysis of 
observational studies (11,12) showed that higher pre-pregnancy body mass index (BMI), excess 
gestational weight gain (GWG), pregnancy-induced hypertension, family history of diabetes, 
polycystic ovary syndrome and multi-parity are significant risk factors of GDM (13). According to 
the ADA, individual who have a first-degree relative with diabetes, high-risk race/ethnicity (e.g., 
African American, Latino, Native American, Asian American, Pacific Islander), history of 
cardiovascular disease, hypertension, high-density lipoprotein, cholesterol level <35 mg/dl and/or 
a triglyceride level >250 mg/dl and physical inactivity are at a higher risk for GDM and diabetes 
in general (7).   
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Other non-classical risk factors in pregnancy include excessive GWG, hypothyroidism, life events 
such as psychological stress, depression and other clinical conditions associated with insulin 
resistance (14). It has also been shown that women with preexisting β-cell dysfunction have 
reduced ability to increase insulin secretion to compensate for the decreasing insulin sensitivity as 
pregnancy progresses leading to an impaired glucose tolerance and the development of GDM.  
GDM of any severity increases the risk of fetal and maternal complications both during and after 
pregnancy (15). Generally, adverse outcomes that are increased in the offspring of women with 
GDM include spontaneous abortion, fetal anomalies, preeclampsia, fetal demise, macrosomia, 
shoulder dystocia, neonatal hypoglycemia, hyperbilirubinemia, neonatal respiratory distress 
syndrome and preeclampsia among several others. In addition, GDM may increase the risk of 
obesity, hypertension and future diabetes in the offspring later in life (6,9,16,17). GDM is 
associated with an increased frequency of maternal hypertensive disorders and the need for 
cesarean delivery. Higher glycemic values lead to increased fetal glucose uptake which in turn 
stimulates fetal insulin secretion (18). This increases fetal adiposity and neonatal hypoglycemia 
once the neonate leaves the hyperglycemic maternal environment but its hyperinsulinemia still 
continues.  
In the postpartum period, women with GDM have a higher risk of prediabetes and of future 
diabetes. Around 48% of women with GDM  develop  prediabetes and between 20%–60% of them 
develop diabetes in the postpartum period (2). The conversion of GDM to prediabetes and 
subsequent development of diabetes continues to be on the rise making GDM one of the important 
risk factor for  diabetes (19). GDM also leads to longer-term risk of metabolic syndrome and 
cardiovascular morbidity and mortality (15,18,20–23).  
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A recent systematic review and meta-analysis including 9 studies in more than 5 million women 
found that GDM was associated with a 56% higher risk of future cardiovascular events and 
conferred a 2.3-fold increased risk of cardiovascular events within the first decade after pregnancy 
(24). This risk remained increased even in the absence of the development of diabetes (24).  
 
Fig 3: Risk factors and adverse outcomes of gestational diabetes (25).  
The figure above however focuses more on insulin resistance and has little information on the reduction in 
insulin secretion in women with GDM. It does not also capture all the risk factors associated with GDM 
(indicated above) which include for example polycystic ovarian syndrome, history of cardiovascular disease 
including hypertension and physical inactivity as well as non-classical risk factors including excessive 
gestational weight gain, life events and depression.  
GDM: gestational diabetes mellitus; IR: insulin resistance; IS: Insulin secretion; T2DM: type 2 diabetes 
mellitus; CVD: cardiovascular diseases; FHx: family history; BGL: blood glucose level 
 
 
 
 
 
 
 
 
 8 
 
1.5 GDM and postpartum weight retention  
Postpartum weight retention (PPWR) is defined as the difference between pre-pregnancy weight 
and weight at the 1-year postpartum period (26). PPWR is frequent (27) and represents a huge 
public health concern because of its contribution to the increase in non-communicable  diseases  
and associated morbidities (28,29). Specifically, although women are advised to return to their pre-
pregnancy weight after delivery, a significant proportion of  pregnant women are unable to meet 
this recommendation (30,31). At 6-8 weeks postpartum for example, women with or without GDM 
retain an average of 3–7kg of GWG and at least two-thirds of women will still be above their pre-
pregnancy weight even at 1-year postpartum (29,31). In the long term, PPWR leads to an upwards 
weight trajectory for women following childbirth and may lead to the development of several 
metabolic outcomes (32–34). It has been shown that modest PPWR increases the risk of obesity 
and higher PPWR leads to an increased risk of permanent obesity 5-10years after birth, risk of 
diabetes and other cardiovascular diseases (35). In women with GDM (36), PPWR is associated 
with a higher risk of overweight/obesity (37), of prediabetes (38), of recurrent GDM (39) and of 
future diabetes (40,41). According to a study, PPWR of 4.5kg during a 7.5year follow-up was 
independently associated with a two-fold increase in the risk of future diabetes in women with 
GDM (42). In a 23 years follow-up, 42% of women with PPWR developed diabetes while the 
incidence of diabetes was almost half in the women without PPWR (43).   
 
 
 9 
 
 
Fig 4: Long and short-term metabolic consequences of (excess) gestational weight gain (GWG) and 
postpartum weight retention in reproductive age women. (44). 
BMI: body mass index; GDM: gestational diabetes mellitus 
 
1.6 Predictors of PPWR  
Knowledge of the factors associated with PPWR can help to focus efforts and target optimal timing 
for interventions to reduce the long-term complications of PPWR in women with GDM. In the 
general population, the most important predictors of PPWR are higher pre-pregnancy BMI and 
excessive GWG (45,46). Other studies have also associated high fat and high energy-dense diets, 
physical inactivity, age, single women (47–49) and minority ethnic groups with PPWR (50).  
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A study reported that excess GWG, physical inactivity and increased amount of  food intake in the 
postpartum period have increases the risk of PPWR (49). A systematic review also indicated that 
women aged below 20 or over 40 years at delivery, single women and women with lower income 
have a higher risk for PPWR (49). Other studies have shown that eating behavior (increase in 
intuitive eating habits), exclusive breastfeeding and lack of depression during and after pregnancy 
are protective factors for PPWR (51–53). It has been show that exclusive breastfeeding over 6 
months and up to 24 months is protective of diabetes in women with GDM (54). In non-GDM 
populations many studies support excess GWG as a strong and pronounced predictor of PPWR at 
6 weeks (55) and up to 12 months postpartum (56–59). Other studies suggest that exceeding the 
institute of medicine (IOM) guidelines according to pre-pregnancy BMI increases the risk of 
PPWR at 6 to 18 months (60–62). In 2009, the IOM published a revision of GWG guidelines that 
are based on pre-pregnancy BMI. These GWG recommendations were 12.5–18kg for underweight 
(<18.5kg/m2), 11.5–16kg for normal weight (18.5–24.9kg/m2), 7–11kg for overweight (25.0–
29.9kg/m2) and 7kg for obese women (≥30kg/m2). These recommendations were supported by the 
WHO and were independent of age, parity, smoking history, race and ethnic background (63). 
However, studies in non-GDM populations only investigated excessive GWG without including 
total or absolute GWG. No study has investigated the effect of both exceeding IOM guidelines 
(=excessive GWG) and total GWG on PPWR and in the current population these guidelines may 
not be appropriate (anymore). In women with GDM, only one small study (n=75) has investigated 
the predictors of weight loss or lack of PPWR in women with GDM but it exclusively focused on 
the early postpartum period (6 weeks postpartum) (31). In that study, less GWG and no insulin use 
during pregnancy predicted a loss of at least 75% of GWG.  
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It is however not clear if those are also predictors of the recommended “complete” lack of PPWR 
(i.e. no weight increase at all when compared to the pre-pregnancy weight) and it is also not clear 
from a pathophysiological point of view why the authors chose a loss of at least 75% and not the 
recommended lack of PPWR.  
1.7 Interventions to manage GDM 
The goal of GDM management is to promote glucose control and improve pregnancy outcomes 
(2). As part of the recommendation for the management of GDM, all women with GDM are to 
receive nutritional and physical activity counseling. This is to help improve and stabilize glycemic 
targets. If nutritional and physical activity counselling are not sufficient to improve glycemic 
targets, other approaches such as medical nutrition therapy (MNT), insulin therapy or oral anti-
diabetic pharmacological therapies including metformin are adopted (6,64).  
Regarding the use of MNT, provision for adequate calories and nutrients to meet the needs of 
pregnancy are made to be consistent with established maternal blood glucose goals. Non-caloric 
sweeteners are to be used in moderation and for obese women, a 30–33% calorie restriction (to 25 
kcal/kg actual weight per day) has been shown to reduce hyperglycemia (65,66). The ADA medical 
nutrition therapy recommendations for women with GDM include developing an individualized 
nutrition plan based on a minimum of 175g of carbohydrate, a minimum of 71g of protein, 28g of 
fiber and to have a diet low in saturated fat (6). The Endocrine society recommends 35-45% of 
carbohydrates, 3 small-to-moderate-sized meals, 2 to 4 snacks for non-obese women and restricting 
one-third of 1600-1800kcal/d calorie intake for obese women (67). The objectives of these 
guidelines are to provide optimal calorie intake needed to promote fetal/neonatal and maternal 
health while achieving glycemic goals and promoting optimal GWG.  
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A recent Cochrane review suggested that although dietary advice is the main strategy for managing 
GDM, it however remains unclear what type of advice is best and hence more evidence on the type 
of nutritional advice is needed (68). Studies show that a restriction of carbohydrates to 35–40% of 
calories decreases maternal glucose levels and improves maternal and fetal outcomes (69).  
Regular physical activity during pregnancy in general improves or maintains physical fitness, 
promotes weight and glucose control and enhances psychological well-being. Although there are 
no specific or detailed physical activity guidelines for women with GDM, it is recommended to 
engage in both aerobic (including walking, jogging, aerobic dance, swimming, hydrotherapy 
aerobics, rope skipping, hiking and rowing) and resistance exercise (e.g. weightlifting) at a 
moderate intensity of a minimum of three times a week (30-60min each time for at least 150minutes 
per week) (70).  
Regarding GDM treatment recommendations, the ADA recommends insulin as the preferred 
medication for treating hyperglycemia. The use of metformin and glyburide is not recommended 
as first-line agents as both drugs cross the placenta to the fetus. It also recommends that metformin 
should be discontinued at the end of the first trimester if it is used to treat polycystic ovary 
syndrome and induce ovulation (6). The use of insulin together with MNT also reduces fetal 
morbidities.  
It is worthy to note that several other recommendations include the use of metformin for women 
with GDM (71). For example, the National Institute for Health and Care Excellence (NICE), 
recommends insulin over metformin for women with GDM. However, metformin can be 
administered if blood glucose targets are not met even after changes in diet and exercise (71). 
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Regarding long-term GDM management and the prevention of future metabolic risks, a routine 
screening at 4-12weeks postpartum is recommended (1). Metabolic changes after pregnancy turn 
back to “normal” around 4-6weeks after delivery. Due to insurance purposes, this screening is 
performed before 8weeks postpartum in Switzerland. The ADA recommends performing a 75g 
oGTT. Diagnostic criteria are the same as outside of pregnancy or the perinatal period and are as 
follows: normal glucose: if fasting glucose is <5.6mmol/l, 2h is < 7,8 mmol/l and HbA1c is < 5.7%; 
prediabetes/glucose intolerance: if either fasting glucose is 5.6-6.9 mmol/l, or 2h is 7.8-11.0 mmol/l 
or HbA1c is 5.7- 6.4% and diabetes is diagnosed if fasting glucose is ≥7.0, mmol/l, or 2h is ≥11.1 
mmol/l or HbA1c is ≥6.5% (7).  
If glucose levels are normal at around 6weeks postpartum, reassessment of glycaemia at 1-3 yearly 
interval is recommended using fasting glucose and/or HbA1c (1). Women with impaired fasting 
glucose or impaired glucose tolerance at 6weeks postpartum need annual testing; these patients are 
to receive intervention because of their higher diabetes risk (9). Educating and counselling patients 
with previous GDM on lifestyle modifications helps to lower the risk of insulin resistance including 
maintenance of normal body weight through healthy nutritional habits and physical activity. 
Education should also include the need for family planning to ensure optimal glycemic regulation 
before and from the start of any subsequent pregnancy.  
1.8 Role of lifestyle interventions in GDM management   
The cornerstone of GDM treatment requires nutrition/diet and exercise intervention to achieve 
weight and glucose control and also to reduce the need for medical therapy (64). These 
interventions are collectively termed as lifestyle interventions. These interventions provide dietary 
and lifestyle advice as the primary prevention strategy for women with GDM (10,72).  
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Regarding nutrition several diets such as low glycemic index (GI) diet, total energy restriction diet, 
low carbohydrate diet and ethnic or traditional diets, such as the Mediterranean diets are have been 
studied for the management of weight and glycemic control in women with GDM. Regarding 
physical activity/exercise intervention several exercise regimes also exist.  
The results of these lifestyle interventions have however been unsatisfactory and their sustained 
effects have been controversial (10,73). In a Cochrane review of lifestyle intervention trials among 
women with GDM, only one trial found a difference between the intervention and the control group 
regarding the incidence of type-2 diabetes and prediabetes in the postpartum period (10). In a study 
involving lifestyle intervention during and after pregnancy in women with GDM, there were no 
significant differences in postpartum weight and in physical activity between the intervention and 
control group but the intervention group had a decreased dietary fat intake (74). In another recent 
systematic review and meta-analysis of 15 trials in women with previous GDM, half of the lifestyle 
interventions led to a marginal reduction in weight and the incidence of diabetes but effect sizes 
were small and their sustained effects remain controversial (75). It is therefore of utmost 
importance to explore new approaches to weight and glucose control in these women. In addition 
inconsistency, imprecision and the variation in the content of the lifestyle intervention is of major 
concern. 
1.9 Eating behavior and GDM  
Eating behavior relates to food choices and motives, eating practices, dieting, and eating-related 
problems such eating and feeding disorders (76). Eating behavior focuses on the etiology, 
prevention, treatment of eating disorders as well as the promotion of healthy eating patterns (76). 
Poor dietary behaviors are prevalent among women with GDM and hence confidence associated 
with healthy eating behaviors can help improve GDM outcomes (77).  
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Skills in cooking healthy foods along with family food preferences and time pressures are important 
influences on eating habits (78). Behavioral and cognitive factors mediate healthy behaviors by 
improving eating behaviors and habits (79).  
Negative emotions such as depression are psychological factors related to eating disorders. Some 
individuals who struggle with their weight engage in a maladaptive eating behavior termed 
emotional eating (80). Emotional eating refers to the tendency to eat in response to aversive 
negative states (81) and has been related to both obesity and depressive symptoms (80,82). 
Individuals who engage in disordered eating tend to think of food as either “good or bad”, 
themselves as being “on” or “off” a diet and their weight as “acceptable” or “totally unacceptable” 
(83). Rigid dietary rules and all-or-nothing cognitions are generally present in individuals with 
weight and glucose problems such as those with GDM. Eating behavior plays an important role in 
explaining weight-BMI relationships and cardio-metabolic outcomes (79,84–87). Therefore, in the 
context of identifying interventions to promote healthy weight and glucose levels during and after 
pregnancy in women with GDM due to the inconsistent and controversial results from typical 
lifestyle interventions, other interventions that promote eating behavior and not exclusively focused 
on food choices could play a novel role.  
1.10 The intuitive eating concept   
Research suggests that adaptive eating behaviors that encourage people to recognize and respond 
to their internal signs of hunger and satiety prevents emotional eating and dietary restriction (88–
90) and may lead to lower weight and BMI (91). One such adaptive eating behavior is intuitive 
eating (IE). IE is characterized by eating in response to physiological hunger and satiety cues rather 
than external and/or emotional cues (92,93).  
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IE has interoceptive abilities that determine when and how much to eat and to accurately perceive 
and respect one’s hunger and satiety cues. IE tendencies are related to emotional, psychological 
and physical well-being (94). The concept of IE as interoceptive comprises of sensing the 
physiological condition of the body as well as the representation of the internal state (95).  
IE is a more sustainable long-term eating behavior than dieting and is known to be associated with 
lower levels of cholesterol and cardiovascular risk. It is also inversely associated with disordered 
eating behavior, leads to body shape satisfaction and is associated with lower weight and glucose 
control in cross-sectional studies (96,97).   
IE is assessed with the Intuitive Eating Scale-2 (IES-2); a validated self-report questionnaire (91). 
The original version of the IES-2 (English version) consists of four subscales. These subscales are 
1) Eating for physical rather than emotional reasons subscale that assesses how much eating is 
affected by emotional responses. 2) The Reliance on hunger and satiety cues subscale that evaluates 
the extent to which individuals are aware and able to trust internal signals rather than relying on 
external rules/cues. 3) The Unconditional permission to eat when hungry subscale that assesses 
whether an individual purposefully tries to ignore hunger and satiety signals  and 4) the Body-Food 
Choice Congruence subscale (91). The validated French version however contains three subscales. 
These are the eating for physical rather than emotional reasons subscale, the reliance on hunger 
and satiety subscale and the unconditional permission to eat subscale (98).  
1.11 Intuitive eating and dietary intake  
Despite that fact that IE has shown benefits for psychological wellbeing and improvements in 
physical health and wellbeing, there is scarce information on the relationship between IE and 
food/dietary intake (99).  
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One could attribute this to the concern that nutritionists do not promote IE due to a concern that 
individuals may consume high levels of high fat or high sugar foods (100). On the contrary 
however, IE involves the idea of ‘body wisdom’ (101) and eating intuitively is expected to lead 
and promote healthy dietary patterns and food intakes (102). One principle of IE specifically refers 
to making “food choices that honor your health and taste buds while making you feel well”. Since 
restrained eaters tend to overeat (103) and emotional eaters tend to consume more fatty or sweet 
foods over time (104), reductions in restraint and emotional eating through IE may rather lower 
intakes of such foods. Few studies have explored the relationships between food intake and IE 
among men and non-pregnant women (105). A study that explored the first three dimensions of the 
intuitive eating scale-2 (IES-2; eating for physical rather than emotional reasons subscale, reliance 
on hunger and satiety cues subscale and  the unconditional permission to eat subscale) reported that 
different aspects of IE relate to food intake in different ways (105). Few studies have explored the 
impact of IE interventions on food intake outside of pregnancy and findings were mixed. Three 
studies reported a positive impact on diet quality scores (102,106,107), while others found a 
relationship between higher IE scores and healthy dietary intake (108,109). Results from the Swiss 
food panel study also revealed that the four subscales of IES-2 showed different relationships with 
food intake (99). In contrast to the other subscales, unconditional permission to eat moderately 
correlated with poorer diet quality scores and consistently showed associations with a more 
negative self-evaluation of eating behavior. The other three IES-2 subscales showed a few small 
positive and negative correlations with food intake including positive associations of diet quality 
scores in women with the eating for physical rather than emotional reasons and the reliance on 
hunger and satiety cues subscales.  
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There is therefore the need for further studies to investigate the relationship between IE and dietary 
intake in a quest to find strategies to promote healthy weight and improve glucose control in women 
with GDM. 
1.12 Intuitive eating and metabolic outcomes  
Dietary intake mediates the relationship between IE and metabolic health outcomes and hence there 
is the need to identify strategies that promote both healthy dietary eating and intuitive eating. IE 
practices promote metabolic health by preventing disordered and emotional eating that are 
associated with adverse metabolic health outcomes (88). Compared to studies (110,111) that 
focused on lifestyle interventions and nutritional advice such as total energy intake, macronutrient 
contents of foods, type of carbohydrates, portion sizes and eating frequency, IE represents an 
interesting and different approach to weight loss and glycemic control. Outside of pregnancy, 
evidence from cross-sectional studies suggest that IE is associated with lower BMI (112–114) with 
weight loss in an intervention trial (115,116) and with glycemic control in two observational studies 
involving the general adult population (117,118) and with lower weight and fasting glucose in the 
postpartum period (119). Studies have confirmed the association between IE with improved 
metabolic outcomes such a weight, BMI and fasting glucose (91,93,120). Furthermore, eating in 
response to hunger and satiety signals predicted lower BMI in a study involving 1600 New-Zealand 
women aged 40–50 years. In a study involving adolescent with type-1 diabetes, increased 
adherence to IE was associated with 11% lower HbA1c per unit increase in IE score (117). In 
another cross-sectional study, the relationship between IE and BMI was partially mediated by 
frequency of binge eating. This suggests that higher adherence to IE may prevent disordered eating 
and in turn influence weight and BMI outcomes (114).  
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A large population based study (9581 men and 31,955 women) in France indicated a stronger cross-
sectional association between higher IE scores with lower odds of overweight or obesity in both 
men and women and thus support earlier findings using smaller sample sizes that IE adherence 
leads to favorable metabolic health outcomes (116).  
According to a review of 26 studies (17 cross-sectional survey studies and 9 clinical studies, 8 of 
which were randomized controlled trials) cross-sectional surveys found an inverse association 
between IE and BMI (118). IE was positively associated with various health indicators such as 
blood pressure and cholesterol levels (118). Results from 9 clinical trials involving a total of 941 
obese/overweight women found that IE leads to weight maintenance and improves physical health 
indicators including glucose control (118). Research on IE has increased in recent years. Past 
research demonstrates substantial and consistent associations between IE and metabolic health. 
These notwithstanding, no study have investigated the potential association between IE during 
pregnancy with any metabolic health outcomes including weight and glucose levels. Specifically, 
there is no study focusing on women with GDM either during pregnancy or in the postpartum 
period. It is therefore important that future studies explore the relationship between IE and weight 
and glucose levels outcomes in women with GDM in the perinatal period as they are at a higher 
risk of weight gain and metabolic disturbances such as prediabetes and diabetes during this critical 
time period. This is particularly important in view of the low success of lifestyle interventions and 
the need for new approaches to weight loss and glucose control.  
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2.0 AIMS OF THE THESIS 
2.1 Overall thesis goal  
The overall goal of this thesis was to study the relationship between nutrition behavior (focusing 
on intuitive eating (IE)) with weight and glucose levels in women with GDM. It sought to primarily 
determine cross-sectional and longitudinal relationships between IE and weight and glucose levels 
during and after pregnancy in these women. It also investigated the predictors and consequences 
of PPWR in the early and late postpartum period.  
2.2 Thesis outline and study objectives  
This thesis is divided into three different studies/articles. Below are the individual studies and their 
specific objectives. 
1. Intuitive eating is associated with metabolic health during pregnancy and in the early 
postpartum period in women with GDM (Study 1) 
Objective: To investigate the cross-sectional and longitudinal associations between IE and 
metabolic health during pregnancy and in the early post-partum period. 
Hypothesis: IE is associated with weight and glycemic control during pregnancy and in the early 
postpartum period in women with GDM.    
2. Intuitive eating is associated with improved health indicators at 1-year postpartum in 
women with GDM (Study 2)  
Objective: To evaluate the associations between IE during and after pregnancy with metabolic 
health outcomes at 1-year postpartum in all women with GDM who were followed beyond the 
early postpartum period and in high-risk GDM subgroups with pre-pregnancy overweight/obesity 
or with postpartum prediabetes.  
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Hypothesis: There are longitudinal and cross-sectional associations between IE during and after 
pregnancy with metabolic health at 1-year postpartum in women with GDM and in high-risk GDM 
subgroups with overweight/obesity or with prediabetes.  
3. Predictors and consequences of weight retention in the early and late postpartum period 
in women with GDM (Study 3)  
Objective: To determine the predictors and consequences of PPWR in the early and late postpartum 
period in women with GDM.  
Hypothesis: Anthropometric (e.g. pre-pregnancy weight, changes in weight, BMI) and glucose 
control variables (fasting glucose, HbA1c) are predictors of PPWR and women with PPWR have 
increased adverse metabolic consequences in the early and late postpartum period compared to 
those with no PPWR.  
It is worthy to note that, all three studies (1-3) are published. Details of these studies can be found 
in the appendix section.   
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3.0 GENERAL METHODS 
The first part of this section of the thesis provides a summary of the main methods involved in this 
thesis and the second part summarizes the specific individual methods involved in the different 
studies. Complete and detailed methods used in each study/article can be found in the appendix 
section.  
3.1 Summary of the general methods 
3.2 General participant consent and recruitment  
This thesis utilized data from an ongoing cohort of women with GDM. We invited pregnant women 
diagnosed with GDM to participate in this cohort at the GDM clinic in the Lausanne University 
Hospital (CHUV). Our participants were pregnant women referred by the CHUV antenatal clinic 
and by obstetricians in private practice in the Canton de Vaud. The Human Research Ethics 
Committee of the Canton de Vaud approved the study protocol (326/15).  
3.3 Cohort database   
This ongoing longitudinal cohort started in October 2011. The database consists of data from 
women with GDM followed during pregnancy and in the postpartum period at the GDM clinic in 
the CHUV. In August 2015 we extended the follow-up period from 6-8 weeks postpartum to 1-
year and subsequently also included IE assessment. The individual studies involved in this thesis 
utilized data during pregnancy, in the 6-8 weeks and 1-year postpartum period depending on the 
objective of the individual study/article.  
3.4 General data collection and assessments 
Data from women in this cohort and involved in this thesis were retrieved from seven time points 
that correspond to six clinical visits.  
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Initially, women are screened for GDM using an oGTT (pre-GDM/ first time point). This first visit 
is not in the GDM clinic. Then women are seen for the first time in the GDM clinic (first GDM 
visit/ second time point) where anthropometric measures, HbA1c, assessment of intuitive eating 
(since 2015) and demographic characteristics are assessed. A dietary counseling by a dietitian then 
follows after 1week where participants are advised on the carbohydrate content of their foods and 
drinks and the need to avoid or limit certain foods in order to improve their eating habits and 
glycemic profile (third time point). The fourth time point is the last visit during pregnancy prior to 
delivery. During this visit metabolic and anthropometric variables were again assessed. At delivery 
(fifth time point) obstetric and neonatal outcomes of the study participants and their offspring are 
assessed. This visit is not in the GDM clinic. Women then attend a 6-8weeks postpartum (sixth 
time point) visit after delivery, which is characterized by glucose control assessment i.e. the 
performance of an oGTT and HbA1c, and collection of anthropometric data, intuitive eating 
assessments and a clinical visit with a physician and dietician together. The last visit (seventh time 
point) is the 1-year postpartum visit. During this visit, women are assessed again for glucose control 
assessment i.e. fasting glucose and HbA1c, anthropometric data, and intuitive eating 
measurements. Below is a detailed presentation of the GDM clinic set-up, visits and the measures 
at each time point.  
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Fig 5: GDM cohort set-up and data collection process.   
The cohort database is hosted by an online data management resource called SecuTrial, which is 
jointly managed by the CHUV information technology unit and the GDM research unit. Below is 
an image of the various time points and individual data stored. The ongoing longitudinal cohort 
has 1441 participants who are at various stages of the data collection as of 31.01.2020.   
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Fig 6: The online data management platform of the cohort data 
 
3.5 General inclusion and exclusion criteria  
The general inclusion criteria in this thesis were women who were ≥18 years with GDM diagnosis 
that were followed in the GDM clinic, who understood French or English and consented to 
participate. Data used in all the analyses of this thesis first excluded those with known type-1 
diabetes, type-2 diabetes, newly diagnosed diabetes in pregnancy, glucose intolerance but no GDM, 
those with normal oGTT results, with GDM diagnosed at ≤13 weeks and those participating in an 
active lifestyle intervention study.  
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Depending on the specific study objective, other exclusion criteria were applied. This included the 
removal of those who did not attend the 6-8 weeks postpartum visit, those without IE scores or 
those without data for the 1-year postpartum visit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7. Flow chart describing the selection of study participants 
oGTT: oral glucose tolerance test; GDM: gestational diabetes mellitus; RCT: randomized controlled trials 
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3.6 Specific inclusion/exclusion criteria (studies 1-3) 
In addition to the general inclusion/exclusion criteria, had additional exclusion criteria for studies 
1-3 depending on the specific study objective:  
Study 1: Intuitive eating is associated with metabolic health during pregnancy and in the early 
postpartum period in women with GDM  
For this study, the additional exclusion criteria in addition to those mentioned in section 3.5 (page 
25) were women who did not complete an IE questionnaire at the first GDM visit and those who 
did not attend the 6-8 weeks postpartum appointment visit.  
The flow of selecting study participants for this specific study is as follows: out of the cohort 
population of 1000 participants (at the time of analysis of this analysis) that were followed in our 
clinic (2011-2017), we excluded those who did not complete an IE questionnaire at the first GDM 
visit (N=533) and those who did not attend the 6-8 weeks postpartum visit (N=32). Out of the 
eligible cohort population of 435 participants, we then excluded those who did not sign an informed 
consent (N= 145). Participants with known type 1 diabetes (N= 7), known type 2 diabetes (N= 9), 
GDM diagnosed at ≤13 weeks (N= 11), diabetes diagnosed during pregnancy at ≤20 weeks (N= 
19), normal (i.e. negative) oGTT results (N= 7), with glucose intolerance but no GDM (N= 2) and 
those participating in a form of an active lifestyle randomized controlled trial (RCT) intervention 
(N= 21) were also excluded. Overall, 214 women were included in the final analysis.    
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Study 2: Intuitive eating is associated with improved health indicators at 1-year postpartum in 
women with GDM  
For this study, the additional exclusion criteria in addition to those mentioned in section 3.5 (page 
25) were women who did not complete the IES-2 at the first GDM visit and at 1-year visit and 
those who did not attend the 1-year postpartum appointment visit.  
The flow of selecting study participants for this specific study is as follows: out of a cohort 
population of 1068 participants (at the time of this analysis) that were followed at our clinic from 
2011-2018 we first excluded those who did not sign an informed consent (N= 177) and did not 
complete the IES-2 at the first GDM visit and at 1-year visit (N=558). Out of a cohort population 
of 333 participants that consented, we removed participants who did not come for 1-year 
postpartum appointment visit (N=144) as they did not have valid data for our main questions and 
hypothesis. Participants with known type 1 diabetes (N= 2), known type 2 diabetes (N= 6), had 
GDM at ≤13 weeks (N= 10), had diabetes diagnosed during pregnancy at ≤20 weeks (N= 8), with 
oGTT results that were normal (N= 3), with glucose intolerance but no GDM (N= 1) and were 
participating in a lifestyle intervention study (N=42) who are part of our cohort database were also 
excluded as they did not meet the inclusion criteria. Overall, 117 women were eligible and thus 
included in the final analysis. Figure 1 shows the details of how participants in this study were 
selected. 
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Study 3: Predictors and consequences of weight retention in the early and late postpartum period 
in women with GDM  
For this study, the additional exclusion criteria in addition to those mentioned in section 3.5 (page 
25) were women who did not attend the postpartum appointment visits (i.e. both the 6-8 weeks and 
1-year visits).  
The flow of selecting study participants for this specific study is as follows: out of a total consented 
cohort population of 1039 women (at the time of this analysis) we first excluded those with known 
type 1 diabetes (N=13), type 2 diabetes (N=18), newly diagnosed diabetes in pregnancy (N=9), 
glucose intolerance but no GDM (N=2), with normal oGTT results (N=8), with GDM diagnosed 
at ≤13 weeks (N=13), and those participating in an active lifestyle intervention study (N=53).  
We then excluded those who did not attend the 6-8 weeks postpartum visit (N=61). Following this, 
862 women were eligible and were included in our final analysis. Of these 862 women, all of them 
had completed the 6-8 weeks postpartum visit, whereas 259 (30%) had completed the 1-year 
postpartum visit at the time of this analysis. The main reason for the low numbers of patients at 1-
year postpartum visit is that the implementation of the 1-year postpartum follow-up visit started in 
August 2015. 
The following paragraphs summarize the variables and measures used in my thesis project in either 
of the three studies. 
3.7 Assessment of Intuitive eating (IE) 
We assessed IE (Studies 1 &2) with the French Intuitive Eating Scale-2 (IES-2) corresponding to 
the language of our population.  
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The French IES-2 is an18-item validated self-report questionnaire that assesses individuals’ 
tendency to follow their physiological, hunger and satiety in relation to eating. The French IES-2 
consists of three (3) subscales. These are (1) the Eating for physical rather than emotional reasons 
(EPR, 8 items) subscale; that assesses how much eating is affected by emotional responses, (2) the 
Reliance on hunger and satiety cues (RHSC, 6 items) subscale; that evaluates the extent to which 
individuals are aware and able to trust internal signals rather than relying on external rules/cues.  
The Unconditional permission to eat (UPE, 4 items) when hungry subscale (3) that assesses 
whether an individual purposefully tries to ignore hunger and satiety signals (116,121). The English 
IES-2 (23-item questionnaire), however, consists of four subscales. These are the EPR (8 items) 
subscale, the RHSC (6 items) subscale, the UPE (4 items) and the Body-Food Choice Congruence 
(BFC-C, 5 items) subscale (88,91). Both French and English IES-2 questionnaires have 
demonstrated good psychometric properties in pregnant women (121). In an earlier study, the 
Cronbach’s alphas (α) for the two subscales were 0.92 and 0.87 for EPR and RHSC respectively 
which suggests a good internal reliability among the subscales (121). IE has interoceptive abilities 
that are suggested to determine when/how much to eat, and to accurately perceive and respect one’s 
hunger and satiety cues. Thus IE tendencies are related to emotional, psychological, and physical 
well-being (94).  Details of the IES-2 questionnaire have been previously described (91). For the 
purpose of this thesis, we removed the UPE subscale (4 items) from the French IES-2. This is 
because women involved in this study had in general one pre-partum visit with a registered dietician 
during pregnancy and another visit in the early post-partum period (6-8 weeks postpartum).  
This second visit in the early postpartum period was of short duration and done together with the 
diabetologist or diabetes educator and focused predominantly on reporting the results of the 
postpartum oral glucose tolerance testing (oGTT).  
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Women had no further dietician appointment after this visit. In the general population of our 
women with gestational diabetes, about 85% are usually seeing a dietician and the main reasons 
for not seeing one are: appointment-scheduling problems or arrival at the GDM clinic at a very 
advanced stage of pregnancy. We believe that, discussions during diet counselling could 
significantly influence participant responses to the UPE subscale questions such as: “I try to avoid 
certain foods high in fat, carbohydrates, or calories”, as participants were advised on carbohydrate 
content of their foods and to avoid or limit certain food like soft drinks, sweet products, added 
sugar and fruits juice in order to improve their eating habits and glycemic profile. We therefore 
only used the EPR and RHSC subscales of the French IES-2 and an English translation using the 
forward-backward translation and cultural adaption method (122) made by our research team (with 
the same 14 items; EPR has 8 items and RHSC has 6 items); they were then given to participants 
who speak French and English, respectively. Women completed the EPR and RHSC subscales of 
the IES-2 questionnaire during the first GDM visit (study1 & 2) and at one-year postpartum visit 
(study 2) by responding to a 5-point Likert scale response ranging from one (1) ‘strongly disagree’ 
to five (5) ‘strongly agree’ to each item in both subscales. We then calculated the EPR and RHSC 
subscale scores as recommended by dividing the total scores obtained from the sum of 1-5 from 
each item by the total number of items in each subscale (EPR by 8 and RHSC by 6) leading to a 
possible subscale score between one and five (0 and 5). Higher scores indicated greater levels of 
IE. A higher score of the EPR subscale reflects eating as an answer to hunger and a lower score 
meant eating to cope with emotional distress, whereas a higher score of the RHSC subscale 
signifies trust in internal cues, and a lower score reflects less ability to regulate food intake. 
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3.8 Assessment of glycemic control variables  
Participants underwent a 75g oral glucose tolerance test (oGTT) during pregnancy at 24-32 weeks 
of gestation unless an initial fasting glucose was ≥ 5.1 mmol/L. Women were diagnosed of GDM 
if one of the following criteria were met: fasting glucose ≥ 5.1 mmol/L, 1-hr glucose ≥ 10.0 
mmol/L, or 2-hr glucose ≥ 8.5 mmol/L using the IAPDSG (17) and ADA guidelines (7). At the 
first GDM visit, HbA1c was measured using a chemical photometric method (conjugation with 
boronate; Afinion®). At 6-8 weeks and 1-year postpartum, an oGTT was performed to measure 
fasting glucose, 2-hr glucose and HbA1c with a high performance liquid chromatography method 
(HPLC). Both methods are traceable to the international federation of clinical chemistry and 
laboratory medicine (IFCC) reference method for measurement of HbA1c (123). Prediabetes was 
diagnosed when a participant’s fasting glucose at the postpartum period was between 5.6-6.9 
mmol/l, the 2h glucose was between 7.8-11.0 mmol/l or HbA1c at 1-year postpartum was between 
5.7- 6.4%.    
3.9 Anthropometric variables  
Pre-pregnancy weight was taken from participants’ medical charts or, if missing was self-reported 
(for the 1-2 months before pregnancy). We measured weight at the first GDM visit, at the end of 
pregnancy, at 6-8 weeks and at 1-year postpartum to the nearest 0.1 kg in women wearing light 
clothes and no shoes with a regularly calibrated electronic scale (Seca®). We measured height at 
the first GDM visit to the nearest 0.1 cm with a regularly calibrated Seca® height scale. GWG was 
defined as the difference between pre-pregnancy weight and weight at the end of pregnancy. We 
calculated the BMI as the ratio of weight in kilograms to the square of height in meters (kg/m2). 
We defined overweight and obesity as BMI between 25.0-29.9 Kg/m2 and ≥30 kg/m2 respectively.  
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Based on the pre-pregnancy BMI and GWG, women were classified as being below (inadequate), 
within (adequate) or above (excessive) the Institute of Medicine (IOM) GWG recommendations 
(124).  We calculated PPWR by either subtracting the pre-pregnancy weight from the weight at 6-
8 weeks postpartum (early PPWR) and from the weight at 1-year postpartum (late PPWR). 
Information on GDM treatment during pregnancy (use of insulin and/or metformin; yes/no) and 
caesarean section (yes/no) were obtained from medical charts.  
3.9 Socio-demographic characteristics and additional health variables  
During the first GDM visit, information on participants’ characteristics including age, educational 
level, and ethnic origin, family history of type-2 diabetes, history of previous GDM, parity, gravida, 
and smoking during pregnancy were obtained during a structured face-to-face interview. We 
categorized educational level into “no formal education; compulsory school achieved; general and 
vocational training levels; high school and university education” (125,126). Information on partner 
support was obtained during the face-to-face interview and was categorized as either “living with 
a partner or not”. We categorized family history of type-2 diabetes, as either “first-degree, second 
degree or none” whereas previous history of GDM and smoking during pregnancy were 
categorized as either ‘yes’ or ‘no’. We grouped parity into “none, one, two and ≥ three” whereas 
gravida consisted of “one, two or three”.  In the routine clinical visit at 6-8 weeks postpartum, 
information about breastfeeding (yes/no) and contraception use (yes/no) were obtained. To assess 
their mental health, women completed the Edinburgh Postnatal Depression Scale (EPDS) 
questionnaire during their first GDM visit (at 24-32 weeks) and in the postpartum period. This 
questionnaire is a ten-item self-report questionnaire designed and validated to screen women for 
symptoms of depression during pregnancy and in the postnatal period (127).  
 34 
 
The possible scores of the EPDS questionnaire range from 0 to 30 points, with a higher total score 
indicating more severe depressive symptoms.  
3.10 Statistical analyses (studies 1-3) 
Study 1: Intuitive eating is associated with metabolic health during pregnancy and in the early 
postpartum period in women with GDM.   
All analyses were conducted using the SPSS software version 25 (32). All descriptive variables 
were presented as either means (±standard deviation) or in percentages (%) where appropriate.  
Both predictor (EPR and RHSC subscales of the IES-2 questionnaire) and outcome (BMI, weight 
and glycemic control including fasting glucose, 1hr glucose, 2hr glucose and HbA1c at the different 
time points) variables were normally distributed. The correlation between the two subscales of IES-
2 questionnaire was low-to moderate (r=0.35, P<0.01). We conducted a linear regression analysis 
to determine the cross-sectional and longitudinal associations between the two subscales of IES-2 
at the first GDM visit with BMI, weight, fasting glucose, 1hr glucose, 2hr glucose and HbA1c 
during pregnancy (cross-sectional analysis), at the end of pregnancy and at 6-8 weeks postpartum, 
respectively (longitudinal analysis). We made use of three models in the regression analyses. 
Model 1 consisted of unadjusted regression estimates. In model 2, we adjusted for socio-
demographic characteristics that showed significance with at least one of metabolic health outcome 
variables (BMI, weight, fasting glucose, 1h or 2h glucose, HbA1c) at either the first GDM visit or 
at 6-8 weeks postpartum. This was tested for age, gestational age, education level, nationality, 
employment status, family history of type-2 diabetes, history of GDM, smoking and alcohol intake 
during pregnancy, gravida, parity, and medical treatment during pregnancy.  
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Of these potential confounder variables, age, gestational age, smoking during pregnancy, parity, 
and medical treatment during pregnancy showed significance with one of the metabolic health 
outcome variables and were thus included in Model 2 as confounder variables. We did not adjust 
for medical treatment in our cross-sectional analysis because women had not started medical 
treatment during the first GDM visit, as this had no effect on the potential associations between IE 
and metabolic health at the first GDM visit. We however adjusted for this in our longitudinal 
analyses. When the outcome was glycemic control (fasting glucose and HbA1c), we added a third 
model: model 3, where we adjusted for weight at the respective time points (at the first GDM visit 
and at 6-8 weeks postpartum). All analyses were conducted separately for both subscales of the 
IES-2 questionnaire. All statistical significances were two sided and accepted at p < 0.05. 
Study 2: Intuitive eating is associated with improved health indicators at 1-year postpartum in 
women with GDM  
All descriptive variables were presented as either means (±standard deviation) or in percentages 
(%), where appropriate. Both predictor (EPR and RHSC subscales of the IES-2 questionnaire at 
first GDM visit and at 1-year postpartum visit) and outcome (BMI, weight retention, HbA1c and 
fasting glucose at the different time points) variables were normally distributed. The EPR and 
RHSC subscales showed a moderate correlation of 0.42 (p<0.001) at the first GDM visit and 0.51 
(p<0.001) at 1-year postpartum. We conducted a linear regression analysis to determine the 
associations between IE at the first GDM visit (longitudinal) and at the 1-year postpartum visit 
(cross-sectional) with BMI, weight retention, fasting glucose, and HbA1c at 1-year postpartum. 
We adjusted for socio-demographic characteristics that showed statistical significance with at least 
one of the metabolic health outcome variables (BMI, weight, weight retention, fasting glucose and 
HbA1c) at 1-year postpartum.  
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We tested for age, gestational age at the first GDM visit, education level, nationality, employment 
status, family history of type-2 diabetes, history of GDM, smoking and alcohol intake during 
pregnancy, parity, and breastfeeding in the early postpartum period. Of these potential confounder 
variables, age and gestational age showed significance with at least one of the metabolic health 
outcomes. We therefore adjusted for age and gestational age at the first GDM visit as confounders 
for all analyses. When the outcome was glycemic control (HbA1c or fasting glucose), we further 
adjusted for BMI at first GDM visit. We did this to see if the relationship was mediated by BMI. 
We conducted all analyses separately for EPR and RHSC subscales at the first GDM visit and at 
1-year postpartum. We also evaluated the associations between the two IE subscales at the first 
GDM visit and at 1-year postpartum with metabolic health outcomes in the high-risk GDM 
subgroups with prediabetes or overweight/obesity and in the respective low-risk subgroups. Both 
IE scores at both time points were analyzed using correlation analyses and paired t-tests (between 
first visit and 1-year postpartum). All statistical significances were two sided and accepted at p< 
0.05. 
Study 3: Predictors and consequences of weight retention in the early and late postpartum period 
in women with GDM  
Demographic and other descriptive variables are presented as either means (±standard deviation) 
or in percentages (%). PPWR variable and all outcome parameters were normally distributed. We 
categorized this continuous variable (PPWR) into two groups: either no PPWR when the difference 
between a participant’s weight before pregnancy and weight at the postpartum period (either 6-8 
weeks or 1-year visit) was ≤0kg and into PPWR if the difference is ≥0.1kg. We performed an 
ANOVA analysis to compare the anthropometric and metabolic characteristics (independent 
continuous variables) of participants according to weight retention categories.  
 37 
 
In order to determine the predictors of PPWR at 6-8 weeks and at 1-year postpartum, we conducted 
an initial univariate logistic regression analysis. We selected potential predictors for the univariate 
regression analyses based on the existing literature. These variables were; age, educational level, 
nationality, history of GDM, family history of diabetes, parity, gravida, delivery by caesarean 
section, partner support, GDM treatment, contraception use, breastfeeding and depression score at 
the first GDM visit, pre-pregnancy weight, fasting, 1hr and 2hr glucose after oGTT at GDM 
diagnosis, total GWG, excess GWG according to IOM guidelines, fasting glucose, 2hr glucose 
after oGTT and HbA1c, all at 6-8 weeks postpartum. We then modeled the odds of PPWR (at the 
6-8 weeks and 1-year postpartum visits) using multivariable logistic regression models with 
backward elimination by including variables with p<0.25 in the initial univariate regression 
analysis. Based on this, the following predictor variables were included in the 6-8 weeks 
postpartum model: family history of diabetes, partner support, breastfeeding and depression score 
at the first GDM visit, pre-pregnancy weight, 2hr glucose after oGTT at GDM diagnosis, total and 
excess GWG according to IOM guidelines. The following predictor variables were included in the 
1-year postpartum model: age, family history of diabetes, partner support, depression score at the 
first GDM visit, total GWG, excess GWG, and HbA1c at 6-8 weeks postpartum visit. For the 1-
year postpartum analysis, we made use of two models; one in parallel to the model performed at 6-
8 weeks postpartum and thus without any variable obtained after delivery i.e., without HbA1c at 
6-8 weeks postpartum (model 1) and one including significant variables after delivery, i.e. HbA1c 
at 6-8 weeks postpartum (model 2). We then selected the regression model with the lowest Akaike 
information criterion (AIC) as our final model for both time points. We tested for collinearity of 
the included predictor variables, and none displayed excessive collinearity. The variance inflation 
factor (VIF) in the regression models were less than 2 (between 1.0-1.4), and thus acceptable. All 
statistical significances were two sided and accepted at p< 0.05.     
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4.0 GENERAL RESULTS 
The section of the thesis provides a summary of the main results of the studies involved in this 
thesis. The complete and detailed results of each study can be found in the appendix section.   
Study 1: Intuitive eating is associated with metabolic health during pregnancy and in the 
early postpartum period in women with GDM 
Cross-sectional associations between intuitive eating during pregnancy and metabolic outcomes 
during pregnancy  
This study included 214 women. Their mean score of the eating for physical rather than emotional 
reasons subscale at first GDM visit was 3.8 ± 0.9, whereas the mean score of the reliance on hunger 
and satiety subscale was 3.5 ± 0.9. Table 3 below shows the cross-sectional associations between 
the two scales of intuitive eating scale-2 (IES-2) with BMI, weight and glycemic control at the first 
GDM visit. Cross-sectional analyses showed that both subscales of IES-2 at the first GDM visit 
were associated with lower weight and BMI before pregnancy, weight, fasting glucose and HbA1c 
at the first GDM visit (β= -0.171 to -0.222, all p≤ 0.01). However the reliance on hunger and satiety 
subscale was not significantly associated with HbA1c at the first GDM visit. After adjusting for 
confounders including age, gestational age, smoking, and parity (model 2) the associations between 
the two subscales of IES-2 with weight and BMI before pregnancy and weight at first GDM visit 
remained unchanged. The association between eating for physical rather than emotional reasons 
subscale with fasting glucose and HbA1c also remained largely unchanged, except that the 
association between the reliance on hunger and satiety subscale with fasting glucose was attenuated 
(p=0.095), albeit with a similar beta-coefficient. When fasting glucose or HbA1c was the outcome, 
we adjusted for weight at first GDM visit as a potential confounder (model 3).  
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The relationship between the eating for physical rather than the emotional subscale with fasting 
glucose and HbA1c were attenuated (both p≤0.07), while the relationship between the reliance on 
hunger and satiety subscale and fasting glucose remained insignificant (p=0.261). This shows that 
weight partly mediates the relationship between IE and fasting glucose in our sample.    
Longitudinal associations between intuitive eating during pregnancy and metabolic outcomes at 
6-8 weeks postpartum   
Table 4 shows the longitudinal associations between IES-2 at the first GDM visit with BMI, weight 
and glycemic control at the end of pregnancy and at 6-8 weeks postpartum visit. Both subscales of 
IES-2 at first GDM visit were associated with lower weight at the end of pregnancy, weight, BMI 
and fasting glucose at 6-8 weeks postpartum (β=-0.139 to -0.242, all P≤ 0.046) (model 1). None of 
the IES-2 subscales was related to weight at first GDM visit, change in weight at the end of 
pregnancy and change in weight at 6-8 weeks postpartum. After adjusting for confounders 
including age, gestational age, smoking, parity, and medical treatment during pregnancy (model 
2), the significant associations between the two subscales of IES-2 with weight at the end of 
pregnancy, weight, BMI and fasting glucose at 6-8 weeks postpartum remained unchanged (all p≤ 
0.004). However, the association between reliance on hunger and satiety subscale and weight at 6-
8 weeks postpartum was attenuated (p=0.057), albeit with a similar beta-coefficient. When fasting 
glucose and HbA1c were the outcome variables, we adjusted for weight at 6-8 weeks postpartum 
visit (model 3). Thus, the inverse association between the eating for physical rather than the 
emotional reasons subscale and fasting glucose at 6-8 weeks postpartum remained unchanged (p= 
0.038) whereas the association between the reliance on hunger and satiety subscale and fasting 
glucose at 6-8 weeks postpartum was attenuated (p≤ 0.059).  
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[Table 3] Cross-sectional associations between the two subscales of intuitive eating scale-2 and weight, BMI and glycemic 
control at first GDM visit 
  Model 1 Model 2 Model 3 
Variable 
regression 
coefficient 95% CI P-value 
regression 
coefficient 95% CI P-value 
regression 
coefficient 95% CI 
P-
value 
EPR             
Weight before pregnancy (n=213) -0.203 -5.329 -1.107 0.003 -0.181 -5.002 -0.745 0.008 NA    
BMI before pregnancy (n=213) -0.216 -1.936 -0.463 0.002 -0.194 -1.824 -0.332 0.005 NA    
Weight at first GDM visit (n=211) -0.205 -5.355 -1.126 0.003 -0.191 -5.168 -0.871 0.006 NA    
HbA1c at first GDM visit (n=211) -0.171 -0.126 -0.015 0.013 -0.170 -0.127 -0.013 0.016 -0.123 -0.106 0.004 0.070 
Fasting glucose at first GDM visit (n=206) -0.195 -0.278 -0.050 0.005 -0.196 -0.280 -0.049 0.005 -0.124 -0.213 0.007 0.066 
1-hr glucose at first GDM visit (n=163) 0.122 -0.058 0.490 0.122 0.154 -0.009 0.556 0.058 0.112 -0.081 0.465 0.166 
2-hr glucose at first GDM visit (n=164) -0.030 -0.336 0.226 0.698 -0.033 -0.351 0.232 0.689 -0.065 -0.404 0.169 0.420 
RHSC 
    
        
    
Weight before pregnancy (n=213) -0.194 -5.394 -0.999 0.005 -0.181 -5.171 -0.800 0.008 NA    
BMI before pregnancy (n=213) -0.222 -2.046 -0.518 0.001 -0.215 -2.007 -0.482 0.002 NA    
Weight at first GDM visit (n=211) -0.190 -5.365 -0.934 0.006 -0.188 -5.331 -0.886 0.006 NA    
HbA1c at first GDM visit (n=211) -0.061 -0.085 0.032 0.376 -0.061 -0.085 0.033 0.389 -0.004 -0.060 0.056 0.954 
Fasting glucose at first GDM visit (n=206) -0.148 -0.248 -0.010 0.033 -0.117 -0.222 0.018 0.095 -0.076 -0.182 0.050 0.261 
1-hr glucose at first GDM visit (n=163) 0.072 -0.149 0.409 0.359 0.097 -0.108 0.459 0.224 0.043 -0.209 0.359 0.605 
2-hr glucose at first GDM visit (n=164) -0.072 -0.417 0.153 0.361 -0.068 -0.416 0.165 0.394 -0.124 -0.526 0.070 0.132 
Gestational age at first GDM visit is 24-32 weeks 
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2). Higher scores means higher adherence to the EPR subscale 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2). Higher scores means higher adherence to the RHSC subscale 
Model 1: Unadjusted regression estimates 
Model 2: Adjusted for age, gestational age, smoking, and parity  
Model 3: Adjusted for weight at first GDM visit  
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[Table 4] Longitudinal associations between two subscales of intuitive eating scale-2 and weight, BMI and glycemic control at 
the end of pregnancy and in early postpartum (6-8 weeks) 
  Model 1 Model 2 Model 3 
Variable 
regression 
coefficient 95% CI 
P-
value 
regression 
coefficient 95% CI P-value 
regression 
coefficient 95% CI 
P-
value 
EPR             
Weight at end of pregnancy (n=198) -0.223 -5.450 -1.297 0.002 -0.212 -5.373 -1.063 0.004 NA    
Weight at 6-8 weeks postpartum (n=207) -0.237 -5.700 -1.592 0.001 -0.219 -5.536 -1.267 0.002 NA    
BMI at 6-8 weeks postpartum (n=205) -0.242 -2.003 -0.574 0.000 -0.226 -1.956 -0.474 0.001 NA    
∆weight first GDM visit and end of pregnancy (n=192)1 -0.007 -0.562 0.509 0.922 0.025 -0.452 0.642 0.732 NA    
∆weight first GDM visit and 6-8 weeks PP (n=205)2 -0.061 -1.137 0.438 0.382 -0.062 -1.154 0.448 0.386 NA    
HbA1c at 6-8 weeks postpartum(n=206) -0.002 -0.053 0.051 0.978 -0.003 -0.056 0.054 0.968 0.017 -0.047 0.060 0.815 
Fasting glucose 6-8 weeks postpartum (n=207) -0.200 -0.159 -0.031 0.004 -0.191 -0.158 -0.026 0.007 -0.144 -0.132 -0.004 0.038 
2-hr glucose 6-8 weeks postpartum (n=206) -0.020 -0.261 0.194 0.775 -0.005 -0.253 0.235 0.943 -0.018 -0.264 0.205 0.806 
RHSC                 
Weight at end of pregnancy (n=198) -0.193 -5.276 -0.868 0.007 -0.175 -5.059 -0.545 0.015 NA    
Weight at 6-8 weeks postpartum (n=207) -0.139 -4.486 -0.040 0.046 -0.134 -4.435 0.065 0.057 NA    
BMI at 6-8 weeks postpartum (n=205) -0.164 -1.691 -0.155 0.019 -0.165 -1.708 -0.156 0.019 NA    
∆ weight first GDM visit and end of pregnancy (n=192) 0.092 -0.200 0.926 0.205 0.102 -0.159 0.974 0.157 NA    
∆ weight first GDM visit and 6-8 weeks PP(n=205) 0.105 -0.198 1.467 0.135 0.064 -0.444 1.216 0.360 NA    
HbA1c at 6-8 weeks postpartum(n=206) -0.074 -0.084 0.025 0.291 -0.072 -0.085 0.028 0.315 -0.065 -0.081 0.030 0.358 
Fasting glucose 6-8 weeks postpartum (n=207) -0.163 -0.151 -0.014 0.019 -0.140 -0.140 -0.002 0.045 -0.128 -0.131 0.003 0.059 
2-hr glucose 6-8 weeks postpartum (n=206) -0.025 -0.284 0.196 0.717 -0.006 -0.262 0.239 0.930 -0.024 -0.284 0.201 0.736 
1Means the difference in weight at the end of pregnancy and at first GDM visit  
2Means the difference between weight at the 6-8 weeks postpartum visit and first GDM visit  
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale 2 (IES-2). Higher scores means higher adherence to the EPR subscale 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale 2 (IES-2). Higher scores means higher adherence to the RHSC subscale 
Model 1: Unadjusted regression estimates 
Model 2: Adjusted for age, gestational age smoking, parity and medical treatment during pregnancy 
Model 3: Adjusted for weight 6-8 weeks post-partum  
PP means postpartum  
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Study 2: Intuitive eating is associated with improved health indicators at 1-year postpartum 
in women with GDM  
This study included 117 women. Their mean eating for physical rather than emotional reasons 
subscale at the first GDM visit was 3.86 and 3.76 at 1-year postpartum (p<0.001), and the mean 
scores for reliance on hunger and satiety cues subscale were 3.53 and 3.42 respectively (p<0.001). 
Correlation between the first GDM visit and 1-year postpartum were 0.42 for the eating for physical 
rather than emotional reasons and 0.32 for the reliance on hunger and satiety subscales (both 
p<0.001).  
Associations between intuitive eating during and after pregnancy with metabolic outcomes at 1-
year postpartum  
Table 5 represents the longitudinal and cross-sectional associations between the two subscales of 
IES-2 at the first GDM visit and at 1-year postpartum with metabolic health indicators at 1-year 
postpartum. After adjusting for confounders (age and gestational age at the first GDM visit), the 
eating for physical rather than emotional reasons subscale at the first GDM visit was associated 
with lower BMI (p=0.017), fasting glucose (p=0.014) and tended to predict lower HbA1c (p=0.062) 
at 1-year postpartum. On the other hand, reliance on hunger and satiety subscale at the first GDM 
visit had no association with any of the metabolic health variables at 1-year postpartum (all p>0.2). 
However, both eating for physical rather than emotional reasons and reliance on hunger and satiety 
subscales at 1-year postpartum were associated (cross-sectional) with lower weight retention (both 
p≤0.037) and lower BMI (both p≤0.012). The eating for physical rather than emotional reasons 
subscale was also associated with lower HbA1c and lower fasting glucose (both p=0.018).  
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When fasting glucose and HbA1c were the outcome variables, we further adjusted for BMI at the 
first GDM visit as a potential confounder, which led to the attenuation of the observed associations 
between the two subscales of IES-2 and metabolic parameters (all p≥0.066).  
Associations between intuitive eating during and after pregnancy with metabolic health stratified 
by overweight/obese or with prediabetes 
We also focused on two high-risk GDM subgroups with pre-pregnancy overweight/obese or with 
prediabetes and their lower-risk counterparts. After adjusting for age and gestational age at the first 
GDM visit, in the subgroup of women with prediabetes (Table 6), eating for physical rather than 
emotional reasons and reliance on hunger and satiety subscales at the first GDM visit predicted 
lower fasting glucose at 1-year postpartum (both p≤0.024). At 1-year postpartum, both physical 
rather than emotional reasons and reliance on hunger and satiety subscales were associated with 
less postpartum weight retention (both p≤0.034) and lower BMI (both p≤0.005) in women with 
prediabetes, while no associations were observed in the women with normal glucose tolerance (all 
p ≥0.10) after adjustments for confounders (age and gestational age). In the subgroup of women 
with overweight/obese (Table 7), the physical rather than emotional reasons subscale at the first 
GDM visit predicted lower fasting glucose at 1-year postpartum (p=0.041), whereas the reliance 
on hunger and satiety subscale showed no significance with any of the metabolic variables. At 1-
year postpartum, both physical rather than emotional reasons and reliance on hunger and satiety 
subscales were associated with lower weight retention (both p≤0.009) and fasting glucose (both 
p=0.030). The physical rather than emotional reasons subscale was also associated with lower BMI 
(p<0.001). Thus, in both high-risk subgroups, measures of IE were associated with measures of 
metabolic health such as anthropometric parameters or glucose control variables.  
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Specifically, in both high-risk subgroups, the associations of IES-2 subscales with fasting glucose 
were independent of BMI. However, we found no associations between the two subscales of IES-
2 and metabolic health in the subgroup of women with normal weight. 
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[Table 5] Associations between the two subscales of IES-2 at the first GDM visit and at 1-
year postpartum and metabolic health at 1-year postpartum in the total population  
 
Variable 
Regression 
coefficient 
 
95% CI 
 
P-valuea 
 
P-valueb  
IES-2 at the first GDM visit (longitudinal)      
EPR at the first GDM visit       
Metabolic health at 1-yr pp      
∆Weight retention (kg)1 -0.087 -2.026 0.730 0.350  
BMI  (kg/m2) -0.219 -2.281 -0.151 0.017  
HbA1c (%) -0.171 -0.119 0.008 0.062 0.137 
Fasting glucose (mmol/l) -0.229 -0.251 -0.026 0.014 0.068 
RHSC at the first GDM visit      
Metabolic health at 1-yr pp      
∆Weight retention (kg)1 0.078 -0.815 2.084 0.400  
BMI  (kg/m2) -0.090 -1.637 0.645 0.332  
HbA1c (%) 0.044 -0.048 0.086 0.634 0.327 
Fasting glucose (mmol/l) -0.104 -0.184 0.058 0.272 0.458 
IES-2 at 1-yr pp  (cross-sectional)      
EPR at 1-yr pp      
Metabolic health at 1-yr pp      
∆Weight retention (kg)1 -0.230 -2.976 -0.370 0.012  
BMI  (kg/m2) -0.337 -2.825 -0.829 <0.001  
HbA1c (%) -0.216 -0.129 -0.008 0.018 0.066 
Fasting glucose (mmol/l) -0.222 -0.236 -0.018 0.018 0.237 
RHSC at 1-yr pp      
Metabolic health at 1-yr pp      
∆Weight retention (kg)1 -0.193 -2.847 -0.083 0.037  
BMI  (kg/m2) -0.243 -2.469 -0.313 0.012  
HbA1c (%) -0.095 -0.098 0.032 0.311 0.547 
Fasting glucose (mmol/l) -0.194 -0.230 0.002 0.042 0.208 
1means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2) 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2)  
PP means postpartum  
P-valuea: adjusted for age and gestational age at the first GDM visit 
P-valueb: adjusted for age and gestational age and BMI at the first GDM visit  
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Table 6] Associations between the two subscales of IES-2 at first GDM visit and at one-year postpartum visit with metabolic 
health at one year postpartum stratified by glucose tolerance   
 
 
Variable 
Prediabetes (n=54)  Normal (n=63) 
Regression 
coefficient 
 
95% CI 
 
P-valuea 
 
P-valueb 
Regression 
coefficient 
 
95% CI 
 
P-value 
IES-2 at first GDM visit 
(longitudinal)*     
       
EPR at the first GDM visit               
∆Weight retention (kg) 1 -0.098 -2.598 1.239 0.480  -0.052 -2.461 1.628 0.685 
BMI  (kg/m2) -0.169 -2.415 0.576 0.223  -0.214 -2.748 0.213 0.092 
HbA1c (%) -0.173 -0.158 0.036 0.211 0.189 -0.076 -0.095 0.051 0.553 
Fasting glucose (mmol/l) -0.437 -0.303 -0.063 0.001 0.004 -0.029 -0.106 0.084 0.820 
RHSC at the first GDM visit          
∆Weight retention (kg) 1 -0.090 -2.459 1.254 0.518  0.294 0.453 4.959 0.076 
BMI  (kg/m2) -0.075 -1.857 1.068 0.591  -0.082 -2.300 1.178 0.521 
HbA1c (%) 0.043 -0.080 0.109 0.760 0.751 0.060 -0.064 0.104 0.641 
Fasting glucose (mmol/l) -0.308 -0.247 -0.004 0.024 0.025 0.101 -0.066 0.152 0.432 
IES-2 at 1-year pp (cross-sectional)              
EPR at 1-yr pp              
∆Weight retention (kg)1 -0.288 -3.572 -0.142 0.034  -0.114 -3.111 1.184 0.373 
BMI  (kg/m2) -0.384 -3.248 -0.645 0.004  -0.180 -2.698 0.450 0.158 
HbA1c (%) -1.582 -0.159 0.019 0.120 0.125 -0.001 -0.077 0.077 0.995 
Fasting glucose (mmol/l) -0.204 -0.207 0.031 0.142 0.765 0.083 -0.067 0.132 0.515 
RHSC at 1-yr pp          
∆Weight retention (kg) 1 -0.394 -4.388 -0.935 0.003  -0.030 -2.361 1.861 0.814 
BMI  (kg/m2) -0.378 -3.376 -0.639 0.005  -0.047 -1.851 1.272 0.712 
HbA1c (%) -0.130 -0.139 0.050 0.349 0.253 0.157 -0.028 0.121 0.219 
Fasting glucose (mmol/l) -0.137 -0.190 0.065 0.329 0.842 -0.043 -0.114 0.082 0.740 
*for the fasting glucose, this corresponds to the time point of the GDM diagnosis before the first GDM visit .  
1means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2) 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2) 
P-valuea: Adjusted for age and gestational age at the first GDM visit 
P-valueb: Adjusted for age, gestational age and BMI at the first GDM visit  
PP means postpartum  
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[Table 7] Associations between the two subscales of IES-2 and metabolic health at one year postpartum stratified by BMI 
category 
Variable 
Obese/overweight (n=54)  Normal weight (n=63) 
Regression 
coefficient 
 
95% CI 
 
P-valuea 
 
P-valueb 
Regression 
coefficient 
 
95% CI 
  
P-value 
IES-2 at first GDM visit 
(longitudinal)*         
       
EPR at the first GDM visit              
∆Weight retention (kg) 1 -0.111 -3.466 1.475 0.422  0.026 -1.281 1.567 0.842 
BMI (kg/m2 ) -0.132 -1.779 0.643 0.351  -0.144 -1.183 0.304 0.241 
HbA1c (%) -0.195 -0.157 0.037 0.165 0.169 -0.076 -0.112 0.061 0.553 
Fasting glucose (mmol/l) -0.288 -0.337 0.003 0.041 0.043 -0.083 -0.191 0.098 0.522 
RHSC at  the first GDM visit          
∆Weight retention (kg) 1 0.176 -0.924 4.241 0.203  0.054 -1.188 1.819 0.676 
BMI (kg/m2 ) 0.213 -0.319 2.219 0.137  -0.073 -1.028 0.556 0.554 
HbA1c (%) -0.010 -0.108 0.101 0.967 0.963 0.194 -0.020 0.160 0.127 
Fasting glucose (mmol/l) -0.111 -0.260 0.111 0.419 0.424 0.039 -0.130 0.176 0.765 
IES-2 at 1-year pp (Cross-sectional)                 
EPR at 1-yr              
∆Weight retention (kg) 1 -0.347 -5.152 -0.562 0.009  0.006 -1.349 1.409 0.965 
BMI (kg/m2 ) -0.430 -2.873 -0.735 <0.001  -0.098 -1.019 0.442 0.432 
HbA1c (%) -0.177 -0.156 0.034 0.201 0.233 -0.155 -0.134 0.032 0.225 
Fasting glucose (mmol/l) -0.301 -0.345 -0.015 0.030 0.025 0.001 -0.140 0.140 0.997 
RHSC at 1-yr          
∆Weight retention (kg) 1 -0.405 -6.529 -1.494 0.002  0.077 -0.891 1.656 0.550 
BMI (kg/m2 ) -0.245 -2.467 -1.370 0.780  -0.120 -1.036 0.371 0.348 
HbA1c (%) -0.135 -0.162 0.055 0.329 0.299 0.074 -0.055 0.100 0.564 
Fasting glucose (mmol/l) -0.302 -0.395 -0.021 0.030 0.032 0.040 -0.110 0.151 0.755 
*for the fasting glucose, this corresponds to the time point of the GDM diagnosis before the first GDM visit   
1means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2) 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2) 
P-valuea: Adjusted for age and gestational age at the first GDM visit  
P-valueb: Adjusted for age, gestational age, and BMI at the first GDM visit 
PP means postpartum  
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Study 3: Predictors and consequences of weight retention in the early and late postpartum 
period in women with GDM  
Anthropometric and metabolic characteristics of study participants   
This study included 862 and 259 participants that had data at 6-8 weeks and/or 1-year 
postpartum respectively based on the inclusion criteria. Table 8 shows the anthropometric and 
metabolic characteristics of the study participants. The mean pre-pregnancy BMI was 
25.6±5.4kg/m2 and 52.6%, 27.5% and 19.9% of patients had initial normal weight, overweight 
or were obese before pregnancy, respectively. Total GWG was 12.7±5.9kg. The mean PPWR 
at 6-8 weeks and at 1-year postpartum were 4.6±5.7kg and 4.0±7.4kg respectively. In the 
subgroup of women with 1-year data, the mean fasting glucose increased by 0.48±0.2mmol/l 
between 6-8 weeks and 1-year postpartum, while the mean HbA1c decreased by 0.03±0.01%.  
Anthropometric differences and metabolic consequences of participants according to 
postpartum weight retention categories  
Table 9a shows the participants’ anthropometric differences and metabolic consequences 
according to PPWR categories at 6-8 weeks postpartum. At this time point, 81% of women had 
PPWR. Women with PPWR had significantly higher anthropometric parameters before, during 
and after pregnancy (early postpartum period) compared to those with no PPWR. Specifically, 
they had a 4±3.7kg higher pre-pregnancy weight, a higher pre-pregnancy BMI, a 7.5±0.2kg 
higher total GWG and a 0.23 ±0.1kg higher excess GWG, a higher weight at GDM diagnosis 
and at the end of pregnancy, as well as a 12±2.0kg higher weight at 6-8 weeks postpartum (all 
p≤0.02). In addition, the 2hr glucose after oGTT at GDM diagnosis was slightly higher 
(p=0.034). However, there were no differences in the metabolic parameters (fasting and 2h 
glucose, HbA1c) between both groups at the early postpartum period.  
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At 1-year postpartum, 66.4% of women had PPWR. Compared to those with no PPWR, women 
with PPWR had no differences in anthropometric parameters before and during pregnancy, but 
had a 4±0.4kg higher total GWG, a higher BMI at 6-8 weeks and at 1-year postpartum, and 
were 7±4.2kg heavier at 1-year postpartum (all p≤0.04) (Table 9b). Women with no PPWR, 
on the other hand, had a minimal increase in excess GWG of 0.2 ±0.03kg (p<0.001). In the 
group of women with PPWR, weight did not decrease between the early and late postpartum 
period. The metabolic consequences at 1-year postpartum period showed a 0.2±0.2 mmol/l 
higher fasting glucose in women with PPWR compared to those without PPWR, and a more 
pronounced increase in fasting glucose and in HbA1c between the early and late postpartum 
period (both p≤0.03). We also evaluated the differences in metabolic and medical 
characteristics at 6-8 weeks postpartum in the 259 women with complete 1-year data. The 
results were similar to those in Table 9a.  
Predictors of postpartum weight retention  
In the multivariate logistic regression analysis (Tables 10a and 10b), higher pre-pregnancy 
weight and total GWG predicted higher risk of PPWR at 6-8 weeks postpartum (OR: 1.1, 95% 
CI: 1.03-1.15) and (OR: 1.6, 95% CI: 1.32-1.91), respectively). Higher total GWG also 
predicted higher risk of PPWR at 1-year postpartum (OR: 1.15, 95% CI: 1.07-1.23; model 1). 
This prospective association remained significant in model 2 (OR: 1.2, 95% CI: 1.07-1.24) 
when HbA1c at 6-8 weeks postpartum was included as potential predictor. In model 2, higher 
HbA1c at 6-8 weeks postpartum (OR: 0.16, 95% CI: 0.05-0.49) was associated with less PPWR 
at 1-year postpartum.   
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Table 8: Anthropometric and metabolic characteristics of study participants   
Variable  Mean SD 
Pre-pregnancy weight (Kg) (n=862) 69.09 15.38 
Pre-pregnancy BMI (Kg/m2)1 (n=862) 25.62 5.45 
Weight at the first GDM visit (Kg) (n=862) 79.53 15.36 
BMI at the first GDM visit (Kg/m2) (n=862)  29.72 5.41 
Fasting glucose at the first GDM visit (mmol/l) (n=862) 5.15 0.75 
1hr glucose after oGTT at GDM diagnosis (mmol/l) (n=862) 9.63 1.85 
2hr glucose after oGTT at GDM diagnosis (mmol/l) (n=862) 7.85 1.83 
HbA1c at the first GDM visit (%) (n=862) 5.44 0.41 
Weight at the end of pregnancy (Kg) (n=862) 81.86 15.42 
Total gestational weight gain (Kg) (n=862) 12.75 5.96 
Weight at the 6-8 weeks pp (Kg) (n=862) 73.58 15.05 
BMI at the 6-8 weeks pp (Kg/m2) (n=862) 27.54 5.35 
Fasting glucose at the 6-8 weeks pp (mmol/l) (n=862)  5.00 0.52 
2hr glucose after oGTT at 6-8 weeks pp (mmol/l) (n=862) 5.50 1.68 
HbA1c at the 6-8 weeks pp (%)(n=862) 5.35 0.38 
Weight at 1-year pp (Kg) (n=259) 73.49 17.15 
BMI at 1-year pp (Kg/m2) (n=259)  27.41 6.30 
Fasting glucose at 1-year pp (mmol/l) (n=259) 5.48 0.67 
HbA1c at 1-year pp (%)(n=259)  5.32 0.39 
Weight retention at 6-8 weeks pp2 (n=862) 4.61 5.79 
Weight retention at 1-year pp3 (n=259) 3.99 7.36 
1Data taken from the medical charts or reported at the first GDM visit   
2Weight retention means the difference in weight at 6-8 weeks postpartum and pre-pregnancy weight 
3Weight retention means the difference in weight at 1-year postpartum and pre-pregnancy weight 
BMI means body mass index  
GDM means gestational diabetes mellitus 
oGTT means oral glucose tolerance test  
HbA1c means glycated hemoglobin 
pp means postpartum period 
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Table 9: Anthropometric differences and metabolic consequences of participants 
according to postpartum weight retention categories 
 
9a: At 6-8 weeks postpartum 
 6-8 weeks postpartum 
Weight retention category at 6-8 weeks PP 
(n=862)1 
 
Weight retention 
(n=700) 
No weight retention 
(n=162)  
General and metabolic health variables*  Mean SD Mean SD p value 
Age (years) 33.39 5.43 32.91 5.77 0.340 
Gestational age at delivery (weeks) 38.68 1.49 38.38 3.52 0.283 
Pre-pregnancy weight (Kg) 70.49 17.51 66.76 13.81 <0.001 
Pre-pregnancy BMI (Kg/m2)2 26.35 6.26 24.75 4.86 <0.001 
Weight at the first GDM visit (Kg) 80.93 16.96 71.45 14.76 <0.001 
Fasting glucose at first GDM visit (mmol/l) 5.16 0.65 5.15 0.77 0.843 
1hr glucose after oGTT at GDM diagnosis (mmol/l) 9.70 1.70 9.62 1.88 0.658 
2hr glucose after oGTT at GDM diagnosis (mmol/l) 8.18 1.70 7.78 1.85 0.034 
Weight at the end of pregnancy (Kg) 84.63 16.66 73.58 14.23 0.015 
Total gestational weight gain (Kg) 14.16 5.14 6.63 5.36 <0.001 
Excess gestational weight gain (Kg) 1.73 0.44 1.50 0.50 <0.001 
Weight at 6-8 weeks pp (Kg) 75.40 16.66 63.14 14.62 0.002 
BMI at 6-8 weeks pp (Kg/m2) 27.10 5.91 23.40 5.19 0.020 
Fasting glucose at 6-8 weeks pp (mmol/l)  4.99 0.50 5.01 0.52 0.643 
2hr glucose after oGTT at 6-8 weeks pp (mmol/l) 5.37 1.57 5.53 1.70 0.269 
HbA1c at 6-8 weeks pp (%) 5.32 0.40 5.35 0.37 0.357 
Predictor variables* n % n % P value 
EPDS score at first GDM visit (n=346)      
<13 237 84.0 45 16.0 0.031 
≥13 46 71.9 18 28.1  
Breastfeeding in the postpartum period       
Yes   548 80.1 136 19.9 0.065 
No 152 85.4 26 14.6  
Medication use in pregnancy (n=777)      
None 292 80.0 73 20.0 0.041 
Insulin 284 82.8 59 17.2  
Metformin  48 69.6 21 30.4  
Caesarean delivery       
Yes 281 82.4 60 17.6 0.477 
No 419 80.4 102 19.6  
Contraception use after delivery (n=305)      
Yes 140 82.4 30 17.6 0.897 
No 110 81.5 25 18.5  
Lives with partner      
Yes 566 80.2 140 19.8 0.097 
No 134 85.9 22 14.1  
Exceed IOM guidelines       
Yes 347 89.0 43 11.0 ≤0.001 
No 353 74.8 119 25.2  
EPR at first GDM visit (Mean ±SD) 3.89 0.911 3.93 0.86 0.774 
RHSC at first GDM visit (Mean ±SD) 3.50 0.88 3.56 0.82 0.669 
1Weight retention means the difference in weight at 6-8 weeks and pre-pregnancy weight 
2Data reported at the first GDM visit or taken from the medical charts 
GDM means gestational diabetes mellitus; BMI means body mass index; oGTT means oral glucose tolerance test  
HbA1c means glycated hemoglobin; EPR means eating for physical rather than emotions; RHSC means reliance on hunger 
and satiety cues; EPDS means Edinburg postnatal depression scale; IOM means institute of medicine; pp means postpartum 
period; P value derived from ANOVA for continuous variables and Chi-square for categorical variables  
Bold p values are significant. *All n’s are 826 unless otherwise stated. 
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9b: At 1-year postpartum  
 1-year postpartum  Weight retention category at 1-year PP (n=259)1 
 
Weight retention 
(n=172) 
No weight 
retention  (n=87)  
General and metabolic health variables* Mean SD Mean SD p value 
Age (years) 32.93 5.86 34.00 4.74 0.147 
Gestational age at delivery (weeks) 38.78 1.71 38.82 1.86 0.888 
Pre-pregnancy weight (Kg) 68.78 15.42 69.97 14.10 0.564 
Pre-pregnancy BMI (Kg/m2)2 25.81 5.67 25.62 5.18 0.792 
Weight at the first GDM visit (Kg) 80.28 15.97 78.58 13.48 0.427 
Fasting glucose at first GDM visit (mmol/l) 5.24 1.00 5.11 0.77 0.328 
1hr glucose after oGTT at GDM diagnosis (mmol/l) 9.68 2.00 9.61 1.96 0.817 
2hr glucose after oGTT at GDM diagnosis (mmol/l) 7.85 2.02 7.99 1.85 0.651 
Weight at the end of pregnancy (Kg) 82.82 15.47 80.02 13.60 0.188 
Total gestational weight gain (Kg) 14.16 6.15 10.08 5.76 <0.001 
Excess gestational weight gain (Kg) 1.44 0.49 1.68 0.46 <0.001 
Weight at 6-8 weeks pp (Kg) 74.88 14.92 71.96 13.01 0.121 
BMI at 6-8 weeks pp (Kg/m2) 28.08 5.36 26.66 4.66 0.044 
Fasting glucose at 6-8 weeks pp (mmol/l)  5.00 0.518 4.97 0.45 0.618 
2hr glucose after oGTT at 6-8 weeks pp (mmol/l) 5.26 1.42 5.22 1.63 0.841 
HbA1c at 6-8 weeks pp (%) 5.27 0.36 5.40 0.34 0.009 
Weight at 1-year pp (Kg) 75.79 18.08 68.67 13.92 0.002 
BMI at 1-year pp (Kg/m2) 28.42 6.55 25.05 4.93 <0.001 
EPR at 1-year pp 3.64 0.92 3.75 10.4 0.478 
RHSC at 1-year pp 3.31 0.94 3.59 0.95 0.057 
Fasting glucose at 1-year pp (mmol/l) 5.55 0.72 5.35 0.55 0.026 
HbA1c at 1-year pp (%) 5.33 0.42 5.31 0.33 0.739 
∆Fasting glucose3 0.54 0.61 0.37 0.54 0.032 
∆HbA1c3 0.05 0.39 -0.08 0.37 0.006 
1Weight retention means the difference in weight at 6-8 weeks and pre-pregnancy weight. 2Data reported at the first GDM 
visit or taken from the medical charts. 3Change in metabolic variables (fasting glucose and HbA1c) between 6-8 weeks and 
1year postpartum. GDM means gestational diabetes mellitus; BMI means body mass index; oGTT means oral glucose 
tolerance test; HbA1c means glycated hemoglobin; EPR means eating for physical rather than emotions; RHSC means 
reliance on hunger and satiety cues; EPDS means Edinburg postnatal depression scale; IOM means institute of medicine; pp 
means postpartum period; P value derived from ANOVA for continuous variables and Chi-square for categorical variables. 
*All the N’s are 259 unless otherwise stated. Bold p values are significant.  
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9b: At 1-year postpartum (continued) 
 1-year postpartum  Weight retention category at 1-year PP (n=259)1 
 
Weight retention 
(n=172) 
No weight retention  
(n=87)  
Predictor variables* n % n % P value 
EPDS score at first GDM visit (n=172)      
<13 99       71.7 39 28.3 0.144 
≥13 20 58.8 14 41.2  
EPDS score at first 1-year pp (n=213)      
<13 119 64.7 65 35.3 0.930 
≥13 19 65.5 10 34.5  
Breastfeeding in the postpartum period      
Yes   152 67.3 74 32.7 0.450 
No 20 60.6 13 39.4  
Medication use in pregnancy (n=248)      
None 75 68.2 35 31.8 0.791 
Insulin 83 69.2 37 30.8  
Metformin  11 61.1 7 38.9  
Caesarean delivery      
Yes 70 64.8 38 35.2 0.690 
No 102 6705 49 32.5  
Contraception use after delivery (n=134)      
Yes 39 61.9 24 38.1 0.217 
No 53 74.6 18 25.4  
Lives with partner      
Yes 146 68.2 68 31.8 0.177 
No 26 57.8 19 42.2  
Exceed IOM guidelines       
Yes 96 78.0 27 22.0 ≤0.001 
No 76 55.9 60 44.1  
EPR at first GDM visit (Mean ±SD) 3.84 0.94 3.85 0.90 0.962 
RHSC at first GDM visit (Mean ±SD) 3.50 0.87 3.39 0.86 0.465 
1Weight retention means the difference in weight at 6-8 weeks and pre-pregnancy weight. 2Data reported at the first GDM 
visit or taken from the medical charts. 3Change in metabolic variables (fasting glucose and HbA1c) between 6-8 weeks and 
1year postpartum. GDM means gestational diabetes mellitus; BMI means body mass index; oGTT means oral glucose 
tolerance test; HbA1c means glycated hemoglobin; EPR means eating for physical rather than emotions; RHSC means 
reliance on hunger and satiety cues; EPDS means Edinburg postnatal depression scale; IOM means institute of medicine; pp 
means postpartum period; P value derived from ANOVA for continuous variables and Chi-square for categorical variables. 
*All the N’s are 259 unless otherwise stated. Bold p values are significant.  
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Table 10: Predictors of weight retention 
 
10a: Predictors at 6-8 weeks postpartum (n=862)  
Variable  OR 95% CI P value* 
Pre-pregnancy weight (Kg) 1.09 1.035 1.150 <0.001 
Total gestational weight gain (Kg) 1.59 1.324 1.919 <0.001 
Excess gestational weight gain (Kg) 4.08 0.857 19.466 0.077 
Weight retention means the difference in weight at 6-8 weeks postpartum and pre-pregnancy weight 
*P value from the final model of the multivariable logistic regression with backward elimination  
Variables entered in the multivariable regression models were: family history of diabetes, partner support, breastfeeding and 
depression score at the first GDM visit, pre-pregnancy weight, 2hr glucose after oGTT at GDM diagnosis, total GWG, and 
excess GWG according to IOM guidelines. 
 
 
 
 
 
 
10b: Predictors at 1-year postpartum (n=259) 
 Model 1 Model 2 
Variable  OR 95% CI P value* OR 95% CI P value* 
Total Gestational weight gain (kg) 1.15 1.072 1.231  <0.001 1.15 1.076  1.245 <0.001 
HbA1c at 6-8 weeks pp (%)     0.16 0.052 0.490 <0.001 
pp means postpartum period 
Weight retention means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
Model 1: without HbA1c at 6-8 weeks pp 
Model 2: included HbA1c at 6-8 weeks pp 
* P value from the final model of the logistic regression with backward elimination 
Variables entered in the multivariable regression model were: age, family history of diabetes, partner support, depression 
score at the first GDM visit, total GWG, excess GWG, and HbA1c at 6-8 weeks postpartum visit
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Abstract  
 
Introduction: High pre-pregnancy weight and body mass index (BMI) increase the risk of 
gestational diabetes mellitus (GDM) and diabetes after pregnancy. To tackle weight and 
metabolic health problems, there is a need to investigate novel lifestyle approaches. Outside of 
pregnancy, higher adherence to intuitive eating (IE) is associated with lower BMI and improved 
glycemic control. This study investigated the association between IE and metabolic health 
during pregnancy and in the early postpartum period among women with GDM.  
Methods: Two-hundred and fourteen consecutive women aged ≥18, diagnosed with GDM 
between 2015 and 2017 and completed the “Eating for Physical rather than Emotional Reasons 
(EPR)” and “Reliance on Hunger and Satiety cues (RHSC) subscales” of the French Intuitive 
Eating Scale-2 (IES-2) questionnaire at the first GDM clinic visit was included in this study. 
Results: Participants’ mean age was 33.32±5.20 years. Their weight and BMI before pregnancy 
were 68.18±14.83kg and 25.30±5.19kg/m2 respectively. After adjusting for confounding 
variables, the cross-sectional analyses showed that the two subscales of IES-2 at the first GDM 
visit were associated with lower weight and BMI before pregnancy, and lower weight at the 
first GDM visit (β=-0.181 to -0.215, all p≤ 0.008). In addition, the EPR subscale was associated 
with HbA1c and fasting plasma glucose at the first GDM visit (β=-0.170 and to -0.196; all p≤ 
0.016). In the longitudinal analyses, both subscales of IES-2 at first GDM visit were associated 
with lower weight at the end of pregnancy, BMI and fasting plasma glucose at 6-8 weeks 
postpartum (β=-0.143 to -0.218, all P≤ 0.040) after adjusting for confounders.  
Conclusions: Increase adherence to IE could represent a novel approach to weight and glucose 
control during and after pregnancy in women with GDM.  
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5.2 ABSTRACT OF STUDY 2 
Intuitive Eating is associated with Improved Health Indicators at 1-Year Postpartum in 
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Abstract 
Introduction: In women with GDM, there is a need to investigate novel lifestyle approaches 
to reduce the risk of future diabetes. We evaluated the associations between IE during and after 
pregnancy with BMI, fasting glucose and HbA1c at 1-year postpartum (PP) in women with 
GDM and in high-risk GDM subgroups with prediabetes or overweight/obesity prior to 
pregnancy.  
Methods: 117 women with GDM who consented and completed the “Eating for Physical 
rather than Emotional Reasons (EPR)” and “Reliance on Hunger and Satiety cues (RHSC)” 
subscales of the validated Intuitive Eating Scale-2 questionnaire during the first GDM clinic 
visit at 24-32 weeks of gestation and at 1-year PP were included.  
Results: Participants mean age was 33.21±5.37 years, weight and BMI before pregnancy and 
at 1-year PP were 69.46±13.99kg, 25.82±4.69kg/m2 and 72.79±16.22kg, 27.06±5.54kg/m2, 
respectively. EPR at the first GDM visit predicted lower BMI (β=-0.219, p=0.017) and fasting 
glucose (β=-0.229, p=0.014) at 1-year PP, while associations were not significant for RHSC. 
At 1-year PP, EPR and RHSC were associated with lower BMI (β= -0.337 and -0.243 both p≤ 
0.012) and weight retention (β=-0.230 and -0.193, both p=0.037) and EPR was also associated 
with lower fasting glucose and HbA1c (both β= -0.22, both p=0.018). In the subgroup of women 
with prediabetes, EPR and RHSC at the first GDM visit predicted lower fasting glucose at 1-
year PP, while in the overweight/obese subgroup this was only significant for EPR (all p≤0.02). 
At 1-year PP however, both EPR and RHSC were inversely associated with BMI in women 
with prediabetes and with fasting glucose in overweight/obese women (all p≤0.03).  
Conclusion: Interventions to increase IE could represent a novel approach for PP weight and 
glycemic control in women with previous GDM, particularly in high-risk subgroups with 
prediabetes or obesity.   
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Abstract 
Aims: We investigated the predictors and consequences of postpartum weight retention 
(PPWR) in the early and late postpartum period in women with gestational diabetes (GDM), to 
assist preventive strategies.  
Methods: 862 women with GDM were prospectively included between 2011 and 2019. We 
investigated PPWR at 6-8 weeks and 1-year postpartum. Potential predictors included 
gestational weight gain (GWG), weight, BMI, and glucose control parameters during and after 
pregnancy.  
Results: PPWR at 6-8 weeks and 1-year postpartum were 4.6±5.7kg and 4.0 ±7.4kg. At 6-8 
weeks postpartum, women with PPWR had higher pre-pregnancy weight, 7.5±0.2kg higher 
GWG and higher postpartum weight (all p≤0.02), without presenting metabolic differences. At 
1-year postpartum, there were no differences in anthropometric parameters before and during 
pregnancy between women with or without PPWR, except for a 4±0.4kg higher GWG 
(p<0.001). However, women with PPWR had increased postpartum weight and BMI, higher 
fasting glucose and more pronounced increases in ∆fasting glucose and ∆HbA1c at 1-year (all 
p≤0.03). GWG predicted higher PPWR at both 6-8 weeks and at 1-year PP (all p<0.001).  
Conclusion: Women with PPWR had increased anthropometric parameters and adverse 
metabolic consequences at 1-year postpartum. GWG was the most relevant predictor of PPWR.    
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6.0 GENERAL DISCUSSION 
This thesis provides more insights into the novel cross-sectional and longitudinal relationships 
between IE and weight and fasting glucose levels in women with GDM. It also identifies the 
predictors and the consequences of PPWR in the early and late postpartum period in women 
with GDM.   
Cross-sectional association between intuitive eating and metabolic outcome (Study 1 & 2) 
Our analyses revealed a novel association between IE during pregnancy (at the first GDM visit) 
with lower BMI and weight before and during pregnancy as well as with fasting glucose and/or 
HbA1c during pregnancy (study 1). The relationship between IE and fasting glucose was partly 
mediated by weight (study 1). In study 2, we found that, IE at 1-year postpartum was associated 
with lower BMI, lower weight retention, fasting glucose and HbA1c at 1-year postpartum. Our 
results corroborate the findings of a cross-sectional review which indicated that IE was 
positively related with improved dietary intake and/or healthy eating behaviors. Those factors  
are drivers for weight loss and glucose maintenance (118). Eating intuitively is known to 
improve hunger and satiety cues, exert more cognitive control over eating and increase response 
to physiological signals which leads to lower weight and BMI (36). The results of study 1 and 
2 are also consistent with a cross-sectional study among postpartum women where higher 
practice or adherence to IE was associated with accelerated rates of postpartum weight loss 
(119). Following a more IE approach to food consumption may encourage postpartum weight 
loss without the required diet restrictions, calorie counting and exercise regimes all of which 
are features of traditional weight loss programs. Regarding glycemic control, the findings of 
this study are in line with those of Wheeler and colleagues who showed that higher adherence 
to the eating for physical rather than emotional reasons subscale of the IES-2 was associated 
with lower HbA1c in a cross-sectional study (128).  
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They are also in line with a cross-sectional review in which IE was associated with 
improvements in metabolic health indicators, including fasting glucose (118). The eating for 
physical rather than emotional reasons subscale is known to be negatively associated with 
disordered eating behaviors and may lead to lower fasting glucose and HbA1c levels (38). 
These results indicate that aiming to improve IE during pregnancy and the ability to keep this 
practice stable and even higher in the postpartum period may help to improve weight and fasting 
glucose levels in these women.  
 
Longitudinal association between intuitive eating and metabolic outcomes (Study 1 & 2)  
We also explored the longitudinal relationship between IE with weight and fasting glucose 
levels during the early and late postpartum period. We found that IE during pregnancy (at the 
first GDM visit) was associated with lower weight at the end of pregnancy, lower BMI and 
lower fasting glucose at 6-8 weeks postpartum (study 1). Also, eating for physical rather than 
emotional reasons during pregnancy (at the first GDM visit) was associated with lower BMI at 
1-year postpartum (study 2). These findings are in concordance with a previous study conducted 
in a general non-pregnant population where IE was associated with lower weight gain and BMI 
decreases at 1-year postpartum (119). IE assesses the extent to which eating is affected by 
emotion (92) and women with GDM who engage in eating habits or behaviors driven by 
emotion rather than physical symptoms of hunger during and after pregnancy may have more 
problems with weight loss and fasting glucose control in the postpartum period (119). Adhering 
to IE prevents or reduces eating in response to negative emotional states such as anxiety, 
depression, boredom or loneliness that often leads to overeating, weight retention, higher BMI 
and poor glucose control in women with GDM (129). IE could therefore offer an alternative 
approach that may be rewarding and less exhausting to aid early and late postpartum weight 
loss in women with GDM (119).  
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In study 2, we also found that both subscales of IES-2 during pregnancy (at the first GDM visit) 
were associated with lower fasting glucose at 1-year postpartum in all women with GDM and 
in women with prediabetes at 1-year postpartum. Also the eating for physical rather than 
emotional reasons during pregnancy (at the first GDM visit) predicted lower fasting glucose in 
women with obese/overweight BMI. The relationship between IE and lower fasting glucose in 
women with prediabetes and obese/overweight showed that special focus should be placed on 
these women for follow-up. This is particularly important because in women with GDM and in 
high-risk GDM subgroups (with prediabetes and obese/overweight) each kilogram of weight 
lost in the postpartum period is associated with a 16% decrease in the risk of diabetes (130–
132).  It should also be noted that although women with GDM might have normal glucose 
values after delivery (133), up to 50% develop prediabetes between 6 weeks and 12 months as 
observed in our sample and confirmed by another study (22).    
On the contrary, we found no longitudinal association between the reliance on hunger and 
satiety cues subscale during pregnancy (at the first GDM visit) with either weight or glucose 
control variables studied at 1-year postpartum. This lack of association between the reliance on 
hunger and satiety cues subscale and the weight and fasting glucose variables in our longitudinal 
analyses suggests that in the long-term eating for physical rather than emotional reasons 
overshadows the potential importance of relying on one’s hunger and satiety signals to regulate 
food intake in this sample. Outside of pregnancy, intervention studies have revealed that IE is 
associated with weight loss (115,116) leads to weight maintenance and improves physical 
health indicators including glucose control (102,108). Our results have important clinical 
implications which suggest that IE could represent a novel approach for weight and glycemic 
control during and after pregnancy in women diagnosed with GDM. However, intervention 
studies should be performed to verify these hypotheses.  
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Predictors of PPWR (Study 3) 
In women with GDM, one previous study exists regarding the predictors of PPWR (31). It 
demonstrated that less GWG, increasing age and lack of insulin use during pregnancy were 
associated with losing ≥75% of pregnancy weight at 6-8 weeks postpartum. In our study GWG 
was also associated with PPWR but we did not find an association with age or insulin use during 
the initial univariate regression analyses and hence these variables were not included in the 
main predictor models. In non-GDM populations, many studies support GWG as a strong and 
pronounced predictor of PPWR at 6 weeks (55) and up to 12 months postpartum (56–59) as 
found in our study. Our results are also consistent with those of other studies conducted in non-
GDM populations which showed that women with PPWR had higher GWG leading to higher 
weight status in the late postpartum period (53,134,135). This is explained by the role of excess 
adipose tissue due to sub-optimal diet and physical activity behaviors before/during pregnancy 
that leads to excess weight gain and extends into the postpartum period leading to a higher 
weight retention in the late postpartum period (136–138). Other studies indicate that exceeding 
IOM guidelines (=excessive GWG) increases the risk of PPWR at 6 to 18 months (60–62). To 
our knowledge, these latter studies only investigated excessive GWG without including total or 
absolute GWG. In this study however, although exceeding IOM guidelines (=excessive GWG) 
was associated with PPWR, this relationship did not remain significant after adjusting for total 
GWG. This means that excessive GWG does not impact on PPWR beyond the impact of total 
GWG. Total GWG was the most important predictor of PPWR in our cohort. This is even more 
relevant as excess GWG was not very pronounced and represented less than 2kg even in women 
with PPWR. Based on the results, at least regarding postpartum metabolic health, the currently 
existing IOM guidelines are probably too flexible for a multicultural population with GDM and 
hence should be revised.  
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Consequences of weight retention (Study 3)  
Study 3 revealed that women with and without PPWR at 6-8 weeks postpartum differed 
significantly in anthropometric characteristics (weight, BMI, GWG) before, during and after 
pregnancy. At 1-year postpartum however, they only differed in anthropometric characteristics 
in the postpartum period, i.e. both in the early (BMI) and late (weight, BMI) postpartum periods. 
Regarding metabolic consequences, no differences were seen in the early postpartum period 
between women with and without PPWR. In the late postpartum period, women with PPWR 
had higher fasting glucose and more pronounced increases in both fasting glucose and HbA1c 
between the early and late postpartum period. Thus, regarding metabolic consequences, 
differences between women with and without PPWR were only seen at 1-year postpartum. This 
finding suggests that late PPWR had an impact on glucose control at 1-year postpartum which 
might not reveal itself yet in the early postpartum period. Reasons such as sub-optimal diet and 
physical activity behaviors before/during/after pregnancy (136–138), depressive symptoms 
and/or short sleep duration (139,140) or breastfeeding (54) and its discontinuation as most of 
these patients do not breastfeed beyond 6 months could account for the differences in the 
anthropometric characteristics observed in women with PPWR. Regarding breastfeeding, 85% 
of women in our cohort who were still breastfeeding at 6-8 weeks postpartum had no PPWR in 
the late postpartum period. Findings of one previous study parallels our results (21): it 
demonstrated that weight gain in the first year postpartum was associated with a significant 
increase in  fasting and 2-h glucose in women with GDM.  
It is thus essential to focus on prevention of later PPWR e.g. at 1-year postpartum, which 
actually concerns two thirds of women in our cohort and in published populations. A lack of 
PPWR or of metabolic complications at 6-8 weeks postpartum although reassuring should 
therefore not lead to complacency.  
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This is especially important as only a minority (10%) continues to lose weight after the early 
postpartum period in our study and those with PPWR at 1-year even demonstrated a small 
weight gain between the early and late postpartum period. These findings contradict the usual 
clinical recommendation that the PPWR at 6-8 weeks postpartum is not important as women 
will anyway loose more weight in the first year postpartum.  
Our data regarding the consequences of PPWR also suggest that clinical care with a strong 
focus on lifestyle interventions in order to improve weight and glucose control beyond a pure 
screening should be essential up to the late postpartum. This postpartum follow-up should not 
be limited to screening for metabolic health indicators only but must focus on lifestyle changes. 
This is because even women without PPWR had a significant increase in fasting glucose 
between the early and late postpartum period despite almost a 3kg weight loss between these 
time points suggesting the need for an extended postpartum follow-up period.   
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7.0 STRENGTHS, LIMITATIONS AND PERSPECTIVES 
Strengths of this thesis 
This study has several strengths. It is the first to investigate the relationship between IE with 
metabolic health during and after pregnancy. It is also the first to investigate IE and metabolic 
health in women with GDM and in a real-life clinical setting. We used a well-developed and 
validated tool to measure IE. Clinically, our results if confirmed by an intervention trial could 
help address the issue of postpartum weight retention in women with GDM. It could also help 
augment the management and prevention of diabetes in women with GDM in general and in 
the high-risk subgroups with prediabetes or overweight/obese specifically (141).  This is even 
more important, as lifestyle interventions continue to show inconsistent results and effect sizes 
are small (10,73,75). This study is also the first to investigate both total and excessive GWG as 
predictors of PPWR as most studies focus exclusively on excessive GWG. In our cohort, total 
GWG showed a more important role in PPWR prediction than excess GWG. In terms of 
metabolic consequences of PPWR, adverse metabolic differences and outcomes were only seen 
in the late postpartum period.  
Limitations of this thesis  
Even though the results of this thesis are novel, they must be interpreted with caution and some 
limitations prevail. One limitation of this thesis is the lack of food and dietary intake data in the 
cohort database. Although we focused on the role of nutritional behavior and metabolic 
outcomes in women with GDM, it should be important now to investigate the relationship 
between IE with dietary intake and food quality in these women. In addition, factors such as 
dietary counseling and use of medication during pregnancy could influence weight and 
glycemic control and may account for some observed relationships in our longitudinal analysis, 
even though we measured study variables before dietary counselling and also adjusted for 
medication use during pregnancy in our analyses.  
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Furthermore, women had no medication intake in the postpartum period. The lack of a total 
IES-2 score in our analyses may be a source of limitation as it would have been interesting to 
see the overall effect of IES-2 on our outcomes. Even though the IES-2 has been validated both 
in the general and pregnant population, it is not validated in women with GDM and could be a 
limitation of our study. Other limitations such as a relatively small sample size in our 
longitudinal analyses may limit our ability to generalize those findings. In addition, several 
psychosocial and behavioral factors including family support, smoking status in the postpartum 
period, willingness and change in attitudes following GDM diagnosis which were not the focus 
of this thesis could influence weight changes especially in the postpartum period. Another 
limitation is the inability to test the causality of these associations in an intervention trial as data 
is still ongoing in our randomized controlled intervention trial.  
 
Perspectives for future research  
This prospective clinical cohort of women with GDM showed that IE could potentially be a 
novel approach for weight and glucose management during pregnancy and in the postpartum 
period. Studies 1 and 2, found that, the eating for physical rather than emotional reasons 
subscale of the IES-2 was a better predictor of improved cardio-metabolic outcomes than the 
reliance on hunger and satiety cues subscale independent of covariate adjustment. It is therefore 
important that future studies investigates the individual subscales of the IES-2 as well as the 
influence of the total IES-2 score and its contribution to both weight and glucose control in 
women with GDM. Dietary counseling during pregnancy, can both influence weight and 
glycemic control in the long-term and hence future research should investigate its potential 
longitudinal influence. Most importantly, research that utilizes IE as an intervention for weight 
retention and glucose control in a larger and multicultural population during pregnancy is 
needed to determine the causality of these novel associations we have found.  
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In studies outside of the perinatal period, IE could be modulated and thus can be influenced. 
This hints to the assumption that IE is not just a trait, but also a state that could be influenced.  
In our ongoing lifestyle interventional trial in women with GDM, we hope test the association 
between an IE intervention with metabolic health outcome during and after pregnancy. We will 
also investigate the relationship between dietary intake and IE and if indeed higher IE scores 
relates to dietary quality as well as their relationship with metabolic outcomes. We will also 
investigate the relationship between maternal diet quality and intuitive eating during pregnancy 
with offspring metabolic outcomes.  
Regarding the predictors of weight retention, our results indicate that currently existing IOM 
guidelines for (excess) GWG maybe too relaxed concerning postpartum weight and metabolic 
health in women with GDM. It is thus essential to control GWG. It will also be pertinent for 
these guidelines to be reviewed for women with GDM. It is essential for future research to focus 
on postpartum weight retention even after the recommended postpartum routine screenings 
because the lack of postpartum weight retention or of metabolic complications at 6-8weeks 
postpartum, although reassuring, should not lead to complacency as only a minority continues 
to lose weight after the early postpartum period. There is therefore the need to extend the 
postpartum follow-up period with special focus on lifestyle interventions.  
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8.0 GENERAL CONCLUSION 
This thesis provides insights into the relationships between nutrition behavior (focusing on 
intuitive eating (IE)) and weight and fasting glucose outcomes in women with GDM. It also 
provides an understanding of the predictors and consequences of weight retention in the 
postpartum period in women with GDM. In a prospective clinical cohort of women with GDM, 
we found a novel cross-sectional association between IE, specifically the two subscales of IES-
2 (eating for physical rather than emotional reasons and reliance on hunger and satiety cues) 
with lower weight and BMI before, during pregnancy and at the 6-8 weeks and 1-year 
postpartum in both study 1 and 2. The eating for physical rather than emotional reasons subscale 
was also associated with lower HbA1c and fasting glucose in the cross-sectional analyses. Our 
longitudinal analyses (study 1 & 2) confirmed the novel relationship between the eating for 
physical rather than emotional reasons subscale and lower fasting glucose and HbA1c in our 
cross-sectional associations in study 1. In the high-risk GDM subgroups with 
overweight/obesity or prediabetes, IE was associated with lower BMI, weight retention and 
fasting glucose. These cross-sectional and longitudinal relationships between IE with weight 
and fasting glucose outcomes during and after pregnancy reveals that IE could be a future target 
for screening and a potential intervention in women with GDM especially when success from 
traditional lifestyle interventions remains low. 
In Study 3, total GWG was the most important predictor of PPWR beyond the impact of excess 
GWG. Regarding metabolic consequences between women with and without PPWR, 
differences were only seen in the late postpartum period. However, all women showed an 
increase in fasting glucose between the 6-8 weeks and 1-year postpartum. Our data regarding 
PPWR and metabolic health suggest that beyond the recommended postpartum screenings, 
there is a need for a continuous lifestyle intervention for women with GDM.  
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Weight loss or lifestyle interventions should also focus on GWG and could help reduce the risk 
of PPWR and importantly to improve cardio-metabolic consequences. In conclusion, the 
findings of this thesis imply that IE might have practical implications on weight and glucose 
control during and after pregnancy in women with GDM and in high-risk GDM subgroups with 
prediabetes or overweight/obesity. It also demonstrates that studying the pattern of PPWR can 
help to focus efforts and target optimal timing for interventions in women with GDM in the 
postpartum period in order to prevent diabetes and other cardio-metabolic outcomes. Most 
importantly intervention studies should be performed in order to test our hypotheses.   
8.1 Personal contribution to data acquisition and management  
The GDM research group is a multidisciplinary research group composed of dieticians, 
physiotherapist, physicians and researchers including psychologists, sport scientists and 
graduate students. I participate in two projects managed by the research group. These are the 
GDM longitudinal cohort and a lifestyle intervention trial. In the lifestyle intervention trial 
(Improving Cardio-metabolic and Mental Health in Women With Gestational Diabetes Mellitus 
and their Offspring (MySweetHeart); NCT02890693), I coordinate the participant recruitment 
in English, supervises interns on patient testing, addresses and answer questions from interns 
and clinicians on testing procedures and the trial protocol. The analyses of this ongoing trial 
which include an IE intervention will be part of my Postdoctoral training which will focus on 
testing the hypotheses involved in this thesis. In both the cohort and intervention trial, I manage 
the Secutrial research database and supervises data input by master’s students and performs 
data extraction for different research purposes. In this role, I produced a detailed systematic and 
regular update of data input guideline to aid data input. I also supervise and coordinate the 
preparation of research kits for blood drawing and responsible for weekly contact with 
laboratory for blood samples, analysis and assistance in blood drawing.  
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Abstract  
 
Introduction: High pre-pregnancy weight and body mass index (BMI) increase the risk of 
gestational diabetes mellitus (GDM) and diabetes after pregnancy. To tackle weight and 
metabolic health problems, there is a need to investigate novel lifestyle approaches. Outside of 
pregnancy, higher adherence to intuitive eating (IE) is associated with lower BMI and improved 
glycemic control. This study investigated the association between IE and metabolic health 
during pregnancy and in the early postpartum period among women with GDM.  Methods: 
Two-hundred and fourteen consecutive women aged ≥18, diagnosed with GDM between 2015 
and 2017 and completed the “Eating for Physical rather than Emotional Reasons (EPR)” and 
“Reliance on Hunger and Satiety cues (RHSC) subscales” of the French Intuitive Eating Scale-
2 (IES-2) questionnaire at the first GDM clinic visit was included in this study. Results: 
Participants’ mean age was 33.32±5.20 years. Their weight and BMI before pregnancy were 
68.18±14.83kg and 25.30±5.19kg/m2 respectively. After adjusting for confounding variables, 
the cross-sectional analyses showed that the two subscales of IES-2 at the first GDM visit were 
associated with lower weight and BMI before pregnancy, and lower weight at the first GDM 
visit (β=-0.181 to -0.215, all p≤ 0.008). In addition, the EPR subscale was associated with 
HbA1c and fasting plasma glucose at the first GDM visit (β=-0.170 and to -0.196; all p≤ 0.016). 
In the longitudinal analyses, both subscales of IES-2 at first GDM visit were associated with 
lower weight at the end of pregnancy, BMI and fasting plasma glucose at 6-8 weeks postpartum 
(β=-0.143 to -0.218, all P≤ 0.040) after adjusting for confounders. Conclusions: Increase 
adherence to IE could represent a novel approach to weight and glucose control during and after 
pregnancy in women with GDM.  
 
Keywords:  Intuitive eating; Gestational diabetes mellitus; Body mass index; Glycemic 
control; Pregnancy; Postpartum
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1. Introduction   
Gestational diabetes mellitus (GDM) refers to any degree of glucose intolerance that is 
diagnosed in the second or third trimester of pregnancy but does not fulfil the criteria of overt 
diabetes prior to gestation (1). The negative maternal consequences of GDM are well 
documented (2,3). Pre-pregnancy BMI and weight gain during pregnancy also increase the risk 
for complications, such as cesarean delivery and maternal postpartum weight retention (4). 
Although pre-pregnancy overweight or obesity increase the risk of GDM (5), excess weight 
gain in women with GDM may increase the risk of developing diabetes in the postpartum period 
(5,6).   
The cornerstone of GDM treatment requires nutrition/diet and exercise intervention to achieve 
weight and glucose control and also to reduce the need for medical therapy (7). Regarding 
nutrition, several diets, such as low glycemic index (GI) diet, total energy restriction diet, low 
carbohydrate diet, and ethnic or traditional diets, such as the Mediterranean diets, have been 
used to manage weight and glycemic control in women with GDM (8). Although lifestyle 
interventions (diet and physical activity) led to a lower postpartum weight gain according to a 
recent Cochrane review (9), the review found no differences regarding postpartum glucose 
tolerance, postnatal weight retention or return to pre-pregnancy weight in women with GDM 
between those who had a lifestyle intervention and the control group (9). This evidence suggests 
that, research should focus on interventions targeting specific lifestyle aspects to address the 
long-term outcomes of GDM. BMI and weight are independent risk factors of GDM and of the 
development of diabetes after pregnancy. Therefore, additional methods that improve or 
maintain weight and promote healthier eating options during pregnancy and in the postpartum 
period need to be explored especially in women with GDM.  
 
 94 
 
Research suggests that, adaptive eating behaviors that encourage people to recognize and 
respond to their internal signs of hunger and satiety prevent emotional eating and dietary 
restriction (10–12), and may lead to lower weight and BMI (13). One such adaptive eating 
behavior is intuitive eating (IE). IE is characterized by eating in response to physiological 
hunger and satiety cues rather than external and/or emotional cues (14,15). IE is a more 
sustainable long-term eating behavior than dieting and is known to be associated with lower 
levels of cholesterol and cardiovascular risk. It is also inversely associated with disordered 
eating behavior and leads to body shape satisfaction, lower weight and glucose maintenance 
(16,17).   
Outside of pregnancy, evidence suggests that IE is associated with lower BMI (18–20), weight 
loss (21,22) and glycemic control in the general population (23,24). In the postpartum period, 
higher IE practices were associated with lower weight compared to those who engaged in fewer 
IE practices (25). Even though IE is associated with long-term weight maintenance or weight 
loss (26), no study has investigated the potential benefit of IE in pregnancy, although the IE 
questionnaire has been validated in samples of pregnant women (27). Considering that, IE is 
correlated with BMI, weight and glycemic control as indicated above, we hypothesize that, 
higher adherence to IE may be beneficial for weight and glycemic control in women with GDM 
during and after pregnancy. The objective of this study therefore was to investigate the cross-
sectional and longitudinal associations between IE and BMI, weight and glycemic control, both 
during pregnancy and in the early postpartum period among women with GDM. 
2. Methods 
2.1 Participant consent and recruitment  
Pregnant women diagnosed with GDM according to the International Association of the 
Diabetes and Pregnancy Study Groups (IADPSG) and American Diabetes Association (ADA) 
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guidelines (28,29) were invited to participate in the study at the diabetes in pregnancy clinic, 
where patients from both the University Hospital, Lausanne (CHUV) antenatal care clinic and 
obstetricians in private practice are referred. This study is part of an ongoing cohort of women 
with GDM at the Lausanne University Hospital. Women who agreed to participate in the study 
signed a consent form. The Human Research Ethics Committee of the Canton de Vaud 
approved the study protocol (326/15).  
2.2 Inclusion criteria and exclusion criteria  
Women ≥18 years, with GDM diagnosis and were followed in our clinic between 2015 and 
2017, who understood French or English, consented to the cohort, and completed the French IE 
questionnaire at their first GDM visit, were included in this study.  
Out of the cohort population of 1000 participants that were followed in our clinic, we excluded 
those who did not complete an IE questionnaire at the first GDM visit (N=533) and those who 
did not attend postpartum visit (N=32). Out of the eligible cohort population of 435 participants, 
we then excluded those who did not sign an informed consent (N= 145). Participants with 
known type 1 diabetes (N= 7), known type 2 diabetes (N= 9), GDM diagnosed at ≤13 weeks 
(N= 11), diabetes diagnosed during pregnancy at ≤20 weeks (N= 19), normal (i.e. negative) 
HGPO results (N= 7), with glucose intolerance but no GDM (N= 2), and those participating in 
a form of an active lifestyle randomized controlled trial (RCT) intervention (N= 21) were also 
excluded. Overall, 214 women were included in the final analysis.   
2.3 Data collection  
2.3.1 Assessment of Intuitive eating (IE) 
We assessed IE with the French Intuitive Eating Scale-2 (IES-2); an 18-item validated self-
report questionnaire that assesses individuals’ tendency to follow their physiological, hunger 
and satiety cues in determining when, what and how much to eat.  
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The French IES-2 contains 3 subscales. These are (1) the Eating for physical rather than 
emotional reasons (EPR, 8 items) subscale; that assesses how much eating is affected by 
emotional responses, (2) the Reliance on hunger and satiety cues (RHSC, 6 items) subscale; 
that evaluates the extent to which individuals are aware and able to trust internal signals rather 
than relying on external rules/cues, and (3) the Unconditional permission to eat (UPE, 4 items) 
when hungry subscale that assesses whether an individual purposefully tries to ignore hunger 
and satiety signals (27). The English IES-2 (23-item questionnaire), however, consists of 4 
subscales. These are (1) the Eating for physical rather than emotional reasons (EPR, 8 items) 
subscale; (2) the Reliance on hunger and satiety cues (RHSC, 6 items) subscale, (3) the 
Unconditional permission to eat (UPE, 4 items) when hungry subscale and 4) the Body-Food 
Choice Congruence (BFC-C, 5 items) subscale (13,15).  The French IES-2, just like the English 
version, has demonstrated good psychometric properties in samples of pregnant women (27). 
In an earlier study, the IES-2 indicated a good internal reliability among the subscales. The 
Cronbach’s alphas (α) for the two subscales were 0.92 and 0.87 for EPR and RHSC respectively 
(25). The IES-2 measures interoceptive abilities.  These abilities determine when and how much 
to eat, and help to accurately perceive and respect one’s hunger and satiety cues. Thus, higher 
IE scores are related to emotional, psychological, and physical well-being (30).  
It is also important to note that the conceptualization of IE as interoceptive comprises of sensing 
the physiological condition of the body as well as the representation of the internal state (31). 
For the purpose of our study, we removed the UPE subscale (4 items) from the French IES-2. 
This is because women involved in this study had in general one pre-partum diet visit with a 
registered dietician during pregnancy and one post-partum visit after pregnancy. We believe 
that discussions during diet counselling could significantly influence participants’ responses to 
the UPE subscale such as “I try to avoid certain foods high in fat, carbohydrates, or calories”. 
“If I am craving for a certain food, I allow myself to have it”.  
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“I have forbidden foods that I don’t allow myself to eat”. “I allow myself to eat what food I 
desire at any moment”. “I do NOT follow eating rules or dieting plans that dictate what, when, 
and/or how much to eat”.  This is because during the one-hour dietary counseling, participants’ 
were advised on the carbohydrate content of their foods and to avoid or limit certain foods in 
order to improve their eating habits and glycemic profile. 
In our hospital, 85% of women with gestational diabetes see a dietician. In the general clinic 
population, reasons for not being able to see a dietician included appointment-scheduling 
problems or participants’ visited the GDM clinic at an advanced stage of their pregnancy, 
leaving no time to schedule a dietary counseling session. Before the pre-partum and postpartum 
dietary counseling, glycemic control variables, weight, and BMI were measured.  
We therefore gave the two subscales, i.e., the EPR and RHSC subscales of the French IES-2 
and its English translated version produced by our team (with the same 14 items; EPR has 8 
items and RHSC has 6 items); to participants who speak French and English respectively. 
Women completed the EPR and RHSC subscales of the IES-2 questionnaire during the first 
GDM visit by responding to a 5-point Likert scale response ranging from one (1) ‘strongly 
disagree’ to five (5) ‘strongly agree’ to each item in both subscales.  
We then calculated the EPR and RHSC subscale scores as recommended; by dividing the total 
scores obtained from the sum of 1-5 from each item by the total number of items in each 
subscale (EPR by 8 and RHSC by 6), leading to a possible subscale score between one and five. 
Higher scores indicated greater levels of IE. Higher score of the EPR subscale reflects eating 
as an answer to hunger and lower score meant eating to cope with emotional distress whereas 
higher score of the RHSC subscale signifies trust in internal cues and lower score reflects less 
ability to regulate food intake. 
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2.3.2 Anthropometric measures  
We measured height and weight of participants’ during the first GDM visit. When available, 
weight before pregnancy was obtained from patients’ medical charts and records. Otherwise 
this was self-reported. During the first GDM visit, body weight was measured to the nearest 
0.1kg in women wearing light clothes and no shoes with an electronic scale (Seca®), height 
was measured to the nearest 0.1 cm with a Seca® height scale. The electronic scales were 
regularly calibrated. We also measured participants’ weight at the end of pregnancy, and at the 
6-8 weeks postpartum visit. We calculated gestational weight gain as the difference between 
weight at the end of pregnancy and weight before pregnancy. We also calculated the difference 
between weight at 6-8 weeks postpartum and weight at the first GDM visit. We expressed BMI 
as the ratio of weight in kilograms to the square of height in meters (kg/m2).  
2.3.3 Assessment of glycemic control variables  
Participants underwent a 75g oral glucose tolerance test (oGTT) during pregnancy at 24-32 
weeks of gestation, unless an initial fasting glucose was ≥ 5.1 mmol/L. Women were diagnosed 
of GDM if one of the following criteria were met: fasting glucose ≥ 5.1 mmol/L, 1-hr glucose 
≥ 10.0 mmol/L, or 2-hr glucose ≥ 8.5 mmol/L using the IAPDSG guidelines (28).  
At the first GDM visit, HbA1c was measured using a chemical photometric method 
(conjugation with boronate; Afinion®). At 6-8 weeks postpartum, an oGTT was performed to 
measure fasting glucose, 2-hr glucose and HbA1c using a High Performance Liquid 
Chromatography method (HPLC). Both methods are traceable to the International Federation 
of Clinical Chemistry and Laboratory Medicine (IFCC) Reference Method for Measurement of 
HbA1c (32).  
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2.3.4 Measurement of covariates and other variables  
Potential covariates were age and gestational age at the first GDM visit (model 2) and weight 
when the outcome was fasting glucose or HbA1c (model 3).  
For descriptive analyses, the following parameters that were recorded at the first GDM visit 
were used: Socio-demographic characteristics, including age, education level, nationality, 
employment status, family history of type-2 diabetes, history of GDM, gravida and parity, 
habits (smoking and alcohol status during pregnancy), and medical treatment during pregnancy 
(either metformin or insulin). Age was analyzed as a continuous variable. We grouped 
education level into four categories. These were compulsory school achieved; general and 
vocational training levels; high school; and university education. Nationality consisted of 
Switzerland; Europe and North America; Africa; Asia and Western pacific; and Latin America. 
Employment status was categorized as student; employed; housewife/at home; and 
unemployed. We categorized family history of type-2 diabetes, history of GDM, smoking and 
alcohol intake during pregnancy as either ‘yes’ or ‘no’.  
2.4 Statistical analysis 
All analyses were conducted using the SPSS software version 25 (32). All descriptive variables 
were presented as either means (±standard deviation) or in percentages (%) where appropriate. 
Both predictor (EPR and RHSC subscales of the IES-2 questionnaire) and outcome (BMI, 
weight and glycemic control including fasting glucose, 1hr glucose, 2hr glucose and HbA1c at 
the different time points) variables were normally distributed. The correlation between the two 
subscales of IES-2 questionnaire was low-to moderate (r=0.35, P<0.01). We conducted a linear 
regression analysis to determine the cross-sectional and longitudinal associations between the 
two subscales of IES-2 at the first GDM visit with BMI, weight, fasting glucose, 1hr glucose, 
2hr glucose and HbA1c during pregnancy (cross-sectional analysis), at the end of pregnancy 
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and at 6-8 weeks postpartum, respectively (longitudinal analysis). We made use of three models 
in the regression analyses. Model 1 consisted of unadjusted regression estimates. In model 2, 
we adjusted for socio-demographic characteristics that showed significance with at least one of 
metabolic health outcome variables (BMI, weight, fasting glucose, 1h or 2h glucose, HbA1c) 
at either the first GDM visit or at 6-8 weeks postpartum. Thus, this was tested for age, 
gestational age, education level, nationality, employment status, family history of type-2 
diabetes, history of GDM, smoking and alcohol intake during pregnancy, gravida, parity, and 
medical treatment during pregnancy. Of these potential confounder variables, age, gestational 
age, smoking during pregnancy, parity, and medical treatment during pregnancy showed 
significance with one of the metabolic health outcome variables and were thus included in 
Model 2 as confounder variables. We did not adjust for medical treatment in our cross-sectional 
analysis. This is because women had not started medical treatment during the first GDM visit 
(Table 3), as this had no effect on the association between IE and metabolic health at the first 
GDM visit. However, we adjusted for this in our longitudinal analyses. When the outcome was 
glycemic control, we added a third model: model 3, where we adjusted for weight at the 
respective time points (at the first GDM visit and at 6-8 weeks postpartum). All analyses were 
conducted separately for both subscales of the IES-2 questionnaire. All statistical significances 
were two sided and accepted at p < 0.05.  
3. Results  
Table 1 shows the socio-demographic characteristics of the participants (N=214). The mean 
age of participants was 33.3 ± 5.2 years and the mean gestational age at first GDM visit was 
27.4 ± 3.4 weeks. A third (32.2 %) of the participants was university graduates, and 41% were 
of Swiss nationality. Few women had a history of previous GDM (5.2%) and majority had a 
family history of type-2 diabetes (60.7%). 44% of the women had no medical treatment for 
GDM during pregnancy. 
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The mean weight before and during pregnancy, variables regarding glycemic control and the 
scores of the two subscales of the IES-2 at the first GDM visit is shown in Table 2. Mean weight 
and BMI before pregnancy were 68.2 ± 14.8kg and 25.3 ± 5.2kg/m2 respectively. Mean weight 
and HbA1c at first GDM visit were 79.2 ± 14.9kg and 5.4 ± 0.4% respectively. The mean score 
of the EPR subscale at first GDM visit was 3.8 ± 0.9, whereas the mean score of the RHSC 
subscale was 3.5 ± 0.9. Table 3 shows the cross-sectional associations between the two scales 
of IES-2 with BMI, weight and glycemic control at the first GDM visit. Cross-sectional analyses 
showed that both subscales of IES-2 at the first GDM visit were associated with lower weight 
and BMI before pregnancy, weight, fasting glucose and HbA1c at the first GDM visit (β= -
0.171 to -0.222, all p≤ 0.01), however the RHSC subscale was not significantly associated with 
HbA1c at the first GDM visit. After adjusting for confounders including age, gestational age, 
smoking, and parity (model 2) the associations between the two subscales of IES-2 with weight 
and BMI before pregnancy and weight at first GDM visit remained unchanged. The association 
between the EPR subscale with fasting glucose and HbA1c also remained largely unchanged, 
except that the association between the RHSC subscale with fasting glucose was attenuated 
(p=0.095), albeit with a similar beta-coefficient. When fasting glucose or HbA1c was the 
outcome, we adjusted for weight at first GDM visit as a potential confounder (model 3).  
The relationship between the EPR subscale with fasting glucose and HbA1c were attenuated 
(both p≤0.07), while the relationship between the RHSC subscale and fasting glucose remained 
insignificant (p=0.261). This shows that weight partly mediates the relationship between IE and 
fasting glucose in our sample. Table 4 shows the longitudinal associations between IES-2 at the 
first GDM visit with BMI, weight and glycemic control at the end of pregnancy and at 6-8 
weeks postpartum visit. Both subscales of IES-2 at first GDM visit were associated with lower 
weight at the end of pregnancy, weight, BMI and fasting glucose at 6-8 weeks postpartum (β=-
0.139 to -0.242, all P≤ 0.046) (model 1).  
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None of the IES-2 subscales was related to change in weight at the end of pregnancy and change 
in weight at 6-8 weeks postpartum and weight at first GDM visit. After adjusting for 
confounders including age, gestational age, smoking, parity, and medical treatment during 
pregnancy (model 2), the significant associations between the two subscales of IES-2 with 
weight at the end of pregnancy, weight, BMI and fasting glucose at 6-8 weeks postpartum 
remained unchanged (all p≤ 0.004). However, there was an attenuation of the association 
between RHSC subscale and weight at 6-8 weeks postpartum (p=0.057), albeit with a similar 
beta-coefficient. When fasting glucose and HbA1c were the outcome variables, we adjusted for 
weight at 6-8 weeks postpartum visit (model 3) as a potential confounder. Thus, the inverse 
association between the EPR subscale and fasting glucose at 6-8 weeks postpartum remained 
unchanged (p= 0.038), whereas the association between the RHSC subscale and fasting glucose 
at 6-8 weeks postpartum was attenuated (p≤ 0.059).  
4. Discussion  
We investigated the relationship between the two subscales of IES-2 with weight and glucose 
control during pregnancy and in the early postpartum period in women diagnosed with GDM.  
To the best of our knowledge, this has not been previously studied in a general pregnant 
population or in women with GDM. In this prospective cohort of women followed in a clinical 
setting, we found that, the two subscales of IES-2 (“Eating for physical rather than emotional 
reasons” and “Reliance on hunger and satiety cues” subscales) during pregnancy were 
associated with lower BMI and weight before pregnancy, weight, fasting glucose and/or HbA1c 
during pregnancy and in the early postpartum period. The relationship between intuitive eating 
and fasting glucose was partly mediated by weight.  
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Although certain lifestyle interventions such as low GI diets can lead to a decrease in weight 
gain and postprandial glucose among women with GDM (9,33), the effect size of their impact 
on weight and their influence on fasting glucose and HbA1c remains controversial (9,33,34). 
As opposed to those previous studies that focused on macronutrient contents of foods, type of 
carbohydrates, portion sizes and eating frequency, IE represents an interesting and different 
approach that has never been studied in pregnancy in general and in women with GDM in 
particular (33,34). To fill this gap during pregnancy, where feelings and cues of hunger and 
satiety are distinct from out of pregnancy-states, and in women with GDM where increased 
weight gain during pregnancy and weight retention in the postpartum period can lead to 
recurrent GDM, obesity and future development of diabetes, this study evaluated the 
associations between IE with weight and glucose control during and after pregnancy in an 
observational design.  
Results of our cross-sectional analyses showed that the two subscales of IES-2 at the first GDM 
visit were associated with lower weight and BMI before pregnancy and weight at the first GDM 
visit. These associations may exist due to the following reasons. First, the EPR subscale of the 
IES-2 measures the extent to which individuals use food to satisfy hunger rather than to cope 
with negative emotional states, such as anxiety, depression, boredom, or loneliness, that can 
lead to overeating, weight gain, and an eventual increase in BMI (35).  
The RHSC subscale, on the other hand, uses one’s innate ability to respond to satiety cues by 
determining when, what, and how much to eat. Eating intuitively therefore may lead to 
improved hunger and satiety cues, more cognitive control, and increased response to 
physiological signals. Improvement in cognitive control and response to physiological cues 
may in turn lead to lower weight and BMI (36).     
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The association between the EPR subscale with fasting glucose and HbA1c independent of 
adjustment for confounders in our cross-sectional analyses indicates that eating habits driven 
by emotions and cravings during pregnancy may lead to higher glycemic values (10). This may 
be explained by the following mechanisms: frequent snacking and reduced time without food 
intake might impact on increased hepatic insulin resistance and subsequent increased overnight 
glucose production, which may lead to increased fasting glucose levels (37). On the other hand, 
higher adherence to the EPR subscale prevents disordered eating behaviors and thus may lead 
to lower fasting glucose and HbA1c levels (38). In contrast, the lack of association between the 
RHSC subscale with HbA1c and with fasting glucose after adjustments indicates that when it 
comes to pregnancy, elements of RHSC that assesses the degree of awareness of internal hunger 
and satiety signals may be overshadowed by the potential importance of eating for physical 
rather than emotional reasons. This could be the reason why the adherence to the RHSC 
subscale was comparatively lower than the EPR subscale in our sample. One of the possible 
reasons why IE was not related to the one and two-hour glucose levels was that during the 
oGTT, a fixed amount of 75 g of glucose was given regardless of any signs of IE. In addition, 
the oGTT test overrides all internal stimuli. As explained above, the associations between the 
two subscales of IES-2 with lower weight at the end of pregnancy and lower weight and BMI 
at 6-8 weeks postpartum in the longitudinal analyses could indicate that the sustained adherence 
to IE over a period of time may improve emotional states and disordered eating behaviors, as 
well as help to increase one’s ability to innately recognize hunger and satiety cues. This could 
be beneficial in lowering cognitive restraint that usually lead to weight gain and higher BMI. 
In this context of a clinical setting, women with GDM were followed by either a nurse or a 
physician and likely had a pre-partum and postpartum dietary counseling sessions with a 
dietician.  
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During the postpartum dietary counselling, the general goal was for women to return to their 
weight before pregnancy within one year after delivery. This is because gestational weight 
retention is a known risk factor for recurrent GDM and type-2 diabetes. Therefore, the sustained 
practice of IE and the desire to lose postpartum weight itself may account for the observed 
association regarding weight and BMI outcomes in our longitudinal analyses. The lack of 
associations between IE with weight gain (at the end of pregnancy) and weight retention at 6-8 
weeks postpartum visit remains unclear, however, factors such as little variation and short time 
periods between these time points may be reasons for the lack of association.   
The lack of associations between the two subscales of IES-2 with HbA1c in our longitudinal 
analyses can be explained by the following reasons: in the postpartum period, eating habits, 
such as frequent overeating (especially excess animal fat intake), may influence glucose level 
and can impact on HbA1c (39). Similarly, medical treatment may also have an impact in the 
longitudinal analyses, as it lower fasting and postprandial glucose levels and may confound our 
findings. We therefore adjusted for medical treatment in our longitudinal analysis. In our study, 
the majority (52.5%) of our participants’ received medical treatment during pregnancy either 
in the form insulin or insulin and metformin. The possible impact of iron deficiency anemia 
(40) and the changes in insulin sensitivity in the early weeks after delivery may be implicated 
in the lack of longitudinal associations between the two subscales of IES-2 and HbA1c. Other 
factors, such as breastfeeding in the postpartum period also act to reduce glucose levels and 
may affect HbA1c levels (41).  
Our results corroborate the findings of a cross-sectional review outside of pregnancy which 
indicated that IE was positively related with improved dietary intake and/or healthy eating 
behaviors that are drivers for weight loss and maintenance (24).  The results of our study are 
also consistent with a study among postpartum women where the higher practice or adherence 
to IE was associated with accelerated rates of postpartum weight loss (25).  
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Several attempts by weight loss programs that mainly consists of lifestyle intervention to 
address postpartum weight retention have been inconsistent (42). Difficulties in adhering to 
specific structured diet and physical activity recommendations have been named as the possible 
reason. Following a more IE approach to food consumption may encourage postpartum weight 
loss without the required diet restrictions, calorie counting and exercise regimes, all of which 
are features of traditional weight loss programs. IE could offer an alternative approach that may 
be rewarding and less exhausting for new mothers who have busy lives, limited available time 
and new to parenting (25). Regarding glycemic control, the findings of this study are in line 
with those of Wheeler and colleagues who showed that, higher adherence to the EPR subscale 
was associated with lower HbA1c in a cross-sectional study (43) and with a review in which IE 
led to improvements in metabolic health indicators, including fasting glucose (24).  
Our results have important clinical implications and suggests that IE could represent a novel 
approach for weight and glycemic control in women diagnosed with GDM. Future 
epidemiologic/intervention studies should investigate the long-term and sustained effect of IE 
during pregnancy and in the postpartum period among women with GDM.  
This study has several strengths. It is the first to investigate the relationship between IE with 
BMI, weight and glycemic control in women with GDM in a real-life clinical setting. We used 
a well-developed and validated tool to measure IE during pregnancy. However, the results of 
this study must be interpreted with the following limitations. Factors such as dietary counseling 
and use of medication during pregnancy can influence both weight and glycemic control may 
account for the observed relationships in our longitudinal analysis even though we adjusted for 
medication use during pregnancy in our analyses. We believe that visiting a dietician did not 
impact on our cross-sectional results because we measured weight, BMI and glucose control 
variables at the first GDM visit before the appointment with a dietician was scheduled.  
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Even for the longitudinal results, the impact was probably not major, as we measured the 
outcome variables only at 6-8 weeks postpartum. In this context, we do not believe that one 
hour of consultation with the dietician during pregnancy that focused on the carbohydrate 
content of foods would influence our outcomes in a major way, considering that, many habits 
changes in the postpartum period. Missing data of some socio-demographic characteristics is a 
possible limitation because these variables were potential confounders in our analyses. The lack 
of a total IES-2 score in our analyses may be a source of limitation as it would have been 
interesting to see the overall effect of IES-2 on our outcomes would have been interesting. Other 
limitations such as a relatively small sample size limit our ability to generalize our findings. 
We obtained weight before pregnancy from patients’ medical chart when available, otherwise 
we relied on self-reported pre-pregnancy weight which may be a limitation. In addition, several 
psychosocial and behavioral factors including family support, willingness and change in 
attitudes following GDM diagnosis were not investigated could influence weight changes 
especially in the postpartum period. Further research that utilizes IE as an intervention for 
weight retention and glucose control in a larger population during pregnancy and in the 
postpartum period is needed to determine the causality of these associations found in women 
with GDM.  
5. Conclusions 
In this prospective cohort of women with GDM, cross-sectional analyses showed that the two 
subscales of IES-2 at the first GDM visit were associated with lower weight and BMI before 
pregnancy and weight at first GDM visit after adjusting for confounders. The EPR subscale was 
also associated with lower HbA1c and fasting glucose at the first GDM visit. In the longitudinal 
analyses, both subscales of IES-2 at first GDM visit were associated with lower weight at the 
end of pregnancy, BMI and fasting plasma glucose at 6-8 weeks postpartum after adjusting for 
confounders. The EPR subscale was also associated with weight at 6-8 weeks postpartum.  
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None of the IES-2 subscales was associated with weight changes at the end of pregnancy and 
at 6-8 weeks postpartum. These results suggest that practicing IE may be beneficial and could 
represent an interesting approach to weight and glucose management during and after 
pregnancy in women with GDM. In addition, higher adherence to IE may reduce the risk of 
developing diabetes in the postpartum period in women with GDM. 
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STUDY 1 Tables and captions  
[Table 1] Socio-demographic characteristics of study participants  
Variable  Mean SD Frequency Percent (%) 
Age (year) N= 214) 33.32 5.20 
  
Gestational age at the first GDM visit (weeks) (N= 214) 27.43 3.36   
Educational level (N=164)   
  
Compulsory school achieved1    28 13.1 
CFC2   40 18.7 
High school    27 12.6 
University   69 32.2 
Ethnic origin (N=212)   
  
Switzerland   88 41.1 
Europe + North America   80 37.4 
Africa   25 11.7 
Asia + western pacific   15 7.0 
Latin America   4 1.9 
Employment status (N=186)   
  
Student   5 2.3 
Employed   137 64.0 
Unemployed    22 10.3 
At home/housewife   22 10.3 
Family history of Type-2 Diabetes (N= 214)   
  
1st  degree3   71 33.2 
2nd degree4   59 27.5 
No   84 39.2 
History of GDM (N= 214)   
  
Yes   11 5.2 
No   203 94.8 
Smoking status during pregnancy (N= 214)   
  
Yes   45 21.0 
No   169 79.0 
Alcohol intake during pregnancy (N= 214)   
  
Yes   14 6.5 
No   200 93.5 
Gravida (N= 214)     
1   89 41.6 
2   68 31.8 
≥3   57 26.6 
Parity (N= 214)     
0   116 54.2 
1   70 32.7 
2   22 10.3 
≥3   6 2.8 
Medical treatment during pregnancy (N=207)     
None    95 44.4 
Metformin   7 3.4 
Insulin and Metformin   105 49.1 
1Includes 1 patient who did not complete compulsory school 
2CFC means general and vocational education 
31st degree means 1 degree of relationship of the participant (at least 50% of genetic link, which included mother, father, 
brother, sister, daughter, son) 
4Second degree means 2nd degree of kinship of the participant (at least 25% of genetic link that included grandparents, 
grandchildren, nephews, niece, half-brother, half-sister) 
All results are frequency and percentage unless otherwise stated 
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[Table 2] Mean distribution of study variables at first GDM visit or before pregnancy 
Variable N Mean SD 
Weight before pregnancy (kg) (self-reported) 213 68.18 14.83 
BMI before pregnancy (kg/m2) 213 25.30 5.19 
Weight at first GDM visit (kg) (measured) 211 79.16 14.87 
∆Weight before pregnancy and at First GDM visit (kg) 210 10.92 4.58 
HbA1c at First GDM visit (%) 211 5.36 0.39 
Fasting glucose at first GDM visit (mmol/l) 206 5.08 0.79 
1hr glucose at first GDM visit (mmol/l) 163 9.73 1.70 
2hr glucose at first GDM visit (mmol/l) 164 7.87 1.74 
EPR at first GDM visit 214 3.88 0.93 
RHSC at first GDM visit 214 3.54 0.90 
GDM means gestational diabetes mellitus 
HbA1c means glycated hemoglobin 
BMI means body mass index  
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2). Higher scores means higher 
adherence to the EPR subscale 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2). Higher scores means higher adherence to 
the RHSC subscale  
The differences in Frequency of Fasting glucose, 1hr and 2hr glucose is because GDM was diagnosed with a 75-G oral glucose-tolerance test 
unless an initial fasting glucose was ≥5.1 mmol/L.  
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[Table 3] Cross-sectional associations between the two subscales of intuitive eating scale-2 and weight, BMI and glycemic control at first GDM 
visit 
  Model 1 Model 2 Model 3 
Variable 
regression 
coefficient 95% CI P-value 
regression 
coefficient 95% CI P-value 
regression 
coefficient 95% CI 
P-
value 
EPR             
Weight before pregnancy (n=213) -0.203 -5.329 -1.107 0.003 -0.181 -5.002 -0.745 0.008 NA    
BMI before pregnancy (n=213) -0.216 -1.936 -0.463 0.002 -0.194 -1.824 -0.332 0.005 NA    
Weight at first GDM visit (n=211) -0.205 -5.355 -1.126 0.003 -0.191 -5.168 -0.871 0.006 NA    
HbA1c at first GDM visit (n=211) -0.171 -0.126 -0.015 0.013 -0.170 -0.127 -0.013 0.016 -0.123 -0.106 0.004 0.070 
Fasting glucose at first GDM visit (n=206) -0.195 -0.278 -0.050 0.005 -0.196 -0.280 -0.049 0.005 -0.124 -0.213 0.007 0.066 
1-hr glucose at first GDM visit (n=163) 0.122 -0.058 0.490 0.122 0.154 -0.009 0.556 0.058 0.112 -0.081 0.465 0.166 
2-hr glucose at first GDM visit (n=164) -0.030 -0.336 0.226 0.698 -0.033 -0.351 0.232 0.689 -0.065 -0.404 0.169 0.420 
RHSC 
    
        
    
Weight before pregnancy (n=213) -0.194 -5.394 -0.999 0.005 -0.181 -5.171 -0.800 0.008 NA    
BMI before pregnancy (n=213) -0.222 -2.046 -0.518 0.001 -0.215 -2.007 -0.482 0.002 NA    
Weight at first GDM visit (n=211) -0.190 -5.365 -0.934 0.006 -0.188 -5.331 -0.886 0.006 NA    
HbA1c at first GDM visit (n=211) -0.061 -0.085 0.032 0.376 -0.061 -0.085 0.033 0.389 -0.004 -0.060 0.056 0.954 
Fasting glucose at first GDM visit (n=206) -0.148 -0.248 -0.010 0.033 -0.117 -0.222 0.018 0.095 -0.076 -0.182 0.050 0.261 
1-hr glucose at first GDM visit (n=163) 0.072 -0.149 0.409 0.359 0.097 -0.108 0.459 0.224 0.043 -0.209 0.359 0.605 
2-hr glucose at first GDM visit (n=164) -0.072 -0.417 0.153 0.361 -0.068 -0.416 0.165 0.394 -0.124 -0.526 0.070 0.132 
Gestational age at first GDM visit is 24-32 weeks 
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2). Higher scores means higher adherence to the EPR subscale 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2). Higher scores means higher adherence to the RHSC subscale 
Model 1: Unadjusted regression estimates 
Model 2: Adjusted for age, gestational age, smoking, and parity  
Model 3: Adjusted for weight at first GDM visit  
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[Table 4] Longitudinal associations between two subscales of intuitive eating scale-2 and weight, BMI and glycemic control at the end of 
pregnancy and in early postpartum (6-8 weeks) 
  Model 1 Model 2 Model 3 
Variable 
regression 
coefficient 95% CI 
P-
value 
regression 
coefficient 95% CI 
P-
value 
regression 
coefficient 95% CI 
P-
value 
EPR             
Weight at end of pregnancy (n=198) -0.223 -5.450 -1.297 0.002 -0.212 -5.373 -1.063 0.004 NA    
Weight at 6-8 weeks postpartum (n=207) -0.237 -5.700 -1.592 0.001 -0.219 -5.536 -1.267 0.002 NA    
BMI at 6-8 weeks postpartum (n=205) -0.242 -2.003 -0.574 0.000 -0.226 -1.956 -0.474 0.001 NA    
∆weight first GDM visit and end of pregnancy (n=192)1 -0.007 -0.562 0.509 0.922 0.025 -0.452 0.642 0.732 NA    
∆weight first GDM visit and 6-8 weeks PP (n=205)2 -0.061 -1.137 0.438 0.382 -0.062 -1.154 0.448 0.386 NA    
HbA1c at 6-8 weeks postpartum(n=206) -0.002 -0.053 0.051 0.978 -0.003 -0.056 0.054 0.968 0.017 -0.047 0.060 0.815 
Fasting glucose 6-8 weeks postpartum (n=207) -0.200 -0.159 -0.031 0.004 -0.191 -0.158 -0.026 0.007 -0.144 -0.132 -0.004 0.038 
2-hr glucose 6-8 weeks postpartum (n=206) -0.020 -0.261 0.194 0.775 -0.005 -0.253 0.235 0.943 -0.018 -0.264 0.205 0.806 
RHSC                 
Weight at end of pregnancy (n=198) -0.193 -5.276 -0.868 0.007 -0.175 -5.059 -0.545 0.015 NA    
Weight at 6-8 weeks postpartum (n=207) -0.139 -4.486 -0.040 0.046 -0.134 -4.435 0.065 0.057 NA    
BMI at 6-8 weeks postpartum (n=205) -0.164 -1.691 -0.155 0.019 -0.165 -1.708 -0.156 0.019 NA    
∆ weight first GDM visit and end of pregnancy (n=192) 0.092 -0.200 0.926 0.205 0.102 -0.159 0.974 0.157       NA    
∆ weight first GDM visit and 6-8 weeks PP(n=205) 0.105 -0.198 1.467 0.135 0.064 -0.444 1.216 0.360 NA    
HbA1c at 6-8 weeks postpartum(n=206) -0.074 -0.084 0.025 0.291 -0.072 -0.085 0.028 0.315 -0.065 -0.081 0.030 0.358 
Fasting glucose 6-8 weeks postpartum (n=207) -0.163 -0.151 -0.014 0.019 -0.140 -0.140 -0.002 0.045 -0.128 -0.131 0.003 0.059 
2-hr glucose 6-8 weeks postpartum (n=206) -0.025 -0.284 0.196 0.717 -0.006 -0.262 0.239 0.930 -0.024 -0.284 0.201 0.736 
1Means the difference in weight at the end of pregnancy and at first GDM visit  
2Means the difference between weight at the 6-8 weeks postpartum visit and first GDM visit  
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale 2 (IES-2). Higher scores means higher adherence to the EPR subscale 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale 2 (IES-2). Higher scores means higher adherence to the RHSC subscale 
Model 1: Unadjusted regression estimates 
Model 2: Adjusted for age, gestational age smoking, parity and medical treatment during pregnancy 
Model 3: Adjusted for weight 6-8 weeks post-partum  
PP means postpartum  
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Abstract 
We evaluated the associations between intuitive eating during and after pregnancy with 
metabolic health at 1-year postpartum in women with gestational diabetes mellitus (GDM) and 
in high-risk GDM subgroups. One-hundred-and-seventeen women who consented and 
completed the French intuitive eating questionnaire during and after pregnancy were included. 
We found an association between intuitive eating during and after pregnancy with lower BMI, 
weight retention, fasting glucose and HbA1c at 1-year postpartum in women with GDM and in 
high-risk GDM subgroups with overweight/obese or with prediabetes in the postpartum period. 
Our results suggest that, intuitive eating could be an effective intervention for weight and 
glucose control in women with GDM. 
Keywords: Intuitive eating; Gestational diabetes mellitus; Body mass index; Glycemic control; 
Weight retention 
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Introduction  
Gestational diabetes mellitus (GDM) refers to any degree of glucose intolerance that is 
diagnosed in the second or third trimester of pregnancy but does not fulfil the criteria of overt 
diabetes (American Diabetes Association (ADA), 2019). Between 3-20% of pregnant women 
develop GDM globally (Feig et al., 2018) and 10.9% of all pregnancies in Switzerland are 
complicated with GDM (Rüetschi et al., 2016). The adverse maternal and fetal outcomes of 
GDM are well known (Damm et al., 2016; Nehring et al., 2011). Indeed, about 48% of women 
with GDM are at risk of prediabetes (Huopio et al., 2014) and between 20%–60% of women 
with GDM develop diabetes 5 to 10 years after delivery (Buchanan et al., 2012). Overall, the 
conversion of GDM to prediabetes and subsequent development of diabetes is well known and 
continues to be on the rise, making GDM a significant risk factor of type 2 diabetes (Feig, 
2018).  
Pre-pregnancy body mass index (BMI), excess weight gain during pregnancy and postpartum 
(PP) weight retention contribute to the risk of prediabetes and diabetes among women with 
GDM (Kim, 2015; Miao et al., 2017). Weight retention is indeed a prevalent problem: Studies 
show that, at the early postpartum period, women retain an average of 2–7kg of weight gained 
during pregnancy, and at least two-thirds of women will still be above their pre-pregnancy 
weight (Fadzil et al., 2018; Ha et al., 2019; Walker et al., 2005). Given that postpartum weight 
retention is predictive for GDM recurrence (Ehrlich et al., 2011), prediabetes and future 
diabetes (Bao et al., 2015; Liu et al., 2014), weight loss in the postpartum period is critical for 
women with previous GDM. In the Diabetes Prevention Program (DPP) for example, weight 
loss reduced the risk of future diabetes by 16% for every kilogram of weight lost (Hamman et 
al., 2006) and an intensive lifestyle intervention also led to 50% reduction in the risk of diabetes 
(Ratner et al., 2008).  
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Apart from overweight/obesity, prediabetes in the postpartum period has also been shown to 
augment the risk of diabetes in women with GDM (Bao et al., 2015; Meron and Grajower, 
2017). Focusing on these two high-risk groups (i.e., overweight/obese women and women with 
prediabetes) is therefore crucial.  
Lifestyle interventions are usually recommended as the primary therapeutic strategy in the 
postpartum period for women with previous GDM to reduce diabetes risk factors (Gilbert et al., 
2019). These interventions consist of nutrition and physical activity advice for weight and 
glucose control to reduce and or prevent the risk of diabetes in these women. Even though 
lifestyle interventions have achieved some results in women with GDM, recent systematic and 
meta-analyses have shown that results from lifestyle intervention studies have been 
unsatisfactory and inconsistent. In a recent Cochrane review of lifestyle intervention trials 
among women with GDM, three trials included the incidence of type-2 diabetes and prediabetes 
in the postpartum period, but only one found a difference between the intervention and the 
control group (Brown et al., 2017). In another recent systematic review and meta-analysis of 
15 trials in women with previous GDM, half of the lifestyle interventions led to a reduction of 
weight and the incidence of diabetes, but effect sizes were small and their sustained effects were 
inconsistent (Goveia et al., 2018).  
There is therefore a need to identify other novel approaches that can help reduce weight gain 
during pregnancy and weight retention in order to lower the risk of prediabetes and future 
diabetes in women previously diagnosed with GDM. Compared to studies (Moses et al., 2009; 
Xu and Ye, 2018) that focused on lifestyle interventions and nutritional advice, such as total 
energy intake, macronutrient contents of foods, type of carbohydrates, portion sizes and eating 
frequency, intuitive eating (IE) represents an interesting and different approach to weight loss 
and glycemic control.  
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IE is an adaptive eating behavior that deals with the ability to accurately interpret and adhere 
to instinctive feedback regarding the required amount of food and when to eat (Tylka, 2006). 
IE correlates with lower weight, BMI and improved glycemic control in the general population 
(Van Dyke and Drinkwater, 2014; Wheeler et al., 2016). A study that evaluated the relationship 
between IE and weight in women in the late postpartum period found that IE was associated 
with weight loss and lower BMI (Leahy et al., 2017). Even though we have earlier demonstrated 
that, IE is associated with weight and glucose control during pregnancy and in the early 
postpartum period in women with GDM (Quansah et al., 2019), no study has investigated the 
potential long-term association between IE during and after pregnancy with weight, weight 
retention and glycemic control in the general perinatal population nor in women with GDM and 
their metabolically high-risk subgroups with high BMI or prediabetes.  In these high-risk 
subgroups, the risk of diabetes is higher. To fill this gap, we evaluated the associations between 
IE during and after pregnancy with BMI, weight retention and glycemic control at 1-year 
postpartum in all women with GDM and in high-risk GDM subgroups with pre-pregnancy 
overweight/obesity or with prediabetes in the postpartum period.  
Methods 
Participant consent and recruitment  
This study is part of an ongoing cohort of women with GDM. We invited pregnant women 
diagnosed with GDM according to the American Diabetes Association (ADA) and the 
International Association of the Diabetes and Pregnancy Study Groups (IADPSG) guidelines 
(Dorsey et al., 2018; Metzger, 2010) to participate in the GDM cohort at the gestational diabetes 
clinic at a Swiss University Hospital. We sought for written informed consent before 
participation in the cohort. The Human Research Ethics Committee of the Canton de Vaud 
approved the study protocol (326/15).  
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Inclusion and exclusion criteria  
Women who were ≥18 years, with GDM diagnosis in the second trimester (Metzger et al., 2010) 
that were followed in our clinic between 2015 and 2018, who understood French or English, 
consented to participate, and completed the French Intuitive Eating Scale-2 (IES-2) 
questionnaire at their first visit and at the 1-year visit were included in this study.  
Out of a cohort population of 333 participants that consented, we removed participants who did 
not come for 1-year postpartum appointment visit (N=144) as they did not have valid data for 
our main questions and hypothesis. Participants with known type 1 diabetes (N= 2), known type 
2 diabetes (N= 6), had GDM at ≤13 weeks (N= 10), had diabetes diagnosed during pregnancy 
at ≤20 weeks (N= 8), with HGPO results that were normal (N= 3), with glucose intolerance but 
no GDM (N= 1) and were participating in a lifestyle intervention study (N=42) who are part of 
our cohort database were also excluded as they did not meet the inclusion criteria. Overall, 117 
women were eligible and thus included in the final analysis. Figure 1 shows the details of how 
participants in this study were selected.   
Assessment of Intuitive eating (IE) 
We assessed IE with the French Intuitive Eating Scale-2 (IES-2) due to the language capacities 
of our population (Camilleri et al., 2015). The French IES-2 is an18-item validated self-report 
questionnaire that assesses individuals’ tendency to follow their physiological, hunger and 
satiety in relation to eating. The French IES-2 contains three (3) subscales. These are (1) the 
Eating for physical rather than emotional reasons (EPR, 8 items) subscale; that assesses how 
much eating is affected by emotional responses, (2) the Reliance on hunger and satiety cues 
(RHSC, 6 items) subscale; that evaluates the extent to which individuals are aware and able to 
trust internal signals rather than relying on external rules/cues, and (3) the Unconditional 
permission to eat (UPE, 4 items) when hungry subscale that assesses whether an individual 
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purposefully tries to ignore hunger and satiety signals (Camilleri et al., 2015; Daundasekara et 
al., 2017). The English IES-2 (23-item questionnaire), however, consists of four subscales. 
These are the EPR (8 items) subscale, the RHSC (6 items) subscale, the UPE (4 items) and the 
Body-Food Choice Congruence (BFC-C, 5 items) subscale (Tylka, 2006; Tylka and Van Diest, 
2013). Both the French and English IES-2 questionnaires have demonstrated good 
psychometric properties in pregnant women (Daundasekara et al., 2017). In an earlier study, 
the Cronbach’s alphas (α) for the two subscales were 0.92 and 0.87 for EPR and RHSC 
respectively, which suggests a good internal reliability among the subscales (Daundasekara et 
al., 2017). IE has interoceptive abilities that are suggested to determine when and how much to 
eat, and to accurately perceive and respect one’s hunger and satiety cues. Thus, IE tendencies 
are related to emotional, psychological, and physical well-being (Saunders and Nichols-Lopez, 
2018). Details of the IES-2 questionnaire have been previously described (Tylka and Van Diest, 
2013). 
For the purpose of our study, we removed the UPE subscale (4 items) from the French IES-2. 
This is because women involved in this study had in general one pre-partum visit with a 
registered dietician during pregnancy and another one in the early post-partum period (6-8 
weeks postpartum). The latter was of short duration and done together with the diabetologist or 
diabetes educator and focused predominantly on reporting the results of the postpartum oral 
glucose tolerance testing (oGTT). Women had no further dietician appointment after this visit. 
Allover, in the general population of our women with gestational diabetes, about 85% see a 
dietician, but we do not have the exact numbers for the study population. In the general clinic 
population, reasons for not being able to see a dietician included appointment-scheduling 
problems or participants visited the GDM clinic at an advanced stage of their pregnancy.  
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We believe that, discussions during diet counselling could significantly influence participant 
responses to the UPE subscale questions such as “I try to avoid certain foods high in fat, 
carbohydrates, or calories”. This is because during the one-hour diet counselling during the 
pregnancy, participants were advised on carbohydrate content of their foods and to avoid or 
limit certain food like soft drinks, sweet products, added sugar and fruits juice in order to 
improve their eating habits and glycemic profile. We measured weight, BMI and glycemic 
control variables before the pre-partum counseling with the dietician. This was to ensure that, 
diet counselling with a dietician does not influence study outcomes.  We then measured the 
metabolic health outcomes again at 1 year postpartum.  
We therefore used the EPR and RHSC subscales of the French IES-2 and, an English translation 
using the forward-backward translation and cultural adaption method (Wild et al., 2005) made 
by our research team (with the same 14 items; EPR has 8 items and RHSC has 6 items); they 
were given to participants who speak French and English, respectively. Women completed the 
EPR and RHSC subscales of the IES-2 questionnaire during the first GDM visit and at the one-
year postpartum visit by responding to a 5-point Likert scale ranging from one ‘strongly 
disagree’ to five ‘strongly agree’ to each item in both subscales. We then calculated the EPR 
and RHSC subscale scores as recommended, by dividing the total scores obtained from the sum 
of 1-5 from each item by the total number of items in each subscale (EPR by 8 and RHSC by 
6), leading to a possible subscale score between one and five. Higher scores indicated greater 
levels of IE. A higher score of the EPR subscale reflects eating as an answer to hunger and a 
lower score meant eating to cope with emotional distress, whereas a higher score of the RHSC 
subscale signifies trust in internal cues, and a lower score reflects less ability to regulate food 
intake. 
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Assessment of glycemic control variables  
All women involved in this study were diagnosed with GDM during pregnancy (at 24-32 
weeks) if one of the following criteria were met during a 75g oGTT: fasting venous glucose ≥ 
5.1 mmol/L, 1-hr glucose ≥ 10.0 mmol/L, or 2-hr glucose ≥ 8.5 mmol/L, using the IAPDSG 
guidelines (Metzger, 2010). For the purpose of this analysis, we used the fasting glucose at 
GDM diagnosis, as women with fasting glucose of ≥ 5.1 mmol/L did not have an oGTT. During 
the first GDM visit after diagnosis, we measured HbA1c using a chemical photometric method 
(conjugation with boronate; Afinion®). At 1-year PP, patients had a fasting venous glucose and 
HbA1c measured. The HbA1c was measured using a High Performance Liquid 
Chromatography method (HPLC) (Jeppsson et al., 2002). Both methods are traceable to the 
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Reference 
Method for Measurement of HbA1c (Jeppsson et al., 2002). Prediabetes was diagnosed when a 
participant’s fasting glucose at 1-year postpartum was between 5.6-6.9 mmol/l, or HbA1c at 1-
year postpartum was between 5.7- 6.4%.   
Anthropometric measures  
We measured the height and weight of participants during the first GDM visit. Weight and BMI 
before pregnancy were taken from participants’ medical charts or, if missing, was self-reported; 
we asked for the weight in the 1-2 months before pregnancy if this information is not available 
in the participants’ medical chat. We measured weight at 1-year postpartum to the nearest 0.1 
kg in women wearing light clothes and no shoes with an electronic scale (Seca®) and height at 
the first GDM visit to the nearest 0.1 cm with a regularly calibrated Seca® height scale. We 
calculated weight retention as the difference between weight at 1-year postpartum and weight 
before pregnancy.  
 128 
 
We calculated BMI as the ratio of weight in kilograms to the square of height in meters (kg/m2). 
We defined overweight and obesity as BMI between 25.0-29.9 Kg/m2 and ≥30 kg/m2 
respectively.  
Measurement of other variables  
Sociodemographic characteristics of our participants included age, educational level, 
nationality, employment status, family history of type-2 diabetes, history of GDM, parity, and 
smoking and alcohol status during pregnancy. These were obtained from the patients’ medical 
charts, which were completed during the first face-to-face visit. We grouped educational level 
into four categories. These were compulsory school achieved; general and vocational training 
levels; high school and university education. Nationality consisted of the following five regions: 
Switzerland; Europe and North America; Africa; Asia and Western pacific; and Latin America. 
Employment status was categorized as student; employed; housewife/at home; and 
unemployed. We categorized family history of type-2 diabetes, history of GDM, smoking, and 
alcohol intake during pregnancy as either ‘yes’ or ‘no’.  
Statistical analyses  
We performed all analyses with the SPSS software version 25 (IBM Corp., 2017). All 
descriptive variables were presented as either means (±standard deviation) or in percentages 
(%), where appropriate (Table 1 & 2). Both predictor (EPR and RHSC subscales of the IES-2 
questionnaire at first GDM visit and at 1-year postpartum visit) and outcome (BMI, weight 
retention, HbA1c and fasting glucose at the different time points) variables were normally 
distributed. The EPR and RHSC subscales showed a moderate correlation of 0.42 (p<0.001) at 
the first GDM visit and 0.51 (p<0.001) at 1-year postpartum.  
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We conducted a linear regression analysis to determine the associations between IE at the first 
GDM visit (longitudinal) and at the 1-year postpartum visit (cross-sectional) with BMI, weight 
retention, fasting glucose, and HbA1c at 1-year postpartum (Table 3). We adjusted for socio-
demographic characteristics that showed statistical significance with at least one of the 
metabolic health outcome variables (BMI, weight, weight retention, fasting glucose and 
HbA1c) at 1-year postpartum. Thus, we tested for age, gestational age at the first GDM visit, 
education level, nationality, employment status, family history of type-2 diabetes, history of 
GDM, smoking and alcohol intake during pregnancy, parity, and breastfeeding in the early 
postpartum period (at 6-8 weeks postpartum,). Of these potential confounder variables, age and 
gestational age showed significance with at least one of the metabolic health outcomes. We 
therefore adjusted for age and gestational age at the first GDM visit as confounders for all 
analyses. When the outcome was HbA1c or fasting glucose, we further adjusted for BMI at first 
GDM visit (Table 3). We did this to see if the relationship was mediated by BMI. We conducted 
all analyses separately for EPR and RHSC subscales at the first GDM visit and at 1-year 
postpartum. We also evaluated the associations between the two subscales of IES-2 at the first 
GDM visit and at 1-year postpartum with metabolic health outcomes in the high-risk GDM 
subgroups with prediabetes or overweight/obesity and in the respective low-risk subgroups 
(Tables 4 & 5). In the Supplementary Analyses, we also compared the metabolic health 
outcomes with the IE scores between the high-risk and low-risk subgroups by performing an 
ANOVA test (Supplementary Table 1 & 2). Both IE scores at both time points were analyzed 
using correlation analyses and paired t-tests (between first visit and 1-year postpartum, 
Supplementary Table 3). All statistical significances were two sided and accepted at p< 0.05. 
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Results  
Table 1 shows the summary of the general characteristics of our study participants (N=117). 
The mean age, gestational age at the first GDM visit, and gestational age at delivery were 
33.21±5.4 years, 28.83±2.87 weeks and 38.8±1.6 weeks, respectively. More than one-third of 
the study participants were university graduates (38.2%) and 44.8% were of Swiss nationality. 
About 59% of the participants had a family history of diabetes and only 4.3% had a history of 
GDM.  
Table 2 describes the study variables at the first GDM visit and at 1-year postpartum. The mean 
pre-pregnancy weight and BMI were 69.46±13.99 kg and 25.82±4.69 kg/m2 respectively. At 1-
year postpartum, these numbers were 72.79±16.22 kg and 27.06±5.54 kg/m2, which translates 
to weight retention of 3.32±7.18 kg. Mean HbA1c was 5.37±0.42% at the first GDM visit and 
5.27±0.33% at 1-year postpartum, while fasting glucose at diagnosis was 5.24±0.93 mmol/l and 
5.49±0.58 mmol/l at 1-year postpartum. Before pregnancy, 46.2% of women were 
overweight/obese and this was the same at 1-year postpartum. At 1-year postpartum, 46.1% 
women had prediabetes. The mean EPR subscale at the first GDM visit was 3.86 and 3.76 at 1-
year postpartum (p<0.001), and these numbers were 3.53 and 3.42 for the mean RHSC 
subscales (p<0.001). Correlation between the first GDM visit and 1-year postpartum were 0.42 
for the EPR and 0.32 for the RHSC subscales (both p<0.001, see also Supplementary Table 3). 
Table 3 represents the associations between the two subscales of IES-2 at the first GDM visit 
and at 1-year postpartum with metabolic health indicators at 1-year postpartum. After adjusting 
for confounders the EPR subscale at the first GDM visit was associated with lower BMI 
(p=0.017), fasting glucose (p=0.014) and tended to predict lower HbA1c (p=0.062) at 1-year 
postpartum. On the other hand, RHSC at the first GDM visit had no association with any of the 
metabolic health variables at 1-year postpartum (all p>0.2).  
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However, both EPR and RHSC at 1-year postpartum were associated with lower weight 
retention (both p≤0.037) and lower BMI (both p≤0.012). The EPR subscale was also associated 
with lower HbA1c and lower fasting glucose (both p=0.018). When fasting glucose and HbA1c 
were the outcome variables, we further adjusted for BMI at the first GDM visit as a potential 
confounder, which led to the attenuation of the observed associations between the two subscales 
of IES-2 and metabolic parameters (all p≥0.066).  
We also focused on two high-risk GDM subgroups with pre-pregnancy overweight/obese or 
with prediabetes and their lower-risk counterparts. The Supplementary Table 1 shows that at 1-
year postpartum all metabolic health indicators, including weight retention, were significantly 
higher in women with prediabetes (all p≤0.026), whereas women with normal glucose values 
had significantly higher scores of the EPR (p=0.025). The Supplementary Table 2 shows that 
all metabolic health indicators at 1 year postpartum except weight retention were significantly 
higher in women who were overweight/obese (all p≤0.042) and they had significant higher 
scores of the EPR subscale (p=0.040). In the subgroup of women with prediabetes (Table 4), 
EPR and RHSC at the first GDM visit predicted lower fasting glucose at 1-year postpartum 
(both p≤0.024). At 1-year postpartum, both EPR and RHSC were associated with lower weight 
retention (both p≤0.034) and BMI (both p≤0.005), while no associations were observed in the 
women with normal glucose tolerance (all p ≥0.10).  
In the subgroup of women with overweight/obese (Table 5), EPR at the first GDM visit 
predicted lower fasting glucose at 1-year postpartum (p=0.041), whereas the RHSC subscale 
showed no significance with any of the metabolic variables. At 1-year postpartum, both EPR 
and RHSC subscales were associated with lower weight retention (both p≤0.009) and fasting 
glucose (both p=0.030). The EPR was also associated with lower BMI (p<0.001).  
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We found no associations between the two subscales of IES-2 and metabolic health in the 
subgroup of women with normal weight. In both high-risk subgroups, the associations of IES-
2 subscales with fasting glucose were independent of BMI.  
Discussion  
To our knowledge, no previous study has looked at the relationship between intuitive eating 
and metabolic health during pregnancy up to the 1-year postpartum period. In the context of 
identifying novel approaches to prevent weight retention and diabetes in women after GDM, 
we evaluated the longitudinal and cross-sectional associations between the two subscales of the 
French intuitive eating questionnaire (the EPR and RHSC subscales) during and after 
pregnancy with weight retention, BMI, fasting glucose, and HbA1c at 1-year postpartum in 
women with GDM. This was also studied in two high-risk GDM subgroups, those with 
prediabetes (46.1%) and those with overweight/obese status (46.2%). IE at the first GDM visit 
and at 1-year postpartum visit was associated with better metabolic health at 1-year postpartum 
in all women with GDM and in the two high-risk subgroups. Specifically, the longitudinal 
analyses revealed that the EPR subscale at the first GDM visit predicted lower postpartum BMI 
and fasting glucose. In the cross-sectional analyses, the EPR and RHSC subscales at 1-year 
postpartum visit were associated with lower BMI and lower weight retention, while the EPR 
subscale was additionally associated with lower fasting glucose and HbA1c. The (cross-
sectional and longitudinal) associations between IE and improved metabolic health were also 
observed in both GDM high-risk subgroups (those with overweight/obese and those with 
prediabetes), but not in the respective low-risk subgroups.   
In women with GDM, there is a tight relationship between weight gain during pregnancy, 
weight retention, and diabetes in the postpartum period (Mamun et al., 2013; Bao et al., 2015; 
Institute of Medicine (IOM), 2009; Nehring et al., 2011).  
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Increased weight retention is related to increased insulin resistance, subsequent dysfunction of 
the beta cells, and development of glucose intolerance (Moyce and Dolinsky, 2018). This is 
partly attributed to the subtle changes in appetite regulatory mechanisms associated with weight 
gain and weight retention (Ciampolini et al., 2010; Perry and Wang, 2012). Alterations in leptin 
(a hormone released from fat cells in adipose tissue altering food intake and control energy 
expenditure over the long term) signaling also act to increase the risk of diabetes in these women 
(Moyce and Dolinsky, 2018; Oh et al., 2018). It is therefore of utmost importance to decrease 
weight retention and to improve glucose control in order to reduce diabetes risk in this 
population. Traditional lifestyle interventions that are used to manage weight and glucose 
control and to prevent the progression to diabetes in the postpartum period have, however, been 
unsatisfactory and their sustained effects are controversial (Brown et al., 2017; Michel et al., 
2018). In order to reduce weight retention and improve glycemic control in women with GDM, 
eating intuitively could help to exert less cognitive control over eating and rely more on satiety 
cues, irrespective of current innate satiety cues, and help to eat in response to hunger and satiety 
signals. We thus explored the relationship between IE and metabolic health in women with 
GDM. 
In our longitudinal analyses, we found that the EPR subscale at the first GDM visit was 
associated with lower BMI and fasting glucose at 1-year postpartum. These findings are in 
concordance with a previous study conducted in a general non-pregnant population where the 
EPR subscale was associated with lower weight gain and lower fasting glucose (39). The EPR 
subscale assesses the extent to which eating is affected by emotion (Tylka, 2006), and women 
with GDM who engage in eating habits or behaviors driven by emotion rather than physical 
symptoms of hunger during and after pregnancy may have more problems with weight loss and 
glucose control in the postpartum period (Leahy et al., 2017).  
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Adhering to IE prevents or reduces eating in response to negative emotional states, such as 
anxiety, depression, boredom, or loneliness that often leads to overeating, weight retention, 
higher BMI, and poor glucose control in women with GDM (Lauzon-Guillain et al., 2006). 
Compared to a study that found a cross-sectional association between the EPR subscale with 
lower levels of HbA1c in a population with type-1 diabetes, our results found a weak 
longitudinal relationship between this subscale and HbA1c (p=0.06). In addition to frequent 
(emotional) overeating, loss of sleep (Dashti et al., 2015) in the postpartum period might 
influence weight and glucose metabolism and confound some of these findings (Kim et al., 
2015; St-Onge, 2017). Other factors, such as breastfeeding in the postpartum period reduce 
glucose levels and may influence HbA1c levels, and also confound some of the analyses 
(Gunderson et al., 2012). Indeed, about 87% of women in our sample reported they were 
breastfeeding during the early postpartum period, but breastfeeding was not a significant 
confounder in our analyses.  
We found no longitudinal relationship between the RHSC subscales at the first GDM visit with 
any of the metabolic health variables studied at 1 year postpartum. This lack of association 
between RHSC and the metabolic health variables such as BMI, weight retention, fasting 
glucose, and HbA1c in our longitudinal analyses suggests that in the long-term, eating for 
physical rather than emotional reasons overshadows the potential importance of relying on 
one’s hunger and satiety signals to regulate food intake in this sample. Therefore, it was not 
surprising that the mean difference between the scores of the EPR subscale during and after 
pregnancy was around 10% higher than that of the RHSC subscale.  
In our cross-sectional analyses however, IE at the 1-year postpartum visit was associated with 
several metabolic health parameters. Thus, the EPR subscale was associated with lower weight 
retention, BMI, fasting glucose and HbA1c, while the RHSC subscale was associated with 
lower weight retention and BMI.  
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Either other parameters interfere less in the cross-sectional analyses, or the nature of IE in the 
postpartum in general relates better to metabolic health compared to the pregnancy period and 
may account for these associations. Thus, aiming to improve IE in pregnancy and the ability to 
keep this practice stable and higher in the postpartum period might help to improve overeating 
and metabolic health in these women.  
 Despite their future diabetes risk, most women with GDM have normal glucose values after 
delivery (Retnakaran et al., 2010), but up to 50% have prediabetes within 12 months as observed 
in our sample and that of another study (Huopio et al., 2014). It is important to prevent further 
glucose intolerance in these GDM subgroups with prediabetes and overweight/obese who are 
at higher risk of progressing to diabetes (Feig, 2018). In the subgroup of women with 
prediabetes or with overweight/obese, we found that IE was associated with fasting glucose in 
the longitudinal analyses and with weight retention, BMI and/or fasting glucose in the cross-
sectional analysis. This results show that special focus should be placed on these women for 
follow-up, but also to test early interventions to improve IE. This is particularly important 
because, in women with GDM and in high-risk GDM subgroups, each kilogram of weight lost 
in the postpartum period is associated with a 16% decrease in the risk of diabetes (Bao et al., 
2015; Hamman et al., 2006; Meron and Grajower, 2017).  The EPR and RHSC subscales 
moderately correlated with each other during the first GDM visit (r=0.41) and at 1-year 
postpartum (r=0.51). The mean score of the EPR subscale was about 10% higher than the mean 
score of the RHSC subscale. Our results are consistent with another study involving a healthy 
non-pregnant population (correlation between EPR and RHSC subscale: r=0.35 and 0.37 in 
women and men respectively) (Tylka and Van Diest, 2013). Although these subscales correlate 
with each other, only 20% of the variability of one subscale seemed to be explained by the other 
and thus they cover different aspects of IE.  
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Our study has several strengths. Clinically, our results if confirmed by an intervention trial 
could help address the issue of postpartum weight retention in women with GDM. It could also 
help augment the management and prevention of diabetes in women with GDM and in the high-
risk subgroups with prediabetes or overweight/obese, especially when results from several 
existing lifestyle interventions still remain controversial (Gilbert et al., 2019) and inconsistent 
(Brown et al., 2017; Goveia P et al., 2018; Michel et al., 2018). We studied the novel 
relationship between IE with BMI, weight retention and glycemic control during pregnancy and 
in the postpartum period up to 1 year postpartum in a longitudinal cohort of women with GDM. 
We also measured IE with a validated tool that has shown to have construct validity and 
reliability among pregnant women (Camilleri et al., 2015, Daundasekara et al., 2017).   
A limitation of this study is the relatively small sample size, which may limit our ability to 
generalize our findings. Furthermore, the nature of the observational study design does not 
allow the modification of IE scores, reduces the control over external, confounding variables, 
although we did test and adjust for potential significant confounders in our regression models, 
as described in the statistics section above. The inability to include the UPE subscale due to the 
fact that, discussions during diet counselling could significantly influence participant responses 
to the UPE subscale may be a source of limitation since the effect of an overall IES-2 subscale 
would have been interesting. Other factors, such as the intention to lose weight in the 
postpartum period and a variety of other behavioral or socioeconomic variables that could 
influence weight loss or impact on metabolic health were not studied. Even though the IES-2 
has been validated both in the general and pregnant population, it is not validated in women 
with GDM and could be a limitation of our study. It is also important to indicate that the IES-2 
questionnaire is self-reported, and therefore the likelihood of over- or under-reporting may 
influence our analyses.  
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We obtained weight before pregnancy from patients’ medical chart when available; otherwise, 
we relied on self-reported pre-pregnancy weight, which may be a limitation. Further research 
that utilizes IE as an intervention to reduce weight retention and improve glucose control in a 
larger population during pregnancy and in the postpartum period is needed to determine the 
causality of these associations in women in general and specifically those with GDM.  
Conclusions   
We found an association between IE during and after pregnancy with lower BMI and weight 
retention at 1-year postpartum, both in cross-sectional and longitudinal analyses. In addition, 
eating for physical rather than emotional reasons was associated with lower fasting glucose and 
HbA1c in this cohort of women with GDM. High-risk GDM subgroups with prediabetes or 
overweight/obese each represented almost 50% of the population. In these high-risk groups, IE 
was associated with lower BMI, weight retention, and fasting glucose. Our results suggest that 
higher sustenance of IE behavior could represent an interesting and novel approach for reduced 
BMI, weight retention, and improved glucose control in women with GDM, and especially in 
high-risk subgroups. IE could therefore be a future target for screening and a potential 
intervention in women with GDM.  
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STUDY 2 Tables and Captions 
[Table 1] General characteristics of study participants   
Variable  Mean SD Frequency Percent (%) 
Age (yr.) (N=117) 33.21 5.37   
Gestational age at the first GDM visit (N=117) 28.83 2.82   
Education level (N=89)     
Compulsory school achieved   15 16.9 
High school   13 14.6 
General and vocational education   27 30.3 
University   34 38.2 
Nationality (N=116)     
Swiss   52 44.8 
Europe + North America   37 31.9 
Asia + Western pacific   6 5.2 
Africa   20 17.2 
Latin America   1 0.9 
Employment status (N=109)     
Student   1 0.9 
Professional worker   82 75.2 
Housewife   13 11.9 
Unemployed   13 11.9 
Family history of diabetes (N=117)     
1st  degree1   41 35.0 
2nd degree2   28 23.9 
No   48 41.0 
History of previous GDM (N=117)     
No   112 95.7 
Yes   5 4.3 
Smoking status during pregnancy (N=117)     
Yes   22 18.8 
No   95 81.2 
Alcohol intake during pregnancy (N=117)     
Yes   6 5.1 
No   111 94.9 
Parity  (N=117)*     
0   68 58.1 
1   36 30.8 
2   11 9.4 
≥3   2 1.7 
Breastfeeding  (N=117)3     
Yes    102 87.2 
No    15 12.8 
11st degree means 1 degree of relationship of the participant (at least 50% of genetic link, which included mother, father, 
brother, sister, daughter, son) 
22nd degree means 2nd degree of kinship of the participant (at least 25% of genetic link that included grandparents, 
grandchildren, nephews, niece, half-brother, half-sister) 
3At 6-8 weeks postpartum  
*10.2% of women who were multiparous had history of previous GDM 
All results are frequency and percentage unless otherwise stated 
GDM means gestational diabetes mellitus 
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[Table 2] Mean and standard deviations of study variables (N=117) 
Variable Mean SD 
First GDM visit    
Pre-pregnancy weight (kg)1  69.46 13.99 
Pre-pregnancy BMI (Kg/m2 )2 25.82 4.69 
Weight at the first GDM visit (kg)  80.26 14.55 
BMI at the first GDM visit (Kg/m2 )  29.87 4.89 
HbA1c at the first GDM visit (%) 5.37 0.42 
Fasting glucose at GDM diagnosis (mmol/l) 5.24 0.93 
EPR at the first GDM visit  3.86 0.94 
RHSC at the first GDM visit  3.53 0.89 
1-year postpartum    
Weight at 1-yr postpartum (kg) 72.79 16.22 
∆Weight retention (kg)3 3.32 7.18 
BMI at 1-yr postpartum (kg/m2) 27.06 5.54 
Waist circumference at 1-yr postpartum (cm) 88.82 11.99 
HbA1c at 1-yr postpartum (%) 5.27 0.33 
Fasting glucose at 1-yr postpartum (mmol/l)4 5.49 0.58 
EPR at 1-yr postpartum  3.76 0.97 
RHSC at 1-yr postpartum  3.42 0.94 
1Data reported at the first GDM visit or taken from the medical charts 
2Body mass index before pregnancy; data reported at the first GDM visit or taken from the medical charts 
3Weight retention means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
4N=116; one missing  
GDM means gestational diabetes mellitus 
HbA1c means glycated hemoglobin 
BMI means body mass index  
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2) 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2)  
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[Table 3] Associations between the two subscales of IES-2 at the first GDM visit and at 1-
year postpartum and metabolic health at 1-year postpartum 
 
Variable 
Regression 
coefficient 
 
95% CI 
 
P-valuea 
 
P-valueb  
IES-2 at the first GDM visit (longitudinal)      
EPR at the first GDM visit       
Metabolic health at 1-yr pp      
∆Weight retention (kg)1 -0.087 -2.026 0.730 0.350  
BMI  (kg/m2) -0.219 -2.281 -0.151 0.017  
HbA1c (%) -0.171 -0.119 0.008 0.062 0.137 
Fasting glucose (mmol/l) -0.229 -0.251 -0.026 0.014 0.068 
RHSC at the first GDM visit      
Metabolic health at 1-yr pp      
∆Weight retention (kg)1 0.078 -0.815 2.084 0.400  
BMI  (kg/m2) -0.090 -1.637 0.645 0.332  
HbA1c (%) 0.044 -0.048 0.086 0.634 0.327 
Fasting glucose (mmol/l) -0.104 -0.184 0.058 0.272 0.458 
IES-2 at 1-yr pp  (cross-sectional)         
EPR at 1-yr pp          
Metabolic health at 1-yr pp      
∆Weight retention (kg)1 -0.230 -2.976 -0.370 0.012  
BMI  (kg/m2) -0.337 -2.825 -0.829 <0.001  
HbA1c (%) -0.216 -0.129 -0.008 0.018 0.066 
Fasting glucose (mmol/l) -0.222 -0.236 -0.018 0.018 0.237 
RHSC at 1-yr pp      
Metabolic health at 1-yr pp      
∆Weight retention (kg)1 -0.193 -2.847 -0.083 0.037  
BMI  (kg/m2) -0.243 -2.469 -0.313 0.012  
HbA1c (%) -0.095 -0.098 0.032 0.311 0.547 
Fasting glucose (mmol/l) -0.194 -0.230 0.002 0.042 0.208 
1means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2) 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2)  
PP means postpartum  
P-valuea: adjusted for age and gestational age at the first GDM visit 
P-valueb: adjusted for age and gestational age and BMI at the first GDM visit  
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Fig 1. Flow chart describing how the study participants were selected. Removed participants did not 
meet the inclusion criteria (see methods section). 
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6. Glucose intolerance but no   
GDM (n= 1) 
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intervention group of an RCT 
(n=42) 
  
 
 
 
1. Known type 1 diabetes (n=2) 
2. Known type 2 diabetes (n = 6) 
3. GDM at ≤13 weeks (n=10) 
4. Diabetes at ≤20 weeks (n= 8) 
5. Normal HGPO results (n= 3) 
6. Glucose intolerance but    
GDM (n= 1) 
7. Participating in an active 
intervention group of an RCT 
(n=42) 
  
 
 
Included in final analyses  
(n = 117) 
 
Included in final analyses  
(n = 117) 
 I
d
en
ti
fi
ca
ti
o
n
 
  I
d
en
ti
fi
ca
ti
o
n
 
Consented cohort 
population (n = 333) 
 
Consented cohort 
population (n = 333) 
Removed those who did not 
come for 1-year postpartum 
visit (n = 144) 
 
Removed those who did not 
come for 1-year postpartum 
visit (n = 144) 
 150 
 
[Table 4] Associations between the two subscales of IES-2 at first GDM visit and at one-year postpartum visit with metabolic health at one year 
postpartum stratified by glucose tolerance   
 
 
Variable 
Prediabetes (n=54)  Normal (n=63) 
Regression 
coefficient 
 
95% CI 
 
P-valuea 
 
P-valueb 
Regression 
coefficient 
 
95% CI 
 
P-value 
IES-2 at first GDM visit 
(longitudinal)*     
       
EPR at the first GDM visit               
∆Weight retention (kg) 1 -0.098 -2.598 1.239 0.480  -0.052 -2.461 1.628 0.685 
BMI  (kg/m2) -0.169 -2.415 0.576 0.223  -0.214 -2.748 0.213 0.092 
HbA1c (%) -0.173 -0.158 0.036 0.211 0.189 -0.076 -0.095 0.051 0.553 
Fasting glucose (mmol/l) -0.437 -0.303 -0.063 0.001 0.004 -0.029 -0.106 0.084 0.820 
RHSC at the first GDM visit          
∆Weight retention (kg) 1 -0.090 -2.459 1.254 0.518  0.294 0.453 4.959 0.076 
BMI  (kg/m2) -0.075 -1.857 1.068 0.591  -0.082 -2.300 1.178 0.521 
HbA1c (%) 0.043 -0.080 0.109 0.760 0.751 0.060 -0.064 0.104 0.641 
Fasting glucose (mmol/l) -0.308 -0.247 -0.004 0.024 0.025 0.101 -0.066 0.152 0.432 
IES-2 at 1-year pp (cross-sectional)              
EPR at 1-yr pp              
∆Weight retention (kg)1 -0.288 -3.572 -0.142 0.034  -0.114 -3.111 1.184 0.373 
BMI  (kg/m2) -0.384 -3.248 -0.645 0.004  -0.180 -2.698 0.450 0.158 
HbA1c (%) -1.582 -0.159 0.019 0.120 0.125 -0.001 -0.077 0.077 0.995 
Fasting glucose (mmol/l) -0.204 -0.207 0.031 0.142 0.765 0.083 -0.067 0.132 0.515 
RHSC at 1-yr pp          
∆Weight retention (kg) 1 -0.394 -4.388 -0.935 0.003  -0.030 -2.361 1.861 0.814 
BMI  (kg/m2) -0.378 -3.376 -0.639 0.005  -0.047 -1.851 1.272 0.712 
HbA1c (%) -0.130 -0.139 0.050 0.349 0.253 0.157 -0.028 0.121 0.219 
Fasting glucose (mmol/l) -0.137 -0.190 0.065 0.329 0.842 -0.043 -0.114 0.082 0.740 
*for the fasting glucose, this corresponds to the time point of the GDM diagnosis before the first GDM visit .  
1means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2) 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2) 
P-valuea: Adjusted for age and gestational age at the first GDM visit 
P-valueb: Adjusted for age, gestational age and BMI at the first GDM visit  
PP means postpartum  
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[Table 5] Associations between the two subscales of IES-2 and metabolic health at one year postpartum stratified by BMI category 
Variable 
Obese/overweight (n=54)  Normal weight (n=63) 
Regression 
coefficient 
 
95% CI 
 
P-valuea 
 
P-valueb 
Regression 
coefficient 
 
95% CI 
  
P-value 
IES-2 at first GDM visit 
(longitudinal)*         
       
EPR at the first GDM visit              
∆Weight retention (kg) 1 -0.111 -3.466 1.475 0.422  0.026 -1.281 1.567 0.842 
BMI (kg/m2 ) -0.132 -1.779 0.643 0.351  -0.144 -1.183 0.304 0.241 
HbA1c (%) -0.195 -0.157 0.037 0.165 0.169 -0.076 -0.112 0.061 0.553 
Fasting glucose (mmol/l) -0.288 -0.337 0.003 0.041 0.043 -0.083 -0.191 0.098 0.522 
RHSC at  the first GDM visit          
∆Weight retention (kg) 1 0.176 -0.924 4.241 0.203  0.054 -1.188 1.819 0.676 
BMI (kg/m2 ) 0.213 -0.319 2.219 0.137  -0.073 -1.028 0.556 0.554 
HbA1c (%) -0.010 -0.108 0.101 0.967 0.963 0.194 -0.020 0.160 0.127 
Fasting glucose (mmol/l) -0.111 -0.260 0.111 0.419 0.424 0.039 -0.130 0.176 0.765 
IES-2 at 1-year pp (Cross-sectional)                 
EPR at 1-yr              
∆Weight retention (kg) 1 -0.347 -5.152 -0.562 0.009  0.006 -1.349 1.409 0.965 
BMI (kg/m2 ) -0.430 -2.873 -0.735 <0.001  -0.098 -1.019 0.442 0.432 
HbA1c (%) -0.177 -0.156 0.034 0.201 0.233 -0.155 -0.134 0.032 0.225 
Fasting glucose (mmol/l) -0.301 -0.345 -0.015 0.030 0.025 0.001 -0.140 0.140 0.997 
RHSC at 1-yr          
∆Weight retention (kg) 1 -0.405 -6.529 -1.494 0.002  0.077 -0.891 1.656 0.550 
BMI (kg/m2 ) -0.245 -2.467 -1.370 0.780  -0.120 -1.036 0.371 0.348 
HbA1c (%) -0.135 -0.162 0.055 0.329 0.299 0.074 -0.055 0.100 0.564 
Fasting glucose (mmol/l) -0.302 -0.395 -0.021 0.030 0.032 0.040 -0.110 0.151 0.755 
*for the fasting glucose, this corresponds to the time point of the GDM diagnosis before the first GDM visit  
1means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2) 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2) 
P-valuea: Adjusted for age and gestational age at the first GDM visit  
P-valueb: Adjusted for age, gestational age, and BMI at the first GDM visit 
PP means postpartum  
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Supplementary tables  
[Table 1] 1-year postpartum metabolic health indicators and IE scores according to glucose 
tolerance  
Variable  N Mean SD P-value* 
Weight at 1-year pp (kg)     
Normal  63 69.15 15.07 0.008 
Prediabetes  54 77.03 16.62 
 
∆Weight retention (kg)1     
Normal  63 1.96 7.22 0.026 
        Prediabetes 54 4.92 6.86  
BMI  (kg/m2)     
Normal  63 25.72 5.35 0.004 
Prediabetes 54 28.63 5.40  
HbA1c (%)     
Normal  63 5.14 0.25 <0.001 
Prediabetes 54 5.41 0.34 
 
Fasting glucose (mmol/l)     
Normal  63 5.10 0.33 <0.001 
Prediabetes 54 5.96 0.46  
EPR     
Normal  63 3.95 0.85 0.025 
Prediabetes 54 3.55 1.06  
RHSC     
Normal  63 3.53 0.87 0.171 
Prediabetes  54 3.29 1.01  
1means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
*P-value from ANOVA test  
GDM means gestational diabetes mellitus 
HbA1c means glycated hemoglobin 
BMI means body mass index  
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2) 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2) 
PP means postpartum  
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[Table 2] 1-year postpartum metabolic health indicators and IE scores according to weight 
status/category 
Variable  N Mean SD P-value* 
Weight at 1-year pp (kg)     
Normal 63 61.79 7.70 <0.001 
OW/OB 54 85.61 13.98  
∆Weight retention (kg)1     
Normal 63 2.13 4.78 0.053 
OW/OB 54 4.71 9.08  
BMI  (kg/m2)     
Normal 63 23.11 2.61 <0.001 
OW/OB 54 31.67 4.37  
HbA1c (%)     
Normal 63 5.21 0.29 0.042 
OW/OB 54 5.33 0.36  
Fasting glucose (mmol/l)     
Normal 63 5.34 0.48 0.002 
OW/OB 53 5.67 0.64  
EPR     
Normal 63 3.94 0.88 0.040 
OW/OB 54 3.57 1.04  
RHSC     
Normal 63 3.55 0.95 0.110 
OW/OB 54 3.27 0.91  
1means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
*P-value from ANOVA test  
GDM means gestational diabetes mellitus 
HbA1c means glycated hemoglobin 
BMI means body mass index  
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2) 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2) 
PP means postpartum  
OW/OB means Overweight/Obese 
 
 
 
 
[Table 3] Paired t-test and correlation between the two scales of IES-2 at the first GDM visit 
and at 1-year postpartum (N=117) 
Variable  Mean SD P-value (t-test) r. P-value (r) 
EPR at the first GDM visit  3.86 0.94 0.862 0.422 <0.001 
EPR at 1-yr pp 3.76 0.97    
RHSC at the first GDM visit  3.53 0.89 0.995 0.320 <0.001 
RHSC at 1-yr pp 3.42 0.94    
EPR at the first GDM visit 3.86 0.94 <0.001 0.415 <0.001 
RHSC at the first GDM visit  3.42 0.89    
EPR at 1-yr pp 3.76 0.97 <0.001 0.510 <0.001 
RHSC at 1-yr pp 3.42 0.94    
EPR means Eating for Physical Rather than Emotional Reasons subscale of the Intuitive Eating scale2 (IES-2) 
RHSC means Reliance on Hunger and Satiety Cues subscale of the Intuitive Eating scale2 (IES-2) 
PP means postpartum  
r means correlation 
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Abstract 
Aims: We investigated the predictors and consequences of postpartum weight retention 
(PPWR) in the early and late postpartum period in women with gestational diabetes (GDM), to 
assist preventive strategies. Methods: 862 women with GDM were prospectively included 
between 2011 and 2019. We investigated PPWR at 6-8 weeks and 1-year postpartum. Potential 
predictors included gestational weight gain (GWG), weight, BMI, and glucose control 
parameters during and after pregnancy. Results: PPWR at 6-8 weeks and 1-year postpartum 
were 4.6±5.7kg and 4.0 ±7.4kg. At 6-8 weeks postpartum, women with PPWR had higher pre-
pregnancy weight, 7.5±0.2kg higher GWG and higher postpartum weight (all p≤0.02), without 
presenting metabolic differences. At 1-year postpartum, there were no differences in 
anthropometric parameters before and during pregnancy between women with or without 
PPWR, except for a 4±0.4kg higher GWG (p<0.001). However, women with PPWR had 
increased postpartum weight and BMI, higher fasting glucose and more pronounced increases 
in ∆fasting glucose and ∆HbA1c at 1-year (all p≤0.03). GWG predicted higher PPWR at both 
6-8 weeks and at 1-year PP (all p<0.001). Conclusion: Women with PPWR had increased 
anthropometric parameters and adverse metabolic consequences at 1-year postpartum. GWG 
was the most relevant predictor of PPWR.    
Keywords: Postpartum weight retention; Gestational diabetes mellitus; Gestational weight 
gain; Anthropometric; Metabolic consequences; Predictors
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1.0 Introduction  
Postpartum weight retention (PPWR) is the difference between pre-pregnancy weight and 
weight in the postpartum period (1). This includes the immediate PPWR at the early postpartum 
(6-8 weeks after birth), or a long-term PPWR at different stages in the postpartum period (such 
as at 6 months or at 12 months) (2). It is recommended for women to return to their pre-
pregnancy weight 12 months after childbirth in order to avoid any PPWR (3–5). Unfortunately, 
PPWR is frequent (3) and represents a significant public health concern (6,7) because, in the 
long term, PPWR leads to an upwards weight trajectory following childbirth (8–10). Modest 
PPWR increases the risk of obesity and higher PPWR leads to an increased risk of permanent 
obesity 5-10 years after birth (11). For any preventive efforts, it is important to understand the 
pattern of PPWR (3).   
In women with a history of gestational diabetes mellitus (GDM) (12), PPWR is associated with 
a higher risk of overweight/obesity (13), of prediabetes (14) and of recurrent GDM (4). Higher 
PPWR also augments the risk for future diabetes (15,16). In these women, weight changes in 
the postpartum period have been associated with higher risk of future diabetes (15–17). One 
study revealed that, in this population, PPWR of 4.5kg during a 7.5-year follow-up after 
pregnancy was independently associated with a twofold increase in the risk of future diabetes 
(18). In another study, 42% of women with PPWR developed diabetes after 23years of follow-
up, while the incidence of diabetes was almost half in the women without PPWR (19). These 
results show that PPWR is an independent risk factor of diabetes and its related morbidities in 
women with GDM. Reducing PPWR or weight loss is therefore recommended (13,14). For 
example, in a sample of 72 women, weight loss of ≥2 kg during the postpartum period led to a 
significant improvement in glucose control at 1-year postpartum period (17).  
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In the general population, the most important predictors of PPWR are higher pre-pregnancy 
body mass index (BMI) and excessive gestational weight gain (GWG) (20,21). Other studies 
have also associated diet, physical activity, age, marital status, and ethnicity with PPWR (22–
24). We are only aware of one small study (n=75) that investigated predictors of weight loss or 
no PPWR in women with GDM exclusively in the early postpartum period (25). In that study, 
less GWG and no insulin use during pregnancy predicted a loss of at least 75% of GWG. 
However, it is not clear if those factors are also predictors of the recommended lack of PPWR 
(i.e., no weight increase at all compared to the pre-pregnancy weight). To our knowledge, no 
previous study has investigated the differences between women with and without PPWR, the 
metabolic consequences and the predictors of PPWR in the early and late postpartum period in 
women with GDM. This can help to focus efforts and target optimal timing to reduce long-term 
complications of GDM. We therefore conducted this study to determine the anthropometric 
characteristics and differences between women with and without PPWR and the adverse 
metabolic consequences of PPWR in the early and late postpartum period in a cohort of women 
with GDM. This prospective cohort study also aimed to identify the predictors associated with 
PPWR in the early and late postpartum period.   
2.0 Methods 
2.1 Study design and patient population  
This is a prospective observational clinical cohort of women with GDM followed in the 
Diabetes and Pregnancy Unit at the Lausanne University Hospital (CHUV) between 2011-2019 
(26–28). Pregnant women diagnosed with GDM between 24-32 weeks of gestation according 
to the American Diabetes Association (ADA) and the International Association of the Diabetes 
and Pregnancy Study Groups (IADPSG) guidelines (29,30) were invited to participate.  
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The Human Research Ethics Committee of the Canton de Vaud (326/15) approved the study 
protocol. All participating women signed an informed consent. The total cohort population 
consisted of 1039 women who understood French and English and consented to participate. We 
first excluded those with known type 1 diabetes (N=13), type 2 diabetes (N=18), newly 
diagnosed diabetes in pregnancy (N=9), glucose intolerance but no GDM (N=2), those with 
normal oral glucose tolerance test (oGTT) results (N=8), with GDM diagnosed at ≤13 weeks 
(N=13), and those participating in an active lifestyle intervention study (N=53). We then 
excluded those who did not attend the 6-8 weeks postpartum visit (N=61). Following this, 862 
women were eligible and were included in our final analysis. Figure 1 shows the details of the 
participants’ selection. Of these 862 women, all of them had completed the 6-8 weeks pp visit, 
whereas 259 (30%) had completed the 1-year postpartum visit at the time of this analysis. The 
main reason for the low numbers of patients at 1-year postpartum visit is that the 
implementation of the 1-year postpartum follow-up visit started in August 2015. 
2.2 Measures 
2.2.1 Socio-demographic characteristics  
During the first GDM visit, information on participants’ characteristics including age, 
educational level, and ethnic origin, family history of type-2 diabetes, history of previous GDM, 
parity, gravida, and smoking during pregnancy were obtained during a structured face-to-face 
interview. We categorized educational level into “no formal education; compulsory school 
achieved; general and vocational training levels; high school and university education” (27,28). 
Information on partner support was obtained during the face-to-face interview and was 
categorized as either “living with a partner or not”. We categorized family history of type-2 
diabetes, as either “first-degree, second degree or none” whereas previous history of GDM and 
smoking during pregnancy were categorized as either ‘yes’ or ‘no’.  
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We grouped parity into “none, one, two and ≥ three” whereas gravida consisted of “one, two or 
three” (see Table 1 for more details).     
2.2.2 Anthropometric and other health variables  
Pre-pregnancy weight was taken from participants’ medical charts or, if missing, was self-
reported (for the 1-2 months before pregnancy). We measured weight at the first GDM visit, at 
the end of pregnancy, at 6-8 weeks and at 1-year postpartum to the nearest 0.1 kg in women 
wearing light clothes and no shoes with a regularly calibrated electronic scale (Seca®). We 
measured height at the first GDM visit to the nearest 0.1 cm with a regularly calibrated Seca® 
height scale. GWG was defined as the difference between pre-pregnancy weight and weight at 
the end of pregnancy. We calculated the body mass index (BMI) as the ratio of weight in 
kilograms to the square of height in meters (kg/m2). Based on the pre-pregnancy BMI and 
GWG, women were classified as being below (inadequate), within (adequate) or above 
(excessive) the Institute of Medicine (IOM) GWG recommendations (31). PPWR was the 
outcome variable for our main analyses. We calculated PPWR by either subtracting the pre-
pregnancy weight from the weight at 6-8 weeks postpartum (early PPWR) and from the weight 
at 1-year postpartum (late PPWR). Information on GDM treatment during pregnancy (use of 
insulin and/or metformin; yes/no) and caesarean section (yes/no) were obtained from medical 
charts. In the routine clinical visit at 6-8 weeks postpartum, information about breastfeeding 
(yes/no) and contraception use (yes/no) at this time point were obtained. During the first GDM 
visit (at 24-32 weeks), women completed the Edinburgh Postnatal Depression Scale (EPDS) 
questionnaire. This is a ten-item self-report questionnaire designed and validated to screen 
women for symptoms of depression during pregnancy and in the postnatal period (32). The 
possible scores of the EPDS questionnaire range from 0 to 30 points, with a higher total score 
indicating more severe depressive symptoms.  
 
 160 
 
2.2.3 Metabolic health variables  
All women involved in this study were diagnosed with GDM during pregnancy (at 24-32 weeks 
of gestational age) if one of the following criteria were met during a 75g oGTT: fasting venous 
glucose ≥5.1 mmol/L, 1-hr glucose ≥10.0 mmol/L, or 2-hr glucose ≥8.5 mmol/L, using the 
IAPDSG guidelines (29,30). At 6-8 weeks postpartum visit, another oGTT was performed to 
measure fasting glucose, 2-hr glucose and HbA1c using a High Performance Liquid 
Chromatography method (HPLC). At the 1-year postpartum visit, women had a fasting venous 
glucose and HbA1c measured using a High Performance Liquid Chromatography method 
(HPLC) (33). Both methods are traceable to the International Federation of Clinical Chemistry 
and Laboratory Medicine (IFCC) Reference Method for the Measurement of HbA1c (33).  
2.3 Statistical analysis  
We performed all statistical analyses with the SPSS software version 26 (34). Demographic and 
other descriptive variables are presented as either means (±standard deviation) or in percentages 
(%), where appropriate (Table 1 and 2). PPWR variable and all outcome parameters described 
in Table 2 were normally distributed. We categorized this continuous variable (PPWR) into two 
groups: either no PPWR when the difference between a participant’s weight before pregnancy 
and weight at the postpartum period (either 6-8 weeks or 1-year visit) was ≤0kg and into PPWR 
if the difference is ≥0.1kg.  
We performed an ANOVA analysis to compare the anthropometric and metabolic 
characteristics (independent continuous variables) of participants according to no PPWR and 
PPWR (at 6-8 weeks and at 1-year postpartum) (Table 3a and 3b). In order to determine the 
predictors of PPWR at 6-8 weeks and at 1-year postpartum (outcome variable), we first 
conducted a univariate logistic regression analysis. We selected potential predictors tested in 
the univariate regression analyses based on the existing literature.  
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These variables were; age, educational level, nationality, history of GDM, family history of 
diabetes, parity, gravida, delivery by caesarean section, partner support, GDM treatment, 
contraception use, breastfeeding and depression score at the first GDM visit, pre-pregnancy 
weight, fasting, 1hr and 2hr glucose after oGTT at GDM diagnosis, total GWG, excess GWG 
according to IOM guidelines (31), fasting glucose, 2hr glucose after oGTT and HbA1c, all at 
6-8 weeks postpartum. We then modeled the odds of PPWR (at the 6-8 weeks and 1-year 
postpartum visits) using multivariable logistic regression models with backward elimination by 
including variables with p<0.25 in the univariate regression analysis. Based on this, the 
following predictor variables were included in the 6-8 weeks postpartum model (Table 4a): 
family history of diabetes, partner support, breastfeeding and depression score at the first GDM 
visit, pre-pregnancy weight, 2hr glucose after oGTT at GDM diagnosis, total GWG, and excess 
GWG according to IOM guidelines. The following predictor variables were included in the 1-
year postpartum model (Table 4b): age, family history of diabetes, partner support, depression 
score at the first GDM visit, total GWG, excess GWG, and HbA1c at 6-8 weeks postpartum 
visit. For the 1-year postpartum analysis, we made use of two models; one in parallel to the 
model performed at 6-8 weeks postpartum and thus without any variable obtained after delivery 
i.e., without HbA1c at 6-8 weeks pp (model 1) and one including significant variables after 
delivery, i.e. HbA1c at 6-8 weeks postpartum (model 2).  
We then performed a multivariate logistic regression analysis with backward elimination and 
selected the regression model with the lowest Akaike information criterion (AIC) as our final 
model for both time points (25). We tested for collinearity of the included predictor variables, 
and none displayed excessive collinearity. The variance inflation factor (VIF) in the regression 
models were less than 2 (between 1.0-1.4), and thus acceptable. All statistical significances 
were two sided and accepted at p< 0.05.   
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3.0 Results  
Table 1 shows the socio-demographic characteristics of the 862 study participants. Their mean 
maternal age and gestational age at delivery were 33.0±5.7years and 38.4±3.2weeks 
respectively. The majority of the study participants had a vocational or university education 
(68%), 28% were Swiss and 33% were Europeans or from North America (33%).  In addition, 
44% of the women were nulliparous. Overall, only 6% of the women had a previous history of 
GDM (11.6% of those were multiparous), whereas 50% had a family history of diabetes. Table 
2 shows the anthropometric and metabolic characteristics of the study participants. The mean 
pre-pregnancy BMI was 25.6±5.4kg/m2 and the total GWG was 12.7±5.9kg. The mean PPWR 
at 6-8 weeks and at 1-year postpartum were 4.6±5.7kg and 4.0±7.4kg respectively. In the 
subgroup of women with 1-year data, the mean fasting glucose increased by 0.48±0.2mmol/l 
between 6-8 weeks and 1-year postpartum, while the mean HbA1c decreased by 0.03±0.01%. 
Table 3a summarizes the participants’ anthropometric differences and metabolic consequences 
according to PPWR categories at 6-8 weeks postpartum. At this time point, 81% of women had 
PPWR. Women with PPWR had significant higher anthropometric parameters before, during 
and after pregnancy (early postpartum period) compared to those with no PPWR.  
Specifically, they had a 4±3.7kg higher pre-pregnancy weight, a higher pre-pregnancy BMI, a 
7.5±0.2kg higher total GWG and a 0.23 ±0.1kg higher excess GWG, a higher weight at GDM 
diagnosis and at the end of pregnancy, as well as a 12±2.0kg higher weight at 6-8 weeks 
postpartum (all p≤0.02). In addition, the 2hr glucose after oGTT at GDM diagnosis was slightly 
higher (p=0.034). However, there were no differences in the metabolic parameters (fasting and 
2h glucose, HbA1c) between both groups at the early postpartum period (all p=ns). Table 3b 
summarizes the participants’ anthropometric differences and metabolic consequences 
according to PPWR categories at 1-year postpartum in the subgroup of patients (n=259/862; 
30%) who had attended the 1-year postpartum visit.  
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At 1-year postpartum, 66.4% of women had PPWR. Compared to those with no PPWR, women 
with PPWR had no differences in anthropometric parameters before and during pregnancy, but 
had a 4±0.4kg higher total GWG, a higher BMI at 6-8 weeks and at 1-year postpartum, and 
were 7±4.2kg heavier at 1-year postpartum (all p≤0.04). Women with no PPWR, on the other 
hand, had a minimal increase in excess GWG of 0.2 ±0.03kg (p<0.001). In the group of women 
with PPWR, weight did not decrease between the early and late postpartum period. The 
metabolic consequences at 1-year postpartum period showed a 0.2±0.2 mmol/l higher fasting 
glucose in women with PPWR compared to those without PPWR, and a more pronounced 
increase in fasting glucose and in HbA1c between the early and late postpartum period (both 
p≤0.03). We also evaluated the differences in metabolic and medical characteristics at 6-8 
weeks postpartum in the 259 women with complete 1-year data (supplementary Table 1). The 
results were similar to those in Table 3a.  
3.1 Predictors of postpartum weight retention  
In the multivariate logistic regression analysis (Tables 4a and 4b), higher pre-pregnancy weight 
and total GWG predicted higher risk of PPWR at 6-8 weeks postpartum (OR: 1.1, 95% CI: 
1.03-1.15) and (OR: 1.6, 95% CI: 1.32-1.91), respectively).  
Higher total GWG also predicted higher risk of PPWR at 1-year postpartum (OR: 1.15, 95% 
CI: 1.07-1.23; model 1). This prospective association remained significant in model 2 (OR: 1.2, 
95% CI: 1.07-1.24) when HbA1c at 6-8 weeks postpartum was included as potential predictor. 
In model 2, higher HbA1c at 6-8 weeks postpartum (OR: 0.16, 95% CI: 0.05-0.49) was 
associated with less PPWR at 1-year postpartum. 
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4.0 Discussion  
In this clinical cohort of women with GDM, we found that women with and without PPWR at 
6-8 weeks postpartum differed significantly in anthropometric characteristics (weight, BMI, 
GWG) before, during and after pregnancy. At this time point, there were no differences 
regarding metabolic consequences between both groups. On the other hand, women with and 
without PPWR at 1-year postpartum did not differ significantly in weight or BMI before or 
during pregnancy, except for less pronounced differences in GWG. However, they differed in 
anthropometric characteristics in both the early (BMI) and late (weight, BMI) postpartum 
period. Regarding adverse metabolic consequences, women with late PPWR had higher fasting 
glucose and more pronounced increases in both fasting glucose and HbA1c between the early 
and late postpartum period than those without PPWR. Although excessive GWG beyond the 
IOM guidelines was less than 2kg, total GWG was the most important predictor of PPWR, both 
in the early and late postpartum period. Although women are advised to return to their pre-
pregnancy weight after delivery, a significant proportion of pregnant women are unable to meet 
this recommendation (25,35). At 6-8 weeks postpartum for example, women with or without 
GDM retain an average of 3–7kg of GWG, and at least two-thirds of women will still be above 
their pre-pregnancy weight at 1-year postpartum (7,25). Our results are in accordance with the 
literature: mean PPWR at 6-8 weeks postpartum was 4.6±5.7kg and 4.0±7.4kg at 1-year 
postpartum and two-third (66%) of the women had PPWR at 1-year.  
Given that PPWR is predictive of adverse long-term cardio-metabolic outcomes (17) in women 
with GDM (36,37), it is important to study the pattern of PPWR in order to develop 
prevention/intervention strategies and to define their optimal timing. To fill this gap, we 
conducted this study to determine the anthropometric differences and metabolic consequences 
of PPWR and the predictors of PPWR in the early and late postpartum period in a clinical cohort 
of women with GDM.  
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According to our results, women with PPWR in the early postpartum period differed in BMI 
and weight before, during, and after pregnancy and in GWG, whereas those with PPWR at 1-
year postpartum differed in GWG and especially in BMI and/or weight during the postpartum 
period. In women with PPWR, we found that differences in GWG in the late postpartum period 
were about half of those observed in the early postpartum period. Importantly, women with 
PPWR in the late postpartum period had small and non-significant weight differences compared 
to their counterparts in the early postpartum period, but they did not continue to lose weight up 
to 1-year postpartum. 
Several reasons could account for the differences in the anthropometric characteristics observed 
in women with PPWR. Excess adipose tissue due to sub-optimal diet and physical activity 
behaviors before/during pregnancy leads to excess weight gain that extends into the postpartum 
period, leading to an increased risk of obesity in the late postpartum period (38–40). Studies 
have also shown that women who breastfeed several months after delivery have lower PPWR 
due to the energy cost of producing breast milk (41). Hence, breastfeeding may potentially have 
an impact or at least represent a marker for beneficial lifestyle behavior in our cohort. In our 
cohort, 85% of women who were still breastfeeding at 6-8 weeks postpartum had no PPWR at 
the late postpartum period. Depressive symptoms and lower/short sleep duration could also 
reduce weight loss in the postpartum period by influencing energy expenditure and appetite 
regulation (42).  
Our results are consistent with those of other studies conducted in non-GDM populations which 
showed that, women with PPWR had a higher GWG, leading to higher weight status in the late 
postpartum period (43–45). Regarding adverse metabolic consequences, differences between 
women with and without PPWR were seen at 1-year postpartum only. At 1-year postpartum, 
women with PPWR had higher fasting glucose values and more pronounced increases in 
metabolic parameters (increases in ∆fasting glucose and ∆HbA1c) than their counterparts did.  
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This finding suggests that late PPWR had an impact on glucose control at 1-year postpartum, 
which might not reveal itself yet in the early postpartum period. It is thus essential to focus on 
prevention of PPWR at 1-year postpartum, which actually concerns two thirds of women in this 
cohort and previous ones. A lack of PPWR or of metabolic complications at 6-8weeks 
postpartum, although reassuring, should not lead to complacency. This is especially important, 
as only a minority continues to lose weight after the early postpartum period and those with 
PPWR at 1-year demonstrated a small weight gain, between the early and late postpartum 
period. The findings of one previous study parallels our results (17): it demonstrated that weight 
gain in the 1-year postpartum was associated with a significant increase in fasting and 2-h 
glucose in women with GDM.  
The link between PPWR and deteriorations in glucose control is mediated by the lack of further, 
more pronounced, weight loss during the later postpartum period (38). Lack of sleep in the 
postpartum period also increases insulin resistance in women with PPWR by impacting on 
metabolic pathways (42). Our data showed that clinical care beyond a pure screening with a 
focus on metabolic health should be essential in the late postpartum. Importantly, even women 
without PPWR had a significant (p<0.001) increase in fasting glucose between the early and 
late postpartum period, despite almost a 3kg weight loss.  
These findings suggest the need to extend the postpartum follow-up period from 6-8 weeks to 
at least 1-year with special focus on metabolic health.   
In women with GDM, a previous study (25) demonstrated that less GWG, increasing age, and 
lack of insulin use during pregnancy were associated with losing ≥75% of pregnancy weight at 
6-8 weeks postpartum. In our study, GWG was associated with PPWR, but found no association 
with age or insulin use. In non-GDM populations, many studies support GWG as a strong and 
pronounced predictor of PPWR at 6 weeks (46) and up to 12 months postpartum, as found in 
our study (47–50).  
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Other studies indicate that exceeding IOM guidelines according to pre-pregnancy BMI 
increases the risk of PPWR at 6 to 18 months (51–53). To our knowledge, these latter studies 
only investigated excessive GWG without including total or absolute GWG. In our study 
however, exceeding IOM guidelines (=excessive GWG) was not associated with PPWR beyond 
the impact of total GWG. Total GWG was the most important predictor of PPWR in our cohort, 
although excess GWG beyond the IOM guidelines was less than 2kg, even in women with 
PPWR. These data suggest that, at least regarding postpartum weight and metabolic health, the 
currently existing IOM guidelines for GWG are too indulgent for a multicultural population 
with GDM and should be refined for these women. Other potential predictors of PPWR, such 
as sociodemographic characteristics, physical activity, eating behavior (intuitive eating) 
exclusive breastfeeding, and depression scores during and after pregnancy were not 
significantly associated with PPWR in our study in contrast to some studies in non-GDM 
populations (44,54,55).  
This study has several strengths. This is the first study to investigate the anthropometric 
differences and metabolic consequences in women with and without PPWR in both the early 
and late postpartum period in a large clinical cohort of women with GDM. We also identified 
the most essential role of GWG on PPWR in these women. This study seems to be the first to 
investigate both total GWG and excess GWG based on IOM guidelines on PPWR, as most 
studies focus exclusively on excess GWG. Excess GWG is based on guidelines that may be 
subject to change. Indeed, in our cohort, total GWG has shown to have a more important role 
than excess GWG. One of the limitations of this study is that, the associations found in this 
study may be correlational and not necessarily causal, despite its prospective design. We 
obtained weight before pregnancy from patients’ medical chart when available; otherwise, we 
relied on self-reported pre-pregnancy weight.  
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However, there was a strong correlation between clinically measured weight during and after 
pregnancy with self-reported pre-pregnancy weight. Other factors, such as the intention to lose 
weight in the postpartum period and a variety of other variables, including sleep in the 
postpartum period, which were not investigated in this study, may have influenced these 
associations.  
5.0 Conclusion 
In this prospective clinical cohort of women with GDM, 81% had PPWR at 6-8 weeks 
postpartum, whereas two-third had PPWR at 1-year postpartum. Women with PPWR in the 
early postpartum period showed significant differences in anthropometric characteristics 
(weight, BMI, GWG) before, during and after pregnancy, while those in the late postpartum 
period showed mainly differences in the postpartum. Importantly, adverse metabolic 
consequences between women with and without PPWR were only seen in the late postpartum 
period. Regarding predictors of PPWR, total GWG was the most important predictor of PPWR, 
beyond the impact of excess GWG, which was rather small. These results suggest that currently 
existing IOM guidelines for (excess) GWG maybe too relaxed concerning postpartum weight 
and metabolic health in these women. Our data regarding PPWR and metabolic health suggest 
that beyond the recommended postpartum screenings, there is a need for a continuous follow-
up of women with GDM, focusing specifically on weight and glucose control.  
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STUDY 3 Tables and captions  
Table 1: Socio-demographic characteristics of study participants (N=862) 
Variable  Frequency (n) Percent (%) 
Age (years) mean ±SD 33.00 5.71 
Gestational age at delivery (weeks) mean ±SD 38.43 3.23 
Education level* (N=488)   
No formal education 3 0.8 
Compulsory school achieved 69 18.4 
High school 47 12.6 
General and vocational education 85 22.7 
University 170 45.5 
Nationality    
Switzerland 247 28.7 
Europe + North America 285 33.1 
Africa 143 16.6 
Asia + western pacific 116 13.5 
Latin America 39 4.5 
Others  32 3.7 
Employment status    
Student 23 2.7 
Professional worker 388 45.0 
Housewives/unemployed 451 52.3 
Smoking during pregnancy   
Yes 132 15.3 
No 730 84.7 
Previous history of GDM1    
No 807 93.6 
Yes 55 6.4 
Family history of diabetes2    
First degree 272 31.5 
Second degree 160 18.6 
No 430 49.9 
Parity  (N=842)   
0 375 44.5 
1 283 33.6 
2 119 14.1 
≥3 65 7.7 
Gravida (N=842)   
1 257 30.5 
2 247 29.3 
3 338 40.1 
*488 participants had missing data on education 
1GDM means gestational diabetes mellitus (11.6 % of women who were multiparous had previous history of GDM) 
2First degree means 1 degree of relationship of the participant (at least 50% of genetic link, which included mother, father, 
brother, sister, daughter, son). Second degree means 2nd degree of kinship of the participant (at least 25% of genetic link that 
included grandparents, grandchildren, nephews, niece, half-brother, half-sister) 
All results are frequency and percentage unless otherwise stated 
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Table 2: Anthropometric and metabolic characteristics of study participants   
Variable  Mean SD 
Pre-pregnancy weight (Kg) 69.09 15.38 
Pre-pregnancy BMI (Kg/m2)1 25.62 5.45 
Weight at the first GDM visit (Kg) 79.53 15.36 
BMI at the first GDM visit (Kg/m2)  29.72 5.41 
Fasting glucose at the first GDM visit (mmol/l) 5.15 0.75 
1hr glucose after oGTT at GDM diagnosis (mmol/l) 9.63 1.85 
2hr glucose after oGTT at GDM diagnosis (mmol/l) 7.85 1.83 
HbA1c at the first GDM visit (%) 5.44 0.41 
Weight at the end of pregnancy (Kg) 81.86 15.42 
Total gestational weight gain (Kg) 12.75 5.96 
Weight at the 6-8 weeks pp (Kg) 73.58 15.05 
BMI at the 6-8 weeks pp (Kg/m2) 27.54 5.35 
Fasting glucose at the 6-8 weeks pp (mmol/l)  5.00 0.52 
2hr glucose after oGTT at 6-8 weeks pp (mmol/l) 5.50 1.68 
HbA1c at the 6-8 weeks pp (%) 5.35 0.38 
Weight at 1-year pp (Kg) 73.49 17.15 
BMI at 1-year pp (Kg/m2) 27.41 6.30 
Fasting glucose at 1-year pp (mmol/l) 5.48 0.67 
HbA1c at 1-year pp (%) 5.32 0.39 
Weight retention at 6-8 weeks pp2 4.61 5.79 
Weight retention at 1-year pp3 3.99 7.36 
1Data taken from the medical charts or reported at the first GDM visit   
2Weight retention means the difference in weight at 6-8 weeks postpartum and pre-pregnancy weight 
3Weight retention means the difference in weight at 1-year postpartum and pre-pregnancy weight 
BMI means body mass index  
GDM means gestational diabetes mellitus 
oGTT means oral glucose tolerance test  
HbA1c means glycated hemoglobin 
pp means postpartum period 
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Table 3: Anthropometric differences and metabolic consequences of participants according to 
postpartum weight retention categories 
3a: At 6-8 weeks postpartum 
 6-8 weeks postpartum Weight retention category at 6-8 weeks PP (n=862)1 
 
Weight retention 
(n=700) 
No weight retention 
(n=162)  
Variable  Mean SD Mean SD p value 
Age (years) 33.39 5.43 32.91 5.77 0.340 
Gestational age at delivery (weeks) 38.68 1.49 38.38 3.52 0.283 
Pre-pregnancy weight (Kg) 70.49 17.51 66.76 13.81 <0.001 
Pre-pregnancy BMI (Kg/m2)2 26.35 6.26 24.75 4.86 <0.001 
Weight at the first GDM visit (Kg) 80.93 16.96 71.45 14.76 <0.001 
Fasting glucose at first GDM visit (mmol/l) 5.16 0.65 5.15 0.77 0.843 
1hr glucose after oGTT at GDM diagnosis (mmol/l) 9.70 1.70 9.62 1.88 0.658 
2hr glucose after oGTT at GDM diagnosis (mmol/l) 8.18 1.70 7.78 1.85 0.034 
Weight at the end of pregnancy (Kg) 84.63 16.66 73.58 14.23 0.015 
Total gestational weight gain (Kg) 14.16 5.14 6.63 5.36 <0.001 
Excess gestational weight gain (Kg) 1.73 0.44 1.50 0.50 <0.001 
Weight at 6-8 weeks pp (Kg) 75.40 16.66 63.14 14.62 0.002 
BMI at 6-8 weeks pp (Kg/m2) 27.10 5.91 23.40 5.19 0.020 
Fasting glucose at 6-8 weeks pp (mmol/l)  4.99 0.50 5.01 0.52 0.643 
2hr glucose after oGTT at 6-8 weeks pp (mmol/l) 5.37 1.57 5.53 1.70 0.269 
HbA1c at 6-8 weeks pp (%) 5.32 0.40 5.35 0.37 0.357 
1Weight retention means the difference in weight at 6-8 weeks and pre-pregnancy weight 
2Data reported at the first GDM visit or taken from the medical charts 
GDM means gestational diabetes mellitus 
BMI means body mass index  
oGTT means oral glucose tolerance test  
HbA1c means glycated hemoglobin 
pp means postpartum period 
P value derived from ANOVA for continuous variables  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 180 
 
 
3b: At 1-year postpartum  
 1-year postpartum  Weight retention category at 1-year PP (n=259)1 
 
Weight retention 
(n=172) 
No weight 
retention  (n=87)  
Variable  Mean SD Mean SD p value 
Age (years) 32.93 5.86 34.00 4.74 0.147 
Gestational age at delivery (weeks) 38.78 1.71 38.82 1.86 0.888 
Pre-pregnancy weight (Kg) 68.78 15.42 69.97 14.10 0.564 
Pre-pregnancy BMI (Kg/m2)2 25.81 5.67 25.62 5.18 0.792 
Weight at the first GDM visit (Kg) 80.28 15.97 78.58 13.48 0.427 
Fasting glucose at first GDM visit (mmol/l) 5.24 1.00 5.11 0.77 0.328 
1hr glucose after oGTT at GDM diagnosis (mmol/l) 9.68 2.00 9.61 1.96 0.817 
2hr glucose after oGTT at GDM diagnosis (mmol/l) 7.85 2.02 7.99 1.85 0.651 
Weight at the end of pregnancy (Kg) 82.82 15.47 80.02 13.60 0.188 
Total gestational weight gain (Kg) 14.16 6.15 10.08 5.76 <0.001 
Excess gestational weight gain (Kg) 1.44 0.49 1.68 0.46 <0.001 
Weight at 6-8 weeks pp (Kg) 74.88 14.92 71.96 13.01 0.121 
BMI at 6-8 weeks pp (Kg/m2) 28.08 5.36 26.66 4.66 0.044 
Fasting glucose at 6-8 weeks pp (mmol/l)  5.00 0.518 4.97 0.45 0.618 
2hr glucose after oGTT at 6-8 weeks pp (mmol/l) 5.26 1.42 5.22 1.63 0.841 
HbA1c at 6-8 weeks pp (%) 5.27 0.36 5.40 0.34 0.009 
Weight at 1-year pp (Kg) 75.79 18.08 68.67 13.92 0.002 
BMI at 1-year pp (Kg/m2) 28.42 6.55 25.05 4.93 <0.001 
Fasting glucose at 1-year pp (mmol/l) 5.55 0.72 5.35 0.55 0.026 
HbA1c at 1-year pp (%) 5.33 0.42 5.31 0.33 0.739 
∆Fasting glucose3 0.54 0.61 0.37 0.54 0.032 
∆HbA1c3 0.05 0.39 -0.08 0.37 0.006 
1Weight retention means the difference in weight at 6-8 weeks and pre-pregnancy weight 
2Data reported at the first GDM visit or taken from the medical charts 
3Change in metabolic variables (fasting glucose and HbA1c) between 6-8 weeks and 1-year pp  
GDM means gestational diabetes mellitus 
BMI means body mass index  
oGTT means oral glucose tolerance test  
HbA1c means glycated hemoglobin 
pp means postpartum period 
P value derived from ANOVA for continuous variables  
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Table 4: Predictors of weight retention 
4a: Predictors at 6-8 weeks postpartum  
Variable  OR 95% CI P value* 
Pre-pregnancy weight (Kg) 1.09 1.035 1.150 <0.001 
Total gestational weight gain (Kg) 1.59 1.324 1.919 <0.001 
Excess gestational weight gain (Kg) 4.08 0.857 19.466 0.077 
Weight retention means the difference in weight at 6-8 weeks postpartum and pre-pregnancy weight 
* P value from the final model of the multivariable logistic regression with backward elimination   
 
 
 
4b: Predictors at 1-year postpartum  
 Model 1 Model 2 
Variable  OR 95% CI P value* OR 95% CI P value* 
Total Gestational weight gain (kg) 1.15 1.072 1.231  <0.001 1.15 1.076  1.245 <0.001 
HbA1c at 6-8 weeks pp (%)     0.16 0.052 0.490 <0.001 
pp means postpartum period 
Weight retention means the difference in weight at 1-yr postpartum and pre-pregnancy weight 
Model 1: included HbA1c at 6-8 weeks pp 
Model 2: without HbA1c at 6-8 weeks pp 
* P value from the final model of the logistic regression with backward elimination 
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Fig 1. Flow chart describing the selection of study participants  
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2. Known type 2 diabetes (n = 18) 
3. Newly diagnosed diabetes (n= 9) 
4. Glucose intolerance but no GDM 
(n= 2) 
5. Normal oGTT results (n= 8) 
6. GDM at ≤13 weeks (n=13) 
7. Participating in an active 
intervention group of an RCT (n=53) 
Included in final analyses  
(n = 862) 
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Excluded (n=61):  
Did not attend 6-8 weeks visit  
 
 
 
Excluded (n=61):  
Did not attend 6-8 weeks visit  
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[Supplementary tables] 
 
Table 1: Anthropometric differences and metabolic consequences of participants with 1-year 
data at the 6-8 weeks postpartum  
 6-8 weeks postpartum* Weight retention at 1-year  (n=259)1 
 
 Weight retention  
(n=201) 
 No Weight 
retention  (n=58) 
p 
value  
Variable  Mean SD Mean SD  
Age (years) 33.33 5.42 33.27 5.42 0.937 
Gestational age at delivery (weeks) 39.03 1.85 38.72 1.85 0.238 
Pre-pregnancy weight (Kg)2 72.83 12.19 65.69 12.19 <0.001 
Pre-pregnancy BMI (Kg/m2)3 27.15 4.38 24.47 4.38 <0.001 
Weight at first GDM visit (Kg) 78.06 13.95 69.87 13.95 <0.001 
Fasting glucose at first GDM visit (mmol/l) 5.25 0.96 5.18 0.96 0.631 
1hr glucose at GDM diagnosis (mmol/l) 9.84 2.02 9.61 2.02 0.527 
2hr glucose at GDM diagnosis (mmol/l) 8.13 1.99 7.83 1.99 0.394 
HbA1c at first GDM visit (%) 5.50 0.41 5.39 0.41 0.079 
End of pregnancy weight (Kg) 86.33 13.83 71.61 13.83 0.014 
Gestational weight gain (Kg) 14.54 5.26 6.72 5.26 <0.001 
Excess  gestational weight (Kg) 1.68 0.50 1.47 0.50 0.004 
Weight at 6-8 weeks pp (Kg)4 77.58 13.39 63.84 13.39 0.026 
BMI at 6-8 weeks pp (Kg/m2) 28.04 4.72 24.21 4.72 0.019 
Fasting glucose at 6-8 weeks pp (mmol/l)  4.92 0.50 5.01 0.50 0.253 
2hr glucose at 6-8 weeks pp (mmol/l) 5.04 1.47 5.30 1.47 0.242 
HbA1c at 6-8 weeks pp (%) 5.34 0.35 5.30 0.35 0.450 
*Data at 6-8 weeks are shown for the subgroup of participants who have valid data at 1 year postpartum  
1Weight retention means the difference in weight at 6-8 weeks and pre-pregnancy weight 
2Data reported at the first GDM visit or taken from the medical charts 
GDM means gestational diabetes mellitus 
BMI means body mass index  
oGTT means oral glucose tolerance test  
HbA1c means glycated hemoglobin 
pp means postpartum period 
P-value derived from ANOVA  
 
 
 
 
 
